The synthesis and reactions of deoxyvasicinone and analogous compounds by Kinnear, Kenneth
THE SYNTHESIS AND REACTIONS OF
DEOXYVASICINONE AND ANALOGOUS COMPOUNDS
A THESIS SUBMITTED BY
Kenneth I. Kinnear B.Sc.(Hons)
in partial fulfilment of the requirements 
of The Council for National Academic Awards 
for the award of
DOCTOR OF PHILOSOPHY 
Dundee College of Technology
MARCH 1 9 8 6
D E C L A R A T I O N
I hereby declare that the work presented in this 
thesis was carried out by me at Dundee College of 
Technology, Dundee, except where due acknowledgement 
is made, and has not been submitted by me for any 
other Degree.
Signed
Date
INDEX
Page No
•T
INTRODUCTION
Introduction 1
Nomenclature 4
Pharmacological activity. 6
Synthesis of Pyrro1o[2,1-b]quinazo1inones. 10
Nitroalkanoic Acid Esters. 26
2-Pyrro1idinones. 29
0-A1ky1pyrro1ines. 35
Reactions of Deoxyvasicinone. 38
Enamines. 48
Tautomerism. 48
Protonation and Basicity. 49
Alkylation and Acylation Reactions. ~ 50
Miscellaneous Reactions. 53
Halogenation Reactions. 58
Heterocyclic Enamines. 58
RESULTS AND DISCUSSION
Introduction 61
Preparation of Nitrocarboxy1ic Acid Esters. 63
Preparation of 2-Pyrrolidinones. 65
Preparation of Imidates. 68
Preparation of Pyrroloquinazolones. 69
Explanation of Complex P.M.R. Data. 71
Preparation of Benzylidene Derivatives of 72
Pyrrolo[2,1-b]quinazolinones.
Explanation of Complex P.M.R. Data. 73
Reactions of Pyrrolo[2,1-b]quinazolin-9(1H)-ones 77
at C-3.
Pseudobasicity. 78
Enamine Formation. 80
Reaction with Ethylch1oroformate. 82
Mechanism of 3,3-Dicarbethoxy-2,3-dihydropyrrolo 83
[2,1-b]quinazolin-9(1H)-one formation.
Mechanism of 2-Ethoxy-(4H)-3,1-benzoxazin-4-one 84
formation.
Metallation. 86
Reaction with a-Halocarbony1 Reagents. 87
Reaction with Acylating Reagents. 90
Reaction with Michael Acceptors. 93
Hydrogen Bonding Stabilisation [2,1-b] 94
quinazolin-9(1H)-ones.
Mechanism of Reduction of 3-Hydroxymethylene 97
-2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one.
Mechanism of attempted hydroxymethylation reaction 99' 
on deoxyvasicinone.
Mannich Type Reactions. 100
Mechanistic Pathway to 3-Acetoxymethy1-2,3-dihydro 101
-3-dimethylominomethylpyrrolo[2,1-b]quinazolin 
-9(1H) -one.
Attempted Preparation of 3-0xo-2,3-dihydropyrrolo 102
[2,1-b]quinazolin-9(1H)-one.
Via Oxime. 103
X-ray Crystallographic Determination of 2,3- 105
Dihydro-3-hydroxypheny1 methylenepyrrolo[2,1-b] 
quinazolin-9(1H)-one.
Experimental 117
Bibliography 199
ACKNOWLEDGEMENTS
The work described in this thesis was undertaken at the 
chemical laboratories at Dundee College of Technology.
I wish to thank the Research Committee of the College 
for sanctioning this study and for the provision of the 
necessary facilities and maintenance grant. Thanks are 
also accorded to the technicians of the Chemistry 
Section and the Library staff.
I would like to express my gratitude to Dr. A.D. Dunn 
for his untiring enthusiasm, encouragement and advice 
throughout the entirety of this research.
My thanks are also extended to the following people;
Drs. J.C. Barnes and J.D. Paton of the Chemistry 
Department and Dr. J.N. Low of the Physics Department of 
the University of Dundee for their guidance during the 
X-ray study, Drs. D.H. Bremner and A.R. Edgar for their 
useful suggestions during organised and impromptu 
meetings and finally Christine Kinnear for the typing of 
this manuscript.
The Synthesis and Reactions of Deoxyvasicinone and 
Analogous Compounds.
Kenneth I. Kinnear, B.Sc.^Hons).
Abstract
The synthesis of deoxyvasicinone and a number of its 
C-ring substituted pyrrolo[2,1-blquinazolin-9(1H)- 
one analogues was achieved. Modified 2-pyrrolidinones, 
the precursor molecules in many of the aforementioned 
syntheses, were prepared using standard techniques or 
via the reduction of nitrocarboxy1ic acid esters with 
reduced iron in acetic acid. The ability of 
deoxyvasicinone analogues to react at C-3 with 
electrophiles was demonstrated, the reactions yielding 
a range of modified pyrrolo[2,1-blquinazolones. 
Mechanistic pathways to account for the products formed 
are included. A deuterium labelling experiment indicated 
that these reactions probably progress through the 
intermediacy of a pseudo-enamine. Deprotonation at the 
C-3 methylene group of 2,3-dihydro-pyrrolo[2,1-b] 
quinazolin-9( 1H)-one and 2,3-dihydro-1,1-dimethylpyrrolo 
[2,1-b]quinazol in-9(1H)-one was achieved using lithium 
diisopropylamide and the lithiated species were used in 
situ for further synthetic transformations.
Attempts to prepare novel tetracyclic systems utilising 
the sp2 nitrogen atom of the quinazolinone ring were 
unsuccessful. However, the tetracyclic spiroenone 
(A) was produced from deoxyvasicinone via an intermediate 
hydroxymethylene derivative.
FOREWORD
Bracketed arabic numerals in the text refer to the 
diagrams of the formulae and the arabic superscripts 
indicate references.
The following abbreviations have been used in the text
m. p. - melting point
m.m.p. - mixed melting point
g . 1. c . - gas liquid chromatography
p . 1. c . - preparative layer chromatography
t. 1. c . - thin layer chromatography
i. r. - infra red
u. v. - ultra violet
n.m.r. - nuclear magnetic resonance
p.m.r. - proton magnetic resonance
m. s. - mass spectrum
Ac - acyl
Ar - aryl
Et - ethyl
Me - methyl
Ph - phenyl
DMAD - dimethyl acetylenedicarboxy1 ate
DMF - dimethyl formamide
DMS - dimethyl sulphate
DMSO - . dimethyl sulphoxide
EDTA - ethylenediaminetetraacetic acid
LDA - lithium diisopropylamide
NBS - N-bromosuccinimide
PTSA - para toluenesulphonic acid
THF - tetrahydrofuran
Rf - retention index for thin layer chromatography
Rt - retention time
J - coupling constant
Hz - hertz
<5 - p.p.m.
* _ molar extinction coefficient
INTRODUCTION
Introduction
The leaves of Adhatoda Vasica Nees, a highly reputed 
Ayurvedic medicinal plant, have been used in Indian 
medicine for more than 2,000 years. During the latter 
half of the nineteenth century medical scholars and 
authors began to investigate the use of Adhatoda Vasica 
Neas and other plants containing quinazoline derived 
alkaloids in the treatment of respiratory ailments, 
particularly cough, bronchitis, asthma and tuberculosis. 
The 'active' components from the medicines derived from 
these leaves were subsequently extracted, characterised 
and unambiguously synthesised. The history of the 
alkaloid deoxyvasicinone (1) is therefore linked 
inexorably with the histories of the numerous similar 
'active' alkaloids present in these crude medicines.
1
Hooper in 1888 undertook the chemical investigation of
the plant Adhatoda Vasica and separated the volatile and
non volatile fractions by steam distillation. The non
volatile fraction showed positive tests for alkaloids
and also behaved as an organic acid and was therefore
named Adhatodic acid. Further work on the chemistry of
the plant remained at a standstill for approximately
2four decades when Sen and Ghosh started investigations 
again and isolated a solid they named as vasicine (2).
It was whilst establishing the structure of (2) that
1
Morris, Hanford and Adams? obtained the compound (1) via 
hydrogen peroxide oxidation of deoxyvasicine(3).
Deoxyvasicinone was assigned structure (1) by an 
unambiguous synthesis involving anthrani1 amide
(4) and 4-phenoxybutyry1 chloride (5). (Scheme 1).
Thermal cyclisation of the intermediate 2-(3- 
phenoxybutyry1 amino)benzamide (6 ) gave 2-(3- 
phenoxypropy1)quinazolin-4-one (7) which could be 
brominated at the 3-position in the alkyl side chain 
with concommitant removal of the phenoxy ether grouping 
Cyclisation of this bromo compound 2-(3-bromopropy1)- 
quinazolin-4-one (8 ) in alkaline media gave (1).
2
( 6 )
Scheme 1
Deoxyvasicinone (1) was shown to be identical with the
product 9-pegen-8-one synthesised several months earlier 
ii 4
by Spath and Platzer . Spath's synthesis involved 
heating 2-pyrrolidinone (9) with one equivalent of 
isatoic anhydride (10) at 120° - 130°. Loss of carbon 
dioxide gave the intermediate 1 -(2 -aminobenzoy1 ) 
pyrrolidin-2 -one (1 1 ) which by elimination of 
water yielded a compound mp 110-111° named 9- 
Pegen-8 -one after Peganum Harmala the original 
floral source of alkaloids used by Spath. (Scheme 2, Pg.10).
5 6 7 8Chatterjee and Ganguly , Koretskaya ’ , Liljegren and
g
Plekhanova have all since recovered deoxyvasicinone (1)
from this same species. Deoxyvasicinone (1) has also
1 0been isolated from Mackinlaya Macrosciadia , Peganum
1 1  1 2  Nigellastrum and Linaria Transiliensis .
Nomenc1ature
The different names given to (1) by Spath and Adams
highlight the problems encountered when reviewing the
literature for these, alkaloids. Indeed the numbering
system for vasicine type alkaloids which involve fused
pyrroloquinazoline or pyrrolo benz-1:3-diazine systems
13
have developed quite strangely e.g. the earlier 
numbering system was as shown in (3A).
4
7 8
3A
which was later changed to (3B)^.
However, the numbering system^ normally encountered in 
the literature in the present day for vasicine type 
alkaloids involves the pyrroloquinazoline condensed ring 
system with numbering shown as in (3C).
7
6
3C
The N of the pyrrolo ring (saturated) and 3N of the 
quinazoline being common N to both pyrrolo and 
quinazoline systems, i.e.
Y
a , b , c , d..............
define the facets of 
the quinazoline moeity.
5
Thus according to the above numbering system 
deoxyvasicinone (1 ) will be 1 ,2,3,9-tetrahydropyrrolo- 
[2,1-b]quinazolin-9-one. However, it should be 
noted that chemical abstracts use 2,3- 
dihydropyrrolo[2,1-b]quinazolin-9(lH)-one as the 
preferred name for deoxyvasicinone and it will be called 
as such during this discussion.
Pharmacological Activity
The pharmacological activity associated with the
16-22quinazolone moeity is well documented " and two
23 24excellent review articles by Johne ’ are available which 
describe quinazolines as central nervous system 
depressants, e.g. methaqualone (1 2 ),
anti-inflammatories, diuretics, antihypertensives and 
antial lergics or with anti-infectious, antimalarial 
coccoidiostatic or anthelmentic properties.
6
Other groups have reported the use of quinazolones as 
fungicides^* acaricides^ and herbicides^ .
Despite the numerous studies undertaken in an effort to
establish structure activity relationships in the 2,3-
substituted quinazoline alkaloids extracted from
Adhatoda Vasica, no definitive rules have been
established, indeed conflicting reports have tended to
confuse the issue, Devi et al^ . However, a
3 ncomprehensive investigation by Sharma et al has shown 
that bronchodi1 atory activity may be enhanced with the 
inclusion of an oxygen at C-3 or C-9 in the 6,6,5 
pyrroloquinazoline molecule. An N-N-0 triangle can be 
visualised (Fig 1). These triangles have identical bond 
lengths whether the molecule is deoxyvasicinone (1 ) or
7
If either the carbonyl group in deoxyvasicinone (1) type 
derivatives or the hydroxyl group in vasicine (2 ) type 
analogues is absent then a subsequent reduction in 
activity is recorded.
An investigation into the roles of the A and C rings 
(Fig 2) by Sharma^O discovered that not only must the C 
ring be present for bronchodi1atory activity (i.e. 2,3- 
dialkylquinazolones are not as active as their cyclic 
counterparts) but that the ring should be large (i.e. a 
7 membered ring has enhanced bronchodi1atory activity 
when compared to a cyclic 5 membered ring.)
Pharmacological screening of vasicine derivatives 
following substitution in the A ring revealed no 
enhancement of activity. Presumably deoxyvasicinone 
type compounds were excluded from this study due to 
their aforementioned correlation in activity with 
vasicine analogues. Earlier negative results reported 
by Devi, Kapil and Popli^, who introduced hydroxy, 
alkoxy, acetoxy and chloro substituents into the A ring 
may also have influenced this decision.
Numerous other groups have also generated substituted A- 
ring pyrroloquinazolones. Hydroxyl, halo^2,33s 
carboxyl, nitro and amino g r o u p s ^ > 3 2 , 3 3 , 3 4 , 3 5  #
benzamido^ # alkyl^, and acetamido^»3 2 , 3 3 , 3 4  groups 
have all replaced hydrogen in the A ring. Johne^ 
illustrated that the benzo ring in position A may be
8
replaced by similar aromatic heterocycles with the 
preparation of 8 -azadeoxyvasicinone (13).
Unfortunately, much of the work has provided little 
biological data and that obtained^iends support to the 
ineffectiveness of this type of substitution. Despite 
this, interest in A ring substitution continues and
an Italian pharmaceutical company have recently published 
a patent application for the preparation of numerous 
substituted pyrrolo[2 ,1 -b]quinazolones and pyrido[2 ,1 - 
bjquinazolones.
36
(13)
9
Synthesis of pyrrolo[2,1-b]quinazolones
As previously noted, the alkaloid deoxyvasicinone (1)
4
was first synthesised in vitro by Spclth and Platzer . 
The pyrido analogue (14) of (1) was also prepared by 
this group from 2-piperidone (15). (Scheme 2).
pyrido[2 ,1 -b]quinazolin- 
ll-one (14).
4-
( D
HoO
Scheme 2
Since then interest in pyrroloquinazolones has grown and
consequently so has the number of synthetic routes to
them. This interest, generated mainly by the latent
biological activity of these molecules has been
heightened by the use of pyrroloquinazolones as
37 38intermediates in natural product synthesis ' and as
39models for larger compounds such as steroids
10
A method developed by Landii Vittory and Gatta4 0  for the 
preparation of (1 ) and its [1 ,2 -a] analogue (16) 
involves the base catalysed thermal cyclisation of 2-(4- 
chlorobutyrylamino)benzamide (17) previously prepared 
from anthrani1 amide (4) and 4-ch1orobutyry1 chloride 
(18). This reaction, although similar to that reported
q
by Morris et al allows the nitrogen atom of the 
secondary amide to act as a nucleophile with the 
subsequent formation of (16) (Scheme 3). No such attack 
is possible using the method of Morris as this route to 
cyclisation is blocked by the presence of the tertiary 
amino group in the preformed quinazolone ring.
1,2,3,5-tetrahydropyrrolo[1,2-a]
quinazolin-5(1H)-one.(16).
Scheme 3
Similarly Mohrle and Siedel describe the synthesis of 
these isomeric [1 ,2 -a] and [2 ,1 -b] pyrro1 oquinazo1 ones 
or their pyridoquinazolone counterparts (14) and (19) 
from the reaction of (4) with either Y-butyrolactone 
(2 0 ) or §-va1 erolactone (2 1 ) at high temperature and 
pressure (sealed tube). The reported yields are good 
(64% for the pyrroloquinazolones) but unlike the Vittory 
Landii synthesis shown earlier the product ratio lies in 
favour of the [1,2-a] analogues (Scheme 4). Although 
the reactions of Mohrle and Landii Vittory are not 
identical the alteration in product ratio may 
indicate that the [2 ,1 -b] analogue is the kinetic 
product in this type of cyclisation reaction although 
this is by no means certain.
42In 1936 Schopf synthesised deoxyvasicine (3) under the
i
so called "physiological conditions" in vitro from A - 
pyrroline (22) and 2-ami-nobenzaldehyde (23).
12
The condensation product of these two compounds the 
dihydroquinazolinium derivative (24), undergoes a 
rearrangement to give (3) in the presence of a platinum 
catalyst. However it was not until 1947 when Schbpf^ 
revised this synthesis that (24) was used to prepare 
deoxy^asicinone(1). In this revised scheme Schttpf 
employed (23) and 4-aminobutanal-diethylacetal (25) to 
obtain (24) which was then oxidised at constant pH 
with potassium ferricyanide. The deoxyvasicinone (1) 
thus obtained was characterised via its picrate.
Sakamoto4 5  has since modified the Schtipf synthesis and 
isolated (24) as its hydroxide from a -pyrroline (22) 
and 2-aminobenzaldehyde (23). This hydroxide was almost 
quantitatively converted to (1 ) by.chromic acid 
oxidation in dilute sulphuric acid.
A^-pyrroline (22) has been identified4 4  as the product 
of enzymatic oxidation of putrescine (1,4-diaminobutane)
(26) and this may explain the choice of reactants by 
Chatterjee and Ganguly5 in their synthesis of 
deoxyvasicinone (1). In this synthesis anthranilic acid
(27) and 4-aminobutanoic acid (28) were heated at reflux
13
in xylene with one equivalent of P 2 O 5 as dehydrating
reagent. Purification of the reaction mixture by
chromatography gave (1) as the major product. Johne et 
35 22al and Jain et al have subsequently used this 
preparatory method to good effect in their respective 
investigations into nitrated A ring analogues of 
deoxyvasicinone. Such derivatives were subsequently 
reduced to benzamido and amino derivatives using 
standard reductive techniques.
nh 2 -ch 2 -ch 2 -ch 2 -ch 2 -nh 2 nh 2 -ch 2 -ch 2 -ch2-cooh
(26) (28)
^ s^ c o 2h
(27)
45Mohrle and Gundlach discovered that the mercuric EDTA
dehydrogenation of eye l ie amines with neighbouring
aromatic amino groups yielded in every case a
, 4 2
cyclic amidine identical to Sch&pf's (Scheme 5).
Thus, deoxyvasicine (3) was obtained from 1-(2- 
aminobenzyl) pyrrolidine (29) derived from 2-nitrobenzy1 
chloride (30) and pyrrolidine (31), via reduction of 
the intermediate 1-(2-nitrobenzyl)pyrrol idine (32) with 
stannous chloride.
14
^ \ ^ C H 2CI
(30) (31)
(32)
E D T A
»
Scheme 5
15
A r
Meth Cohn, Suschitzky and Sutton previously postulated 
an intermediate dihydroquinazolone in their preparation 
of quinazolones via the dehydrogenation/oxidation of 2 - 
aminobenzylamines with manganese dioxide. Mohrle and 
Gundlach employed this oxidation technique and prepared
(1), (14.) and 1,2,3,4,5,11 -hexahydroazepino[2,1 -b]- 
quinazolin-11-one (33) in good yields.
Although the synthetic pathways illustrated are 
effective and allow the preparation of pyrrolo[2 ,1 -
b]quinazolones in reasonable yields, the facts that 
isomeric pairs are often formed and that the syntheses 
are circuitous or time consuming is unsatisfactory. In 
order to overcome these problems a number of new 
preparatory routes which, utilise the condensation 
reaction between anthranilic acids and cyclic amides or 
their 0 -alkyl ethers have been developed.
The predominant type of pathway involving 0-alkyl ethers 
was instigated by Peterson and Tietze^, who achieved 
the formation of pyrrolo, pyrido and azepino[2 ,1 -b] 
quinazolones in high yields using mild conditions, via 
the reaction of a cyclic 2 -aminocarboxy1 ic acid having 
an unsubstituted amino group with a cyclic lactim ether.
16
Generally the reaction proceeded by mixing the acid and 
the required unsubstituted imidate together in a 
suitable solvent (or neat in some cases). Ring closure 
occurred following simple stirring or was promoted by 
the occasional heating of the reaction mixture. The 
reaction itself is thought to be a two stage process 
which goes to completion through an intermediate cyclic 
amidine, the tautomeric form of which loses one mole of 
water to yield the required product, e.g. the reaction 
of 2-methoxy-1-pyrroline (34) with (27) yielded (1). 
(Scheme 6 ).
^ ^ C O O H
(27) h ,ccr (34)
^ x X O O H
W
(1)
Nucleophilic displacement of the methoxy ether grouping 
by the amino group of the 0 -amino carboxylic acid leads 
to the formation of the amidine intermediate which 
spontaneously rearranges to its tautomer, the existence 
of which is not unreasonable as enamine-imine 
tautomerism is well known4** . Condensat i on/eye 1 isation , 
presumably the driving force for the intermediate
3
rearrangement, then takes place via reaction of the sp 
hybridised nitrogen of the pyrrolidine ring with the 
carboxyl grouping.
49 29Shkrob et al and Devi et al have achieved similar 
results, the latter using benzene as solvent to prepare 
A and C ring substituted analogues of deoxyvasicinone.
31Onaka sought to correlate the in vitro synthesis of
(1) and 5-hydroxy-2,3-dihydropyrrolo[2,1-b]quinazolin- 
9(1H)-one (35) with similar processes in vivo. He thus 
postulated intermediates (37) and (38) as the biological 
equivalents of the cyclic lactim ethers, and proposed 
that these Vilsmeier type amide phosphates or 
pyrophospates could play an important part as active 
precursors in alkaloid biosynthesis.
18
0 0® 0
(36) R1 =0H (38) R= -P -0 -P -0® (35)R1 =0H
0® 0e
It may have been this observation which prompted
50Shakhidoyatov et al to initiate their major study into 
polymethylenequinazolone formation. Pyrrolo, pyrido and 
azepino[2 ,1 -b]quinazolones were isolated following the 
reaction of a lactam with an anthranilic acid in the 
presence of a dehydrating reagent such as phosphorus 
oxychloride, thionyl chloride or phosphorus trichloride 
/phosphorus pentachloride.
The first step in the reaction is assumed to be the
formation of a cyclic imine (39) similar to that
31postulated by Onaka . This was substantiated following 
the treatment of 2-pyrrolidinone (9) with POCl^ at room 
temperature. An exothermic reaction is observed with 
vigorous evolution of hydrogen chloride. The reaction 
between this Vilsmeier type imine (39) and an 
anthranilic acid gave cyclic amidines, which cyclised 
following rearrangement to yield the desired 
pyrrolo[2,1-b]quinazo1inones . (Scheme 7).
19
20
This revised synthetic route has been used by 
Shakhidoyatov to prepare numerous substituted and 
unsubstituted pyrrolo, pyrido and azepino[2 ,1 -
b]quinazolones. The effects of introducing substituents 
into the A and C rings via substituted anthranilic acids 
and substituted lactams respectively were investigated. 
Although the introduction of nitro, amino and halo 
substituents into the aromatic nucleus had little effect 
on the subsequent yield of the product, the reactivity 
of various lactams was shown to decrease with increasing 
ring size and with the introduction of substituents 
(chloride and phenyl). Following this investigation two 
other groups developed synthetic routes to pyrrolo[2 ,1 - 
b]quinazolones using dehydrating conditions.
Koizumi et al^ prepared numerous A-ring substituted 
pyrrolo and azepino[2 ,1 -b]quinazolones from the reaction 
of anthranilic acids with lactams and thionyl halides in 
a variety of non polar solvents.
Koizumi has since postulated an intermediate anthranoyl 
chloride (40) unlike the intermediate.(39) proposed by 
Shakhidoyatov. (Scheme 8 ).
21
»CN>
f Y * *  (^yOn
(40)
^ / ' N M H ;
(27)
Scheme 8
While solvent effects cannot be disregarded in this 
context, the Koizumi intermediate (40) has already been 
postulated and repudiated by the Shakhidoyatov group^0, 
who cite as evidence the formation of an anthranilic 
acid lactam, presumably of structure (41) following 
reaction of anthranilic acid with P0C1  ^ at 0° . This 
lactam (41) when heated to 100° with or without POCI3  
gave the dianthrani1 ate (42). (Scheme 9)
^ ^ C O O H
L I
(27)
100°
o
II
° -H N
c
, , II(42) O
Scheme 9
22
A similar intermediate would be expected to be formed in
the reaction of anthranilic acids with the other
dehydrating reagents (PCI3 /PCI5 , SOCI2 ) consequently
leading to the formation of dianthrani1 ate (42). The
dianthrani1 ate was in fact isolated as the major product
from the reactions of anthranilic acids with lactams in
the presence of these dehydrating reagents and because
it is known that anthranilic acid chlorides react with
lactams to given anthranilamide derivatives which then
cyclise to give (1 ) or its analogues as the major 
50product it seems unlikely that (40) is an intermediate
in the syntheses. Further substantiation of
Shakhidoyatov's claims is provided by examining the
38results of Kametani and co-workers obtained during 
their investigations into the synthesis of 
evodiamine (43) and ruteacarpine (44).
In the Kametani approach anthranilic acids were
treated with thionyl chloride in a non polar solvent
(benzene) prior to the addition of cyclic lactams or
51their derviatives. Unlike Koizumi no intermediate
anthranoyl chloride (40) was proposed because of the
isolation of an intermediate anthranilic acid lactam
50similar to that produced by Shakhidoyatov . This
23
sulphur analogue (45) was isolated as a pale yellow
syrup and identified as the sulfinamide anhydride after
52comparing mass spectral and infrared data . The 
reaction of (9)^®e or (34)^^ with this precursor (45) 
in dry benzene afforded (1) in 93% and 64.5% yields 
respectively. The authors have proposed two mechanistic 
pathways for the latter of these syntheses (Scheme 10).
Scheme 10
24
In the first pathway the anhydride (45) may have
spontaneously rearranged to the iminoketene (46) with
loss of SO^. Regiospecific addition of (46) to (34) via
a concerted (4 + 2 ) n  cycloaddition reaction would give
the required product. However, since (45) is prepared
at 80° without such a decomposition to the iminoketene
(46) taking place, a step wise mechanism via the
intermediate (47) is more likely. A number of errors
exist in these papers. The most obvious and blatant of
these being the inclusion of the melting point of
deoxyvasicinone (1) as 196°- 198°, an error of almost
90° and consistent with the melting point of the
hydrochloride of (1). This error is compounded by the
fact that Kametani refers to Onaka's spectral data in
38dsupport of his own proposed structure
Unfortunately, Onaka’s data is itself erroneous showing 
the C-2 methylene group of (1) at 5 3.17 and not at the 
normally recognised 5 2.30. Also no mention is made to 
a melting point for (1) by Onaka except by means of 
reference.
The methods derived from the techniques of 
Shakhidoyatov5 0  and Peterson and Tietze4  ^ have obvious 
advantages over the other synthetic routes outlined 
above. They both yield monoisomeric product and are 
relatively simple reactions (one and two step from the 
required 2-pyrrolidinone respectively). This compares 
favourably with the circuitous routes illustrated.
25
Nitroa1kanoic Acid Esters
The addition of nitromethane as the sodio derivative, to 
esters of benzalmalonic, cinnamalmalonic and 
benzoy1 aery 1ic acids has been described by Kohler et 
al53’54.
C r
Kloetzel attempted such Michael condensations using 
feebly basic condensing agents such as piperidine but 
was unable to obtain analytically pure compounds.
c c
It was Bruson who eventually succeeded in using 
amines as catalysts in the condensation of acrylic acid 
esters and mononitroalkanes having a reactive hydrogen 
atom contiguous to the nitro group. This was achieved 
using benzyltrimethylammonium hydroxide (Triton B) as 
catalyst in inert solvents, such as benzene, ether or 
dioxan. Compounds such as methyl 4-methyl-4- 
nitropentanoate (48) and dimers such as dimethyl 4- 
nitropimelate (49) were isolated in high yields from the 
appropriate nitroalkane and methyl acrylate. (Page 27).
c c
Kloetzel eventually effected such condensations with
triethylamine as catalyst and succeeded in isolating
58similar compounds to those of Bruson. Moffett used a 
refinement of the Bruson technique in the preparation of 
(48) for organic syntheses and this remains a most 
detailed account of this type of reaction.
26
c q
Nelson J. Leonard and Gradus L. Shoemaker^ prepared 
mono and dl-esters such as methyl 2-methyl-4- 
nitrobutanoate (50) and dimethyl 2,6 -dimethy1-4- 
nitropimelate (51),
CH.
09 N-C-CH9 -CH9 -C09 CH9
2 k
(48)
CH
o 2 n-ch 2 -ch 2 -ch-co 2 ch 3
(50)
/ ^CH2 -CH2 -C02 CH3
o 2 n-ch
CH2 -CH2 -C02 CH3
(49)
o 2 n-ch
c h 3
^ C H 2 -CH-C0oCH2" "3
•ch 2 -ch-co 2 ch 3
ch 3
(51)
which they found useful as precursors in their 
subsequent synthesis of substituted pyrrolizidines.
They seemed oblivious to Bruson's work and identified 
diethylamine as the most effective catalyst for 
promoting the formation of (50) and similar compounds. 
Interestingly the group did employ quaternary ammonium 
salts as catalysts in the subsequent reaction of (50) or 
its analogues with acrylic esters to prepare (51) or its 
analogues in improved yields.
A comprehensive investigation was conducted by Cologne
c n
and Pouchol into the use of sodium alkoxides, Triton B 
and secondary and tertiary amines as promoters of
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Michael type condensations between nitroalkanes and 
esters of acrylic acids or between esters having an 
active methylene group and nitroalkenes61. The methods 
of Bruson^’^  and Bahner^ being routinely employed to 
prepare a wide range of esters of substituted 
nitroa1 kanoic acids.
An interesting choice of catalyst was made by Kambe and
(TO
Yasude . This group had previously reported the
additions of reactive methylene compounds to «,? -
unsaturated compounds using potassium fluoride as
catalyst and found that compounds of general formula
2 3k f r  d41 i
09N - C - CH - C H < ~ 5  2 . ‘ R
R1
could be prepared in a similar fashion from nitroalkanes
and a range of Michael acceptors, e.g. methyl 3-methyl-
4-nitrobutanoate (52).
CHq I 3
o2n - ch 2 - ch - ch 2 - co 2 ch 3
(52)
The yields of all the compounds mentioned by Kambe and 
Yasude were found to increase with increased KF 
concentrations and increased solvating power of the. 
solvent employed.
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2 -Pyrro1 i d i nones
Numerous preparatory routes to 2-pyrrol idinone (9) have 
been developed since the early work of Gabriel and
r a
Tafel . These routes were devised due to the increased 
usage of 2 -pyrrolidinones as solvents for polymers,i
insecticides, in petroleum processing and separation or 
as plasticisers for acrylic polymers and copolymers or 
as decolourising agents in kerosene or other 
hydrocarbons . As a consequence both 2-pyrro1idinone 
(9) and its analogue 5-methy1-2-pyrro1idinone (53) are 
now established commercial reagents. Other 2- 
pyrro1 idinones have as yet no commercial importance but 
recent interest in these 7 -amino acid derivatives as
fi fi fi 7precursors of different biologically active substances ’ 
or in the area of heterocyclic polymers^®”^^  has 
resulted in a number of pathways for their synthesis 
being developed e.g. catalytic hydrogenation or chemical 
reduction.
7 ?Cologne and Pouchol developed a simple method of 
preparing numerous 2 -pyrro1 idinones via the catalytic 
hydrogenation of the esters of nitro-alkanoic acids over 
Raney nickel. 3-Carba1koxy-2-pyrrolidinones were also 
prepared from the esters of 7 -nitrodiacids. These 
pyrrolidonyl esters were saponified and then 
decarboxy 1 ated at high temperature to give the required
2 -pyrrolidinone.
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(9) r=r 1 =r 2 =r3=h
(53) 1 2 3 R=CH3 ,R=R =R°
(54) 1 1 2  r =ch 3 ,r =r =r
(55) r 1 =r 2 =ch 3 ,r=r 3
(56) 3 1 2 R =CH3 ,R=R=R^
Smirnova^ et al have used similar techniques to prepare
(9), (54) and 5-carbethoxy-2-pyrrolidinone (57), whilst 
73Moffett has written a detailed account of the synthesis 
of 5,5-dimethy1-2-pyrrolidinone (58) also using a
R=H,R1 =C0 2 C2 H5  
r=r 1 =ch 3
The pyrrolidinone (58) has been prepared by the
hydrogenation of 5-amino-2,2-dimethylpyrroline-1-oxide
74over Raney nickel and also via the hydrolysis of 5- 
imino-2,2-dimethylpyrrolidine in the presence of Raney 
nickel^.
A minor deviation from the technique of Cologne and
65Pouchol was devised by Larkin and Kreuz who isolated
2 -pyrrol idinones by the catalytic hydrogenation of 
nitrocarboxy1 ic acids (previously prepared from the 
oxidation of dinitroalkanols).
Although the hydrogenation of gaseous 2-cyanopropionic 
acid alkyl esters over a variety of catalysts is
similar method.
(57)
(58)
H
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efficient, producing 2 -py.rrol idinones in yields 
76
exceeding 90% , the equipment required prohibits its
77general application. However, Henecka et al 
demonstrated that the reductive process could be 
achieved by 'normal' catalytic hydrogenation over Raney 
nickel and isolated 4-ethoxycarbonylmethy1-2- 
pyrro1idinone (59) in excellent yield from diethyl 3- 
cyanog1 utarate (60).
CHo-C0oEt
i 2 2
CH-CN
CH2 -C02Et
H, Et02CH2Cv.
Raney nickel
(60)
H
(59)
Similar compounds to (59) are known. Yakhontov has
, x 79 80reported the acid (61), whilst Evans and Kato et al
have recorded the preparation of the acid (62) and a
number of its esters.
x h 2c o o h
u
(61 )
h o o c h
H
(62)
The hydrogenation techniques illustrated are generally 
more efficient than other chemical routes to 2 - 
pyrro1idinones. However, a number of interesting 
pathways to these 2 -pyrro1 idinones do exist and some of 
these are illustrated in the following section.
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Sircar obtained (9), (54) and (55) from the Hoffman 
degradation of the appropriate sodium glutaramate 
(prepared from the corresponding glutaric anhydride). 
(Scheme 11).
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1- NH OH.yiaOH
3. NaOH/Br2
4. HC1
R —
H
Scheme 11
Other relevant preparations of disubstituted 2-
pyrrolidinones include the method of Bellasio and 
82co-workers , who isolated 5,5-dimethyl-2 -pyrrolidinone
(58) as its hydrochloride following treatment of the
sodium salt of 1 -hydroxy-5,5-dimethyl-2 -pyrrolidinone
(63) with chloramine. The hydroxy compound (63) was
prepared from (48) followed by reduction in the presence
8 3of zinc dust and ammonium chloride. Black et al 
prepared (58) via iron II sulphate treatment of the 
cyanooxaziridine (64) derived from the 
photorearrangement of 2-cyano-5,5-dimethyl-1-pyrroline- 
1 -oxide (65).
( 58)
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A one step synthesis of 2-pyrrol idinones, involving the 
amido ethylation of simple esters with N-acy1aziridines 
was developed by Stamm, Woderer and Wiesert . Thus 
triphenylmethy1 sodium (trityl sodium) was used to 
generate the enolate salt of ethyl 2-methylpropanoate 
the reaction of which with N-benzoylaziridine afforded
3,3-dimethyl-2-pyrroli,dinone.
Monosubstituted analogues of 2-pyrrol idinone have been 
isolated by several groups. •
85Metzger and Seelert discovered that 2-pyrro1idinones 
could be prepared from amides of a,/3-acry 1 ic acids 
following a methylene insertion reaction using the Corey 
reagent dimethy1su1phoxoniurn methylid. For example 
reaction of crotonamide (66) with this oxosulphonium
y 1 id gave (54) in 61 %
CH, CH
> s .^.0 +
H3C *ch2 H
>
Scheme 12
3-^ethyl-2-pyrrolidinone (56) has been prepared by Fles 
et al86 from free 4-amino-2-methylbutanoic acid 
generated in situ from 2-methyl-4-phtha1imidobutanoic 
acid following treatment with hydrazine hydrate. 
Cyclisation of this free acid was effected by
33
esterification and ammonolysis.
Many syntheses of esters of 2-pyrrolidinones exist in
addition to those outlined in the preceeding text.
87
Blicke and Jung Lu successfully converted
diethyl g1utamate to 5-carbethoxy-2-pyrrolidinone (57) by
refluxing the former in xylene, whilst its disubstituted
analogue (67) was isolated as one of the products from
the addition of diethyl acetamidomaloriate (6 8 ) to ethyl
88acrylate by Cocolas and Hartnung . The compound 
(67) was formed at reflux temperatures whereas mild 
conditions favoured the normal Michael adduct (69). 
(Scheme 13). The elevated temperatures which promote 
cyclisation are also condusive to bimolecular hydrolysis 
thereby aiding cleavage of the amide bond and hence 
formation of the desired 2-pyrrolidinone. This type of 
cyclisation was not entirely unexpected having
89previously been reported by Connor and McClellan
COOC2H5
HC—NHCOCHj ♦ H2C=CHCOOC2H5I£ n ^ HH^ (g )^ ? jX
COOC2H5
( 6 8 )
jn i I d
fOOC2H5
C2HPC0CH2CH2-C -N H C 0 C H  
(69) COOC2H5
Scheme 13
A
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Stamm and Budny similarly used heat to induce the 
cyclisation of the substituted urea (70) to give 3,3- 
dicarbethoxy-2-pyrrolidinone (71) (Scheme 14).
90
(C2H5)2N"C_NH"CH2"CH2"CH 
(70)
/ C02 C2H5
\ C0oCoH2 2 5
/co 2 c 2 h 5 " 1
0 = ON-CH 9 -ChL-CH
L L NC02 C2H5 j
Scheme 14
whilst thermal cyclisation of aminomethylsuccinic acid 
(72), by refluxing in a hydrogen chloride saturated 
solution of methanol for three hours afforded 4- 
carbomethoxy-2-pyrrolidinone (73).
0 -alkylpyrrolines.
The application of lactams to the synthesis of
heterocyclic systems depends on the activation of their
amide function. Thus the conversion of 2-pyrrol idinones
into their 0 -alkylpyrroline derivatives offers great
scope for the use of these lactams in organic 
91chemistry
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Two main alkylation techniques are available for the
formation of such O-alkylimino ethers. The first, using
the direct action of dialkyl sulphates on solutions of
the corresponding lactam has been demonstrated by 
92 93Schlack and Benson and Cairns . Schlack proposed the
use of hydroxyl free solvents which aided the
preparation of numerous 0 -a1 ky1 1 actim ether salts by
preventing ring cleavage. The free ethers (74) were
obtained from these salts by carefully discharging them
into potassium carbonate solutions (Scheme 15) and
purifying them by distillation. These techniques have
48been used to good effect by Etienne and Correia and
94Peterson and Tietze
Scheme 15
In cases where alkylation cannot be effected by dimethyl
95sulphate, triethyloxonium tetraf1 uoroborate may be 
used. O-alkylation of secondary amides using 
triethyloxoniurn tetraf1 uoroborate is usually carried out 
in dichloromethane or similar solvent. (Scheme 16).
(C2 H5>30+BF4 -------------------------------->
C H2 C12 c 2H5
Scheme 16 *+“Et2 °
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Isolation of the free ethers was accomplished using the
illustrated the effectiveness of triethy1 oxonium 
tetrafluoroborate when attempting to alkylate 3 -
carbethoxy-2-piperidone (75). DMS proved ineffectual 
yet (7 5 ) was readilly ethylated with triethyloxonium
tetrafluoroborate. Other Russian scientists 
used triethyloxonium tetraf1 uoroborate to prepare 
numerous cyclic Pactim ethers even though DMS or similar 
alkylating reagents may have been as effective.
method previously described. Glushkov et al',91
1
1 2R=R = R - H
R=CH3 ,R1 =R2=H
r=r 2 =h ,r 1 =ch 3
r=r 1 =h ,r 2 =ch 3
R/ ^ N ;?:^ o c2H5
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Reactions of deox.yvasicinone (1)
Tne reaction of deoxyvasicinone (1) and a number of its
analogues with electrophilic reagents have been reported
as following three main pathways. Reaction takes place
either at the active methylene group (C-3 in the pyrrolo
2ring) or via co-ordination of the sp hybridised 
nitrogen atom of the quinazolone fragment or by ‘normal* 
electrophilic aromatic substitution.
34,99Oripov et al * investigated the bromination in 
pyrrolo, 7-nitropyrrolo-, pyrido-, azepino- quinazolones 
and discovered that the product was dependant upon the 
brominating reagent and the solvent system employed 
(Scheme 17). The perbromide (81) was isolated from the 
bromination of (1 ) conducted in various solvent systems 
(chloroform, glacial acetic acid, concentrated sulphuric 
acid and 80% methanol) in the cold with catalysts 
present (iron filings, iron filings and iodine or 
aluminium chloride) or in the absence of catalysts. 
Interestingly no aromatic bromination occurred despite 
the use of ferric chloride or the other catalysts 
illustrated even when the reaction was carried out in 
the presence of pyridine.
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(82)
\
HBr
/  (83)
NaHC03 A /
Zn/HCl
Scheme 17
39
The perbromide (81) was also obtained from the reaction 
of (1 ) with hydrogen bromide and bromine as well as from 
the reaction of the molecular complex (82) with 
hydrobromic acid. This latter reaction may be reversed 
by the addition of a 5% aqueous solution of sodium 
bicarbonate. On heating or prolonged standing (81) 
loses a molecule of bromine to give the hydrobromide
(83) which can be isolated from the reaction mixture 
following preparation of the perbromide (81) or by 
treatment of the molecular complex (82) with either 
acetone or acetophenone. The bromination of (1) 
effected by heating in 75% acetic acid gave only the
3,3-dibromo-2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one
p
(84) . Oripov suggested that the sp hybridised nitrogen 
atom of the quinazolone ring imparts lability to the 
hydrogen atoms of the methylene group in the e x p o s i t i o n  
to the carbon-nitrogen double bond of (1). Subsequent 
abstraction of a hydrogen atom followed by attack by a 
bromine cation leads to the intermediate (85). The 
methine proton of (85) is as a consequence made more 
acidic and therefore rapid conversion to (84) takes 
place. The more selective N-bromosuccinimide was 
employed with benzoyl peroxide as initiator in carbon 
tetrachloride to prepare the monobromo derivative (85). 
Onaka has used this latter technique to prepare (85) 
in 57% yield. Treatment of (85) with a mixture of 
acetic acid and sodium acetate gave acetylvasicinone 
(8 6 ) identical to that obtained via free radical
40
oxidation of (1 ) with lead tetraacetate in benzene3^
whilst nucleophilic displacement of the bromine atom 
with a suitable amine realised a number of anisotes 
alkaloids such as anisessine (87).
Reduction of (85) and (84) using zinc and hydrochloric 
acid resulted in the splitting out of bromine to give
(3)".
The sulphonation of (1) was effected using sulphur
99trioxide in dich1oromethane . Attack takes place at 
the 4-position resulting in the formation of a complex 
(8 8 ) which is easily destroyed by water to give the 
hydrogen sulphate salt (89).
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( 1)
In contrast to bromination and sulphonation the 
chlorosulphonation of (1 ) yielded a product of
Q Q
electrophilic aromatic substitution . The 7- 
chlorosulphony1 derivative (90) thus obtained was shown 
to react with ammonia or dimethyl amine to yield 7- 
sulphonamido- and 7-(N,N-dimethy1su1phonamido)- 
derivatives (91) and (92).
Treatment of (1) with a nitrating mixture of H2 SO4 /HNO3
yielded 2,3-dihydro-7-nitropyrrolo[2,1-b]quinazolin-9-
(1H)-one (93) indicating that nitration followed a
34 99similar course to chlorosulphonation * . Reduction of
the nitro group in (93) with iron in glacial acetic acid
gave a mixture of 7-amino and 7-acetyl amino
deoxyvasicinones (94) and (95) with a total yield of
56%, whilst reduction in the presence of stannous
chloride afforded only (94) in 90% yield. The 7-
benzamido deoxyvasicinone has been isolated in a similar
23fashion by Jain et al . More drastic reduction of (93) 
using zinc and HC1 afforded 7-aminodeoxyvasicine (96) in 
excellent yield.
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Condensation between aromatic aldehydes and
deoxyvasicinone analogues has been investigated by
(3,22,36,100,101,102)
several authors , the usual product
being a 3-arylidene derivative. However when the 
substrate is a 3- or 4-nitrobenza1dehyde the 
intermediate alkanol may be isolated. (Scheme 18).
Heterocyclic aldehydes, such as furfural (furan-2- 
aldehyde) undergo reaction also, yet aliphatic and 
unsaturated aldehydes were shown to be unreactive at
x u • 100 , . J ou 101 uatmospheric pressure . Jain and Sharma have 
recently claimed to have obtained seven derivatives from 
the reaction of (1 ) with these aliphatic and 
unsaturated aldehydes at elevated pressures. However, 
no spectral evidence was provided in support of these 
claims.
(97) R=CH=CH-Ph
(98) R=CH3
(99) R=CH2 CH3
doo) r=(c h 2 )2 ch 3
(1 0 1 ) r=(c h 2 )3 ch 3
(102) R=CH2 CH(CH3 ) 2
(103) R=CH=CH-CH3
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Kametani^^ has attempted to apply the condensation of
2 -nitrobenzaldehyde and deoxyvasicinone (1 ) to the 
preparation of rutaecarpine (44). However the product 
isolated was identified as the isomeric 
pseudorutaecarpine (104) as shown in Scheme 19.
Vi 1smeier-Haack formylation of (1) yielded the 
intermediate (105)^^’104 WhiCh was then converted to
2 ,3 -di hydro-3-hydroxymethylenepyrrolo[2 ,1 -b]quinazolin- 
9(1H)-one (106) or 2,3-dihydro-3-(N,N-dimethylami no ) 
methylenepyrrolo[2,1-b]quinazolin-9(1H)-one (107) 
following treatment with aqueous solutions of either 
sodium acetate or ammonia.
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Oripov^^ showed that the reaction of (107) with acetone 
cyanohydrin afforded the N,N-disubstituted amino acid 
(108), whilst (106) realised the cyanohydrin (109) under 
s imilar conditions.
Both (106; and (107) were shown to be capable of.
acylation, amination and bromination and a detailed
account of the products isolated from these reactions is
104given in the original literature . Treatment of 
deoxyvasicinone (1 ) with phosphors pentasulphide 
yields its 9-thio analogue (110) which may be 
selectively reduced to deoxyvasicine (3) in the presence 
of zinc and HCl^^.
A number of techniques have been employed to reduce
deoxyvasicinone (1). Reduction of the carbonyl group is
effected using dissolving metal reduction'* * , whilst
selective reduction of the carbon-nitrogen double bond
40 107has been achieved using sodium borohydride * . Both
these functional groups may be reduced using lithium 
aluminium hydride^’4  ^ , whereas electrolytic 
reduction yields only the N-(2-aminobenzyl)-2- 
pyrrolidinone following rupture of the quinazolone ring. 
(Scheme 20).
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Scheme 20
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Enami nes
The term 'enamine' was first introduced in 1927 by
108Wittig and Blumenthal to emphasise the structural
similarity between the a, 0 -unsaturated amine system and
the cl> 0 -unsaturated alcohol moeity present in enols.
Isolated reports concerning the reaction of enamines
date back to the early nineteen hundreds; indeed in 1916 
109Robinson correctly interpreted the course of the
reaction between an alkyl halide and ethyl B - -
aminocrotonate. However, it was not until 1954, when
110Stork and his associates described alkylation and 
acylation reactions and demonstrated the ease of 
preparation of a number of enamines that interest was 
aroused.
Tautomer ism
Enamines may be formed via the condensation between an 
aldehyde or ketone and a secondary amine
1 I ^  i
>C-C=0 + H-N< >C=C-N< + H20
Primary amines also react with carbonyl compounds to 
form imines
>c-c=o + h 2 n- ^ = ^  >c-c=n- + h 2o
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and whereas tautomerism is possible with the formation 
of the enamine:
>C-C=N- ^ >C = C-N<
the equilibrium usually lies in favour of the imine 
structure.
Protonation and basicity.
The structure of the enamine system may be regarded as a 
resonance hybrid to which the canonical forms (1 1 1 ) and 
(112) are the important contributors. Hence 
electrophilic reagents,
including protons, may attack the system at either the 
nitrogen atom, to give the ammonium salt or, more 
importantly, at the carbon atom (3 to the nitrogen to 
yield an iminium salt. A direct application of this is 
the preparation of deuterated ketones (112), e.g. (113) 
is formed when the pyrrolidine enamine of 2 -methylcyclo- 
hexanone is treated with deuteroacetic acid in deuterium 
oxide (CH2 CO2 D/D2 O).
( 1 1 1 ) ( 112)
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(113)
In principle, an alkyl halide may attack an enamine at 
nitrogen to give the salt (114) or at the /3-carbon to 
yield the ion (115).
r  RI t  I I ©
>C=C-N< >C-C=N<©
(114) (115)
However, it is the latter reaction that has synthetic 
usefulness.
110In 1954 Stork et al reported that the alkylation of 
the pyrrolidine enamine of cyclohexanone (116) with 
methyl iodide followed by acid hydrolysis led to the 
monoalky 1ated ketone. (Scheme 21).
(116)
Scheme 21
In this original definitive paper Stork et al described 
the acylation reactions of enamines. Reaction can in 
theory, as with alkylation, occur either at the nitrogen 
atom or the carbon atom /3 to the nitrogen. Since the 
N-acylated products are unstable and are themselves good 
C-acylating agents, satisfactory yields of the required 
C-acylated enamines are usually obtained. Stork was 
thus able to prepare the monobenzoyl cyclohexanone 
following treatment of the pyrrolidine enamine of 
cyclohexanone with benzoyl chloride. (Scheme 22).
However, Hunig and Lendle found that the treatment of 
the morpholine enamine of eye 1 opentanone with 2 moles of 
propionyl chloride followed by acid hydrolysis gave the 
enol ester (117) via the intermediate (118) following 0- 
acylation of the original enamine product.
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(118) (117)
114A similar enol ester (119) was reported by Helmers 
being formed via the benzoylation of the morpholine 
enamine of 2 -benzoylcyclohexanone.
C i s / T r a n s  isomers
(119)
whilst other more complex products such as (1 2 0 ) and
(1 2 1 ) have also been isolated in small amounts from
, .. .. 115,116acylation reactions
as
(121)
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It would thus appear that O-acylation is the normal 
course of the acylation of enami noketones.
Enamine acylations have been extended to include the 
Vilsmeier reaction providing a method for the generation 
of formyl ketones without the use of strong base.
117ketoaldehydes have thus been obtained in high yields . 
(Scheme 23).
Miscellaneous Reactions.
The reaction of the morpholine enamine of cyclohexanone 
*(1 2 2 ) with one mole of phenyl isocyanate has been 
reported ’ to give the monoadduct (123) whilst its 
reaction with 2  moles of phenyl isocyanate gives the bis 
adduct (124).
A ,
N r
ONHPh
(123)
*See Page 55.
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However, the reaction of (122) with phenyl 
isothiocyanate led only to the tetrasubstituted isomer 
of the monoadduct (125) which failed to yield the thio 
analogue of (124) despite the addition of more phenyl 
isothiocyanate. The formation of only the 
tetrasubstituted isomer has been attributed by Hunig et
1 1 Q
al to the stronger conjugation of the C=S group with 
the enamine double bond than that of the C=0 group in 
the enamine (123).
SNHPh
(125)
1 Of)
Borowitz has demonstrated that aliphatic sulphonyl 
halides which possess an a  hydrogen yield cyclic 
sulphones when reacted with enamines. The reaction of 
the morpholine enamine of cyclohexanone (1 2 2 ) with 
methanesulphonyl chloride in the presence of a proton 
abstractor gave the cyclic aminosulphone (126) which 
rearranged on heating to give a 2 : 1  mixture of isomers
(127) and (128), (Scheme 24).
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( 122)
Since enamines are nucleophilic reagents they can react
with electrophilic olefines (i.e. olefines in which an
unsaturated electron withdrawing group is directly
attached to the double bond, at the carbon atom. The
undesired N-alkylation is normally reversible so that,
usually, high yields of carbon-alkylation products may 
1 ? 1be obtained . (Scheme 25).
Z = electron withdrawing group.
Scheme 25
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122-125Simple alkylation products (129) or cyclobutanes
1 2 6 - 1 2 8(130) ~ may be obtained from the reaction of
enamines with these electrophilic olefines.
(129) (130)
It has been proposed that the cyclobutane derivatives of
type (130) are intermediates which thermally rearrange
122to give the simple alkylated product (129)
As well as leading to simple alkylated products or
cyclobutane derivatives, alternative pathways of
reaction are available to enamines undergoing reaction
128 129 130with oc , jS-unsaturated ketones. Dihydropyrans * * or
111octalones being common products. (Scheme 26).
N
° \ / C H 3
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A more conventional cycloaddition occurs during the 
reaction of enamines with activated acetylenes. However 
the intermediate cyclobutene adducts undergo 
rearrangement leading to the insertion of two carbon 
atoms into the enamine ring or chain^3 5 ^ ^ j ^ 2  5 1 33 .
Thus the enamine (131) reacts with dimethyl 
acetylenedicarboxylate at room temperature in ether to 
give dimethyl 2,7-dihydro-3-pyrrolidieny1-4,5- 
oxepindicarboxylate (132). (Scheme 27).
(131)
Scheme 27
co2ch
co2ch
3
3
Good yields of 2-alkylidene ketones are easily achieved 
by reaction of an enamine with an aldehyde, especially 
an aromatic aldehyde . (Scheme 28).
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Reaction with Halogens.
Chlorination and bromination reactions of enamines have 
been described yielding the (3 -haloiminium salt
which is readily hydrolysed. (Scheme 29). Stable ( 3 -  
haloenamines have been isolated when N-halosuccinimides 
were used as halogenating agents.
I Br9 ® I I hydrolysis | |
>N-C = C<  — **>N = C-C-Br ---------* >N-H + 0 = C-C-Br
Scheme 29
Heterocyclic Enamines.
The term heterocyclic enamine is used to describe those
compounds that posses the >C=C-N< group as part of the
ring system. Typical behaviour of enamines has been
mainly observed for compounds possessing a tertiary 
1 37nitrogen atom . In this group are included various 
susbstitued dehydroderivatives of pyrrolidine 
(pyrrolines), piperidine (piperideines), the derivatives 
of dehydro-1 -azacycloalkanes with more than six membered 
rings, and finally compounds containing some of the 
basic skeletons : enamines of quinolizidine, 
indolizidine, pyrrolizidine and their benzoderivatives 
which occur in a large number of alkaloids. Analogous 
compounds with a secondary amine group (a ,/5 -unsaturated
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secondary amines) can, in principle, exist in either the 
form of imines (133) or the tautomeric form of enamines
(134).
(133)
All enamines do not react in the same way. Both
reactive sites are available for electrophilic
alkylation. Whether this alkylation occurs on the
nitrogen or the carbon atom depends on the reactivity of
the alkylation reagent, the structure of the enamine,
and finally the polarity of the solvent. Alkylating
reagents exhibit a greater tendency to react with the
nitrogen atom to form quaternary ammonium salts. The
more reactive alkyl halides such as allyl halides, a  -
halogenoketones and a  -halogenoesters would by contrast
react mainly with the fi-carbon atom of the enamine
1 10grouping. Thus treatment of A ’ dehydro-
138 139quinolizidine (135) with methyl iodide ’ gives a 
mixture of three products, (136), (137) and (138) 
containing 83% of the quaternary ammonium salt (137)
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whilst treatment of the same compound (135) with ethyl 
chloroformate furnished only 1-carbethoxy- A 1’10 
dehydroquino 1izidine after basificat ion.
This chapter is by no means a detailed account of the 
chemistry of enamines but intended only as an 
illustrative guide to the nature of enamines and to the 
types of reaction they undergo.
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DISCUSSION
Discussion
Introduction
The alkaloid deoxyvasicinone (1) undergoes a number of 
interesting chemical transformations in the A, B and C 
rings. As illustrated irf the introductory section these 
transformations include several which occur at the C-3 
methylene group of the pyrrolidine ring. The protons in 
this position bear a strong resemblance to the protons 
of the methyl group in 2-picoline (139)140and quinaldine
(140)141
(140)
However, the fact that (1) condenses with aromatic and 
aliphatic aldehydes with no catalysis indicates that 
they are much more reactive (see Introduction). Despite 
this reactivity and the fact that a similar reactive
39methylene group has been observed by Taylor and Shvo
in the fused quinazolone (16) little use has been made
of these or similar reactions to prepare compounds which
could function as intermediates in the synthesis of 
81 102novel alkaloids * . This thesis presents an account
of the synthesis and reactivity at C-3 of 
deoxyvasicinone and a number of its substituted C-ring 
analogues. The reaction of these compounds with a
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variety of reagents resulted in the formation of many 
new pyrrolo[2,1-b]quinazolinones. The thesis also 
describes the utilisation of several of these products 
in further synthetic transformations especially with 
respect to the preparation of novel tetracyclic systems.
Three main techniques were employed to synthesise
deoxyvasicinone (1 ) and analogous compounds.
Deoxyvasicinone (1) was initially prepared by the method
40
of Landii Vittory and Gatta (Scheme 3).
Unfortunately this method though efficient was time
consuming and was abandoned in favour of variations of
less laborious techniques such as those demonstrated by 
50 29
Shakhidoyatov and Devi . Thus (1) and analogous 
compounds where the pyrrolo ring carries a substituent 
were prepared via the condensation of anthranilic acid 
and either the appropriate 2 -pyrrolidinone or its 
imidate (Schemes 6 , 7 and 8 ).
Only 2-pyrrolidinone (9) and 5-methy1-2-pyrro1idinone
(53) were commercially available and the other alkylated
pyrro1idinones (54), (56) and (58) were obtained by a
1 42method devised from the preparation of cyclic amides 
The starting materials were the nitroesters (52), (50) 
and (48) prepared by the condensation of the appropriate
R fi - fi 9nitroalkane and a, ■ j3-unsaturated ester " . The
other 2-pyrrolidinones required, (57) and (59) were
87 7 7prepared using established techniques
62
Preparation of nitrocarboxy1ic acid esters.
58The technique of Moffett (see Introduction) was used to 
prepare methyl 4-methyl-4-nitropentanoate (48) in 71% 
yield following the reaction of 2 -nitropropane with 
methyl acrylate in dioxan. Adapting the Moffett method 
gave methyl 3-methy1-4-nitrobutanoate (52) and methyl 2- 
methy1-4-nitrobutanoate (50) in (50%) and (16%) yields 
respectively, following reaction of nitromethane with 
methyl crotonate or methyl methacrylate. (Scheme 30).
H P
c o 2c h 3
+ CHjNO
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The course of all these reactions was similar involving 
the generation of a carbanion following treatment of the 
original nitroalkane with the base triton B in the 
solvent 1,4-dioxan. Condensation of the desired 
carbanion with the appropriate acrylate derivative 
yielded the expected Michael adduct which had 
spectroscopic data consistent with the proposed
structure. The low yield of (50) and the
dimer (51)
?H3
C\J
o / CH2 '
CH - c o 2 ch3
- CH \
ch2 - CH - 1 CM
OC_J ch3
CH3
(51)
is formed as a minor product is indicative of the 
formation of a second carbanion generated from the 
primary product (50). Attack by this second carbanion 
on another molecule of methyl methacrylate leads to the 
formation of the dimer (51). The formation of this
59compound previously reported by Leonard and Shoemaker
may be minimised by replacing triton B with diethylamine
as catalyst but this was unnecessary as enough of the
59monoester was obtained to continue the study . An 
attempted condensation between nitromethane and methyl 
senecioate (141) using the Moffetttechnique failed to 
realise the desired product methyl 3,3-dimethy1-4- 
nitrobutanoate. The -carbon atom of (141) carries two 
methyl groups and it is this steric effect which 
presumably renders (141) unreactive to normal Michael 
addition reactions.
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HoC3 \ / ° 2 CH3
C
(141 )
A comparable hindering effect resulting from
substitution on the /3-carbon of the acceptor has been
55 5 9observed in other Michael condensations ’ .
Preparation of 2-pyrro1idinones
An extensive review of the techniques available for the 
preparation of 2 -pyrrolidinones has been included in the 
introductory section. This review illustrates that many 
effective and simple techniques leading to the formation 
of alkylated 2 -pyrro1 idinones incorporate high pressure 
hydrogenation to effect cyclisation of a nitroalkanoic 
acid or ester precursor. Unfortunately no hydrogenation 
facilities were initially available and consequently a 
comprehensive literature search and experimental 
programme was initiated to produce an alternative to 
hydrogenation for the production of alkylated 2 - 
pyrrolidinones.
142Lehr, Karlan and Goldberg reported the synthesis of a 
number of substituted 3-thiomorpholinones using three 
different methods. The last step of one of these routes 
involved the reductive ring closure of various 
nitroalkyl mercaptoacetates (142) to 3-thiomorpho1inones
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(143) using a refluxing mixture of iron filings, water 
and acetic acid. (Scheme 31).
Rctf X H 2 Fe/CH3C00H '
RCH C02C2H5
^ n o 2
( 142 )
Scheme 31
(143)
1 42The technique of Lehr et al was subsequently adapted 
and used to prepare the pyrro1idinones (54), (56) and 
(58) from the corresponding nitroesters (Scheme 30). 
Thus the desired nitroester was reductively cyclised 
during heating at 90° with a mixture of acetic acid, 
reduced iron powder and water. Subsequent purification 
by distillation gave the required pyrro1idinone. All 
the pyrrolidinones synthesised in this manner 
crystallised as colourless solids on standing and had 
spectral data in accord with the proposed structures. 
The yields of approximately 50% were satisfactory but 
substantially lower than those reported for the same 
compounds using high pressure hydrogenation techniques.
5-Carbethoxy--2-pyrro 1 idinone (57) was obtained in 64% 
yield via the thermal cyclisation of diethyl glutamate 
in toluene
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The method of Henecka et al^ was used to prepare the
required pyrrolidinone 4-ethoxycarbonylmethyl-2-
pyrrolidinone (59) (Scheme 32). The base catalysed
condensation reaction between t-butyl cyanoacetate and
two mole equivalents of ethyl ch1 oroacetate yielded the
crude diethyl 3-t-butoxycarbony1-3-cyanog1utarate (144)
as a thick red syrup. Selective acidic hydrolysis and
subsequent decarboxylation was effected using a
catalytic amount of para toluenesulphonic acid and gave
the pale yellow product diethyl 3-cyanog1utarate (60) in
75% yield. Intramolecular cyclisation of this diester
(60) was achieved using high pressure hydrogenation and
gave the crude (59) as a syrup. Purification by
distillation under reduced pressure afforded the product
77(59) as described by Henecka et al.
2 NaOC2 H 5
5 nct x o o c (c h 3) 3 ------------------*-
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Imidates of a number of these pyrrolidinones were 
prepared using standard techniques and yields were 
generally in excess of 60%. The compounds (9), (53) and 
(58) were converted into their imidates (34), (145) and
(146) by the reaction of the former with dimethyl 
sulphate followed by conversion of the intermediate 
salts with potassium carbonate. The ethylation of 
compounds (54), (57) and ^59) with triethyloxoniurn 
tetraf1 uoroborate followed by similar basification gave 
the imidates (78), (147) and (148).
(34) R = r1=h
(145) R=H,R1 =CH3
(146) R = R1 =CH3
(78) R = H,R1 =CH3
(147) R = C02  C2 H5 ,R1=H
(148) R = H, R^ =CH? CCU Co H,2 ^  2 2 5
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Pyrroloquinazolinones
Deoxyvasicinone (1) was initially prepared by a
modification of the method of Landii Vittory and Gatta 
(Scheme 3).
Acylation of anthrani1 amide with 4-chlorobutyry1 
chloride in acetic acid/saturated sodium acetate at room 
temperature gave the diamide (17) in 62% yield.
Cyclisation of (17) with sodium methoxide in methanol 
gave a mixture of two isomeric fused quinazo1 inones (1 ) 
and (16). Separation was elegantly achieved by 
continuous soxhlet extraction with ether in which (1 ) is 
soluble and (16) almost completely insoluble, thus 
eliminating the need for chromatography as reported in 
the original literature. This method though efficient 
was time consuming and was abandoned in favour of less 
laborious techniques.
The techniques which proved effective for the synthesis 
of (1 ) and analogous compounds where the pyrrolo ring
carries a substituent were variations of the techniques
50 29 31 49
of Shakhidoyatov , Devi , Onaka and Shkrob . As
indicated earlier these methods involve the condensation
of either the appropriate 2 -pyrro1 idinone or its imidate
(Schemes 6 , 7 and 8 ) with anthranilic acid. When compounds
(9), (53) and (56) were heated with anthranilic acid in
phosphorus oxychloride solution the compounds (1 ),
40
69
(149), (150) were obtained whilst condensation of (78), 
(34), (145), (146), (147) or (148) with anthranilic acid 
in hot toluene gave (151), (1), (149), (152), (153) 
and (154) respectively. Hydrolysis of the ester (154) 
was achieved following treatment with sodium ethoxide 
and yielded the acid (155) in 61% yield.
( 1 ) R - R =H
(149) R-R2 =H,R3 =CH3
(150) R = CH3 ,R1 -R3=H
(151) R = R2 =R3 = H, r1 =ch3
(152) R = R1 =H,R2 =R3 =CH3
(153) R-R2 =H,R3 =C02 C2 H5
(154) R = R2 =R3 =H,R1 =CH2 C02 C2 H5
(155) r=r2 = r3 =h ,r1 =ch 2 co2 h
The method involving condensation with POCl^ was 
abandoned in favour of the imidate/anthrani1 ic acid 
technique for several reasons. The vigorous conditions 
required to prepare the substituted pyrrolo[2 ,1 ~
50b]quinazolinones using the method of Shakhidoyatov 
resulted in some decomposition necessitating extensive 
purification processes and the reaction conditions and 
neturalisation step were clearly unsatisfactory for 
the preparation of esters due to the acid/base 
sensitivity of such groups.
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The pyrro1oquinazo1inones prepared using the 
aforementioned techniques had spectroscopic data which 
was consistent with their proposed structures, however 
the presence of monosubstituents (methyl or ester) in 
the pyrrolo ring in compounds (149), (150), (151), (153) 
and (154) made their p.m.r. spectra extremely complex. 
This complexity was due to the extensive vicinal and 
geminal coupling throughout the spectrum as a result of 
the non equivalence of the protons in the five membered 
ring.
Examination of the p.m.r. spectrum of 2,3-dihydro-2- 
methylpyrrolo[2,1-b]quinazolin-9(1H)-one (151), which 
appeared less complex than those of similar compounds 
allowed the coupling constants to be examined in greater 
detai1 .
Although the signals corresponding to the methylene 
protons at C-3 and the methine proton at C-2 overlapped 
and were not easily interpretable, the signals 
corresponding to the non equivalent methylene protons at 
C-1 were clearly visible as two double doublets each of 
which had an integral of 1 proton at <5 3.64 and 5 4.28 
respectively. The complexity of the total spectrum made
(151)
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definite assignment of the couplings difficult but it is 
thought that each of the methylene protons is geminally 
coupled to the other (12Hz) and vicinally to the methine 
proton at C-2 (7Hz). Shielding or deshielding may 
account for the non equivalence demonstrated by these 
methylene protons.
Benzylidene derivatives (156) to (161) were obtained 
from (151) to (154) and (1) and (149) respectively, 
when the latter compounds were heated with benzaldehyde, 
however no condensation occured when (150) was heated 
with benzaldehyde.
The geminal coupling outlined previously for the 
original pyrro1 o[2 ,1 -b]quinazo1 in-9(1 H)-ones was in 
evidence in a number of these benzylidene derivatives. 
However, the p.m.r. spectra of these compounds was 
further complicated by the long range allylic coupling 
and the extensive vicinal coupling resulting from the 
shielding and deshielding effects of the various 
substituent groups (methyl, ester or phenylmethylene).
H r ^ P h  ( 160) 
(161)
(156)
(157)
(158)
(159)
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The allylic coupling is normally small (0 - 3Hz) and 
often observed where two or more of the intervening 
atoms are Tl-bonded. This coupling was illustrated in
2,3-di hydro-1 ,1-dimeth.yl-3-phenylmethylenepyrrolo[2,1-
b]quinazolin-9(1H)-one (157) whose p.m.r. spectrum shows 
the C-2 methylene group centered on 5 3.08 as a two 
proton doublet. Although the complexity of the 
remainder of the spectrum made assignment difficult it 
is thought that this methylene group is coupled to the 
alkenyl proton of the benzylidene moeity with the 
coupling protons possibly being held in a W-type 
configuration. The coupling constant of 2.4Hz is 
consistent with this type of long range coupling.
The p.m.r. spectra of the benzylidene derivatives 2,3- 
dihydro-1-methyl-3-phenyl methylenepyrrolot 2,1-b] 
quinazolin-9(1H)-one (161) and 1-carbethoxy-2,3-dihydro- 
3 - phenylmethylenepyrrolo[2,1-blquinazolin-9(1H)-one 
(158) superbly illustrate the geminal, the.allylic and 
vicinal couplings previously mentioned.
(157)
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hKN>h nr^Ph
(161) (158)
In (161) the methylene protons of C-2 in the pyrrolo 
ring appear as a doublet of triplets (integral 1 ) at 
8 2 . 8 8  and a doublet of double doublets (integral 1 ) at 
8 3.53. Once again the complexity of the complete 
spectrum makes absolute assignment difficult but 
analysis of the coupling constants indicates that not 
only do these two protons couple with one another 
(17.7Hz) but that their respective coupling with the 
methine proton at C-1 is dependent on the dihedral angle 
each makes with that methine proton.
The influence which the dihedral angle ( 0 ) between two 
vicinal C-H bonds makes on the vicinal coupling is 
easily predicted and the values predicted using the 
Karplus equations are frequently in agreement with the 
observed figures.
Karplus equations.
JVIC = 8.5 cos2 0 - 0.28 0°< 0° < 90°
JVIC = 9.5 cos2 0 - 0.28 90°< 0° <180°
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It is more convenient to express this roughly using a
graph as many variables other than the dihedral
angle are important in deciding the magnitude of JVjC
143(vicinal coupling constant).
In compound (161) the larger vicinal coupling (8.7Hz) is 
consistent with predicted figures for an approximate 0 ° 
orientation of the atoms (HA- HB ) (Fig. 3) whilst the 
smaller coupling 2.7Hz is consistent with the values 
normally associated with protons separated by a dihedral 
angle of 1 2 0 °(HA- Hq ). ^
The signals for protons HB and Hq are subsequently seen 
as a doublet of double doublets and a doublet of 
triplets respectively as a consequence of the small
allylic coupling each of the protons HB and Hq also 
makes with the alkenyl proton of the benzylidene group. 
This coupling being much smaller (3.3Hz) than either the 
vicinal coupling between proton HA and HB (8.7Hz) or the
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normal geminal coupling (17.7Hz) consequently splits the 
signal corresponding to proton Hg a third time and the 
signal for Hg is manifested as eight lines on the 
spectrum. However, the signal corresponding to Hc is 
seen only as six lines on the spectrum because of the 
identical magnitudes of the vicinal and the allylic 
couplings (2.7Hz). The coupling in the ester (158) is 
similarly explained using the Newman projection shown 
below. (Fig. 4).
Fig. 4
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Reaction of Pyrrolo[2,1-b]quinazolin-9(1H)-ones at C-3
It has been shown by a number of authors that fused 
quinazolinones, e.g. (1 ) react with electrophiles at the 
carbon atom fi to the sp^  hybridised nitrogen atom of the 
quinazo1inone ring (see Introduction). Two possible 
mechanisms to account for such reactivity may be 
postulated. The first involves the protopic enamine 
tautomer of the original fused quinazolinone, the 
formation of which would lead to classical enamine 
reactions. (Scheme 33).
This is similar to the mechanism proposed by
1 44Tschitschibabin to account for the reactivity in 2- 
picoline (139) (Scheme 34).
---------------------------------
^ n ^ Nvc h 3
Scheme 34
N ^ C H 2
H
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The second proposal is that the apparent reactivity of
2
the carbon atom to the sp hybridised nitrogen atom of 
the quinazolinone ring may be due to the formation of a 
pseudo-base.
Pseudo-bas i city
145146Hantsch * was the first to recognise a form of 
tautomeric change in the reversible conversion between 
ionised quaternary ammonium hydroxides having double 
bonded nitrogen and the isomeric non-ionic carbinols.
The latter he termed pseudobases. The salts with strong 
acids such as hydrochloric acid are typical quaternary 
salts (162). However on treatment with a sufficiently 
nucleophilic anion such as hydroxide the covalent 
molecule (163) is predominantly produced.
pseudobase of deoxyvasicinone (1 ) may be reasoned as
2follows. Nucleophilic attack by the lone pair of the sp 
nitrogen atom to give the initial quaternary ammonium 
salt. Electronic migration and attack by a basic anion 
would eventually lead to the formation of the C- 
alkylated product via the pseudobase (164). (Scheme 35).
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Scheme 35
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The 'latent enamine' type reaction is thought to be the 
more feasible mechanism. No carbamate derivatives such 
as (165) have been isolated and although the possibility 
of hydrolytic cleavage at the C-N bond should not be 
discounted, the absence of any N-acylated/alkylated 
product would seem to indicate that the pseudobase 
mechanism is unlikely to take place.
The enamine mechanism was investigated using a high 
temperature deuterium exchange study. When (1) was 
treated at 150°- 156° for 15 hours with excess deuterium 
oxide (D2 O) complete exchange of the C-3 hydrogen atoms 
occurred and the 3,3-dideutero analogue of (1 ) (166) was 
recovered in 80% yield.
(165)
Enamine Formation
( 1 6 6 )
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Although this dideutero compound (166) was identical 
(t.l.c., m.p.) to (1 ) the incorporation of deuterium 
into (1 ) can be easily demonstrated from a comparison of 
the spectra (i.r., m.s. and p.m.r.) of (1 ) and (166).
The infrared spectrum of (166) showed only slight
changes to that of (1 ) particularly around the region 
-1
1450 - 1000 cm . The mass spectrum indicates a 
molecular ion two mass units higher than that of (1 ) at 
m/e 188. The p.m.r. spectrum indicated beyond any doubt 
that
a) deuteration had occurred.
b) the 3 position of deoxyvasicinone (1) is the site 
of deuteration.
Comparison of the p.m.r. spectra of (1) and (166) showed
that the low field triplet (integral 2 ) at 63.2
vanished in the spectrum of the deuterated compound and
the signal due to the C-2 hydrogen atoms was
considerably simplified and replaced by a triplet
(integral 2). Other workers have used similar exchange
methods in preparing the deuterated derivatives of more
147
simple nitrogen containing heterocycles. Brown et al 
succeeded in deuterating the methyl protons of various 
substituted pyrimidines following dissolution of their 
salts in deuterium oxide. The deuteration of methyl 
protons in a-picoline (139) was shown to occur in
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deuterium oxide or deuterium oxide-hydrochloric acid at
Previously the reaction of deoxyvasicinone (1) with 
electrophiles has been studied (see Introduction) and it 
was decided to extend our knowledge of such reactions by 
examining the reaction of deoxyvasicinone (1 ) and a 
number of its analogues with electrophiles.
Deoxyvasicinone was originally shown not to react with
chloroformic esters in a variety of solvent/base
mixtures. However, in neat ethyl chloroformate using
(1) as both reactant and base reaction did occur. The
product was dependent upon the reaction times and
temperature. Short reaction times ( 8  - 10 hours) at low 
/ o o.temperatures (110 - 120 ) favoured the formation of 3- 
(ethoxyethoxycarbonyloxymethylene)-2 ,3-d i hydropyrro1 o 
[2,1-b]quinazo1in-9(1H)-one (167).
Longer reaction times at these temperatures gave 3,3- 
dicarbethoxy-2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-
164.6° by Zoltewicz and Kandetzki^^
(167)
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one (168) and 2-ethoxy-(4H)-3,1-benzoxazin-4-one (169). 
Conversion of (167) into (168) was easily accomplished
by heating the former with ethyl chloroformate and the 
hydrochloride of (1 ).
(173) R=CH3 ,R1=H
(174) r=r 1 =CH3
(169)
The alteration in product ratio is consistent with a 
kinetic thermodynamic reaction mechanism. The formation 
of the thermodynamic product (168) may proceed via the 
intermediacy of the enamine of the monoester (170) 
(Scheme 36).
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A possible mechanism to account for the formation of the
benzoxazinone (169) is shown below (Scheme 37).
Protonation of deoxyvasicinone (1) yields the positively
charged species (171). Attack by a nucleophile
(possibly ethanol) followed by a retro Diels-Alder
reaction yields the ketene imine (46) of a type
previously recorded. Acylation at the imine nitrogen
followed by a (4 + 2)n cycloaddition reaction
regenerates the aromatic ring to give (169) which had
physical and spectral properties consistent with its 
149structure
^  N
0
(169)
Scheme 37
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The reaction of deoxyvasicinone (1) with ethyl
ch1 oroformate at higher temperatures (>160°) still gave
(168) as the major product but surprisingly the alcohol
3-carbethoxy-2,3-dihydro-3-hydroxy pyrrolo[2 ,1 -b]
quinazol in-9( 1H)-one (172.) was also recovered in good
yield. No mechanism to account for the formation of
(172) has as yet been postulated. The esters (168) and
(172) and the enol carbonate (167) were identified using 
1 3C nmr spectroscopy.
(172) (170)
Treatment of the diester (168) with a variety of bases
(ethanolic ammonia, hydrazine, sodium methoxide and N-
methy1piperazine) yielded only the monoester 3-
ethoxycarbonyl-2 ,3-dihydropyrrolo[2 ,1 -b]quinazolin-
9(1H)-one (170). Attempted reduction of (168) using the
107technique of Zharakeev produced one polar product 
(t.l.c.). Isolation and purification by preparative 
t.l.c. yielded colourless crystals which decomposed 
prior to positive identification.
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Although early experiments had shown that deprotonation 
of (1 ) in a variety of solvent/base mixtures failed it 
was later found that (1 ) could be lithiated smoothly at 
-20° using lithium diisopropy1 amide (LDA) generated in 
situ from n-butyl lithium and anhydrous 
diisopropylamine. Reaction of the intermediate organo 
metallic species with excess ethyl chloroformate gave 
the diester (168) in 28% yield. However, the treatment 
of lithiated (1 ) with other electrophiles (acetyl 
chloride, ethyl bromopyruvate) produced complex mixtures 
(t.l.c.) the components of which could not be isolated. 
The formation of the diester (168) in low yield is 
thought to be as a result of the lithiation of the 
intermediate monoester (170) by a mole equivalent of the 
original lithiated (1). Such an exchange reaction 
should not be unexpected as the remaining proton at C-3 
in the monoester (170) would be rendered more acidic due 
to electron withdrawal effect of the attached ester 
grouping.
Analogues of (1) demonstrated similar reactivities 
towards electrophiles, e^g. treatment of the monomethyl 
analogue (149) with excess ethyl chloroformate over 47 
hours at 140° produced 3,3-dicarbethoxy-2,3-dihydro-1- 
methy1pyrrolo[2,1-b]quinazo1in-9(1H)-one (173). 
Metallation, using a slight excess of LDA, of the 
dimethyl analogue (152) followed by reaction of the 
organolithiurn derivative with ethyl ch1 oroformate
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produced a 58% yield of 3,3-dicarbethoxy-2,3-dihydro- 
1,1-dimethylpyrrolo [2,1-blquinazolin-9(1H)-one (174).
The condensation reaction between 2-picoline (139) and
chloral hydrate has been known for almost one hundred
150 39
years . More recently Taylor and Shvo have shown
that pyrrolo[1 ,2 -a]quinazolinones also undergo
condensation with chloral to yield adducts. When
deoxyvasicinone (1 ) was heated gently with excess
chloral hydrate a thick dark red paste was isolated from
which was formed the colourless adduct 3-(2,2,2-
trichloro-1 -hydroxyethyl)-2 ,3-dihydropyrrolo[2,1 -b]
quinazo1 in-9(1H)-one (175) in 41% yield.
acid from 1,1,1-trichloro-3-(2-pyridyl)propan-2-ol by 
treating the former with ethanolic potassium hydroxide. 
However, similar treatment of the chloral derivative of
(1) (175) yielded only a purple black solid from which 
only unreacted (175) was recovered.
The preparation of (175) prompted an investigation into 
the reaction of (1 ) with other reagents possessing
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halogen atoms a to a carbonyl group. The reaction of
(1 ) with the halogenated esters ethyl ch1 oroacetate or 
ethyl bromoacetate afforded the expected product, 3- 
ethoxycarbonylmethyl-2 ,3-dihydropyrrolo[2 ,1 -b] 
quinazo1in-9(1H)-one (176) in low yields. When (1) was 
heated with excess chloroacetyl chloride, dich1 oroacety1 
chloride or trichloroacety1 chloride the products 
obtained were the chloroethy1idene derivatives (177) and 
(178) and the enol (179) respectively. A reaction also 
took place when (1) was' heated with 3-ch 1 oropropionoy 1 
chloride but the golden flakes (m.p. 130°) recovered 
have not been identified.
It is probable that the chloroethylidene (177) and (178)
exist in the E configuration and that there is a weak
hydrogen bond between the acidic chloromethyl (or
o
dichloromethy1) protons and the sp nitrogen atom (Fig.
5).
(177) R=CH2 C1,X=C1
(178) R = CHC 12,X = C 1
(179) R=0H,X=CC13
Fig. 5
X = H or Cl
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The hypothesis is supported by the low lvalue for these 
protons (see experimental). It is also likely that an 
unfavourable dipole-dipole interaction between this 
nitrogen atom and chlorine in a Z configuration may be a 
contributing factor for the exclusive stereochemical 
course of these reactions. In all these reactions an 
intermediate of the type shown in Fig. 6 is almost 
certainly involved.
In the case of the trichloroacetyl chloride steric 
factors will compel the trichloromethy1 group to adopt a 
trans position and since a Z chlorine atom is probably 
undesirable, elimination of hydrogen chloride is the 
preferred route in the decomposition of the 
intermediate. It is unclear whether the initial product 
from the reaction of (1 ) and trichloroacetyl chloride is 
the enol (179) or a labile enol trichloroacetate.
A nucleophilic displacement reaction using 
benzylamine was conducted on the chloroethy1 idene 
derivative (177) but proved unsuccessful, however 
reduction of (177) was effected using sodium 
borohydride. Two products were isolated following 
purification by p.l.c. The more polar compound was
Fig. 6
X=H, or C0CHnCl(3_n) 
R=CH„Cl/ 0nUi(3-n)
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identified using spectroscopic techniques as the (E) 3- 
ethylidene-2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one 
(98). The less polar component was shown by elemental 
analysis and mass spectrometry to have the formula C^H^g 
C 1 N2 0 but its actual structure has not been ascertained 
although two possible structures (180) and (181) are 
proposed.
Acylation of (1) with acetyl chloride using free radical
initiation, base catalysis or lithiation techniques
39proved unsuccessful. Taylor and Shvo's investigation 
into active methylene groups resulted in C and N 
acylation of pyrroloC1 ,2 -a]quinazolinones being effected 
by refluxing in acetic anhydride and pyridine. This 
technique proved ineffectual when applied to 
deoxyvasicinone (1). However, when (1) (or its 
hydrochloride) were refluxed with excess acetic 
anhydride for prolonged periods two products were 
produced which, after purification by chromatography, 
were shown to be the isomeric enol acetates (E) 3- 
acetoxyethylidene-2,3-dihydropyrrolo [2 ,1 -b]quinazolin- 
9(1H)-one (182) and (Z) 3-acetoxyethy1idene-2,3- 
dihydropyrro1o[2,1-b]quinazolin- 9(1H)-one (183).
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(182) (183)
The less polar isomer (182), which was the main product, 
was assigned the E-configuration from its p.m.r. 
spectrum. In the p.m.r. spectrum of (182) the acetate 
methyl group appears at 5 2.18 and the alkene methyl 
group at d 2.60 whilst in the p.m.r. spectrum of (183) 
the relative positions are 5 2.38 and 5 2.06 
respectively.
1 51Jackman has reported the value of a methyl group
attached to a C=C bond in an enol acetate (184) at 
81.91.
In the isomeric enol acetates (182) and (183) the 
magnetic environment of the acetate methyl group should 
not vary too much between the two isomers whereas the 
methyl group (attached to the C=C) in the (E)-isomer 
should be more downfield shifted due to the facial 
geometry of the compound and the proximity of the ring
(184)
2
sp nitrogen atom. In the p.m.r. spectrum of both (182)
and (183) the alkene methyl group is complex due to^the
homoallylic coupling to the protons of C-2 in the
pyrrolo ring. No diacetyl compounds of the type
39reported by Taylor and Shvo were isolated from this 
reaction or when the acetic anhydride was replaced with 
acetyl chloride. When (1) was heated with acetyl 
chloride at reflux for 89 hours the enol acetates (182) 
and (183) were recovered in low yield following a 
chromatographica1 separation of the concentrated 
reaction mixture. A third more polar component which 
was also isolated has not as yet been identified.
Interestingly the condensation reaction which occurred 
when (1 ) or its hydrochloride was heated with benzoyl 
chloride yielded the G'-chlorobenzy1idene derivative 
(185) as the major reaction product.
The (E) enol acetate (182) was shown not to undergo
nucleophilic attack when heated with benzylamine but was
107reduced successfully using the Zharakeev technique to 
afford the (Z)3-ethylidene- 2 ,3-dihydropyrrolo[ 2 ,1 -b] 
quinazolin-9(1H)-one (186). The (Z) enol acetate (183)
92
was similarly reduced to (E) 3-ethy1idene-2,3-
dihydropyrrolo[2,1-b]quinazolin-9(1H)-one (98). Both
(186) and (98) were obtained from the condensation of
(1 ) with vinyl acetate and triethylamine in a sealed
tube. The isomers were separated by chromatography and
assigned the relative configurations by examination of
their p.m.r. spectra. In the p.m.r. spectrum of the
major isomer (98) the alkene methyl group appears at d
1.80 and the olefin proton at 6  6.5 - 7.1 which is
consistent with an E-configuration. In the p.m.r.
spectrum of the minor isomer (186) the alkene methyl
group appears at 5 2.38 and the alkene proton at 5 6.1
which is compatible with a Z configuration. In both
these compounds the alkene hydrogen and the methyl group
are allylically and homoa1 ly1 ica1 ly coupled to the
protons of C-2 of the pyrrolo ring. Spin-spin
decoupling experiments confirmed these observations.
The ethylidene derivative (98) has been reported as a
101syrup by Jain et al but both (98) and (186) were
isolated in this study as colourless needles.
When (1) was heated with aerylonitrile in a sealed tube 
a substance derived from the polymerisation of 
acrylonitrile was recovered. The unreacted 
deoxyvasicinone was isolated in 96% yield.
The reaction between (1) and benzoic anhydride was 
investigated following the formation of both the (E) and
93
(Z) enol acetates from the reaction between (1) and 
acetic anhydride. When (1) was treated with an excess 
of benzoic anhydride no significant reaction below 2 0 0 ° 
was observed. However, condensation was rapid at 230° 
and two compounds of almost identical value were 
obtained from the reaction mixture. Separation was 
achieved by repeated fractional crystallisation. The 
major product was shown by spectroscopic methods to be 
the enol benzoate (187) and the Z stereochemistry is 
assumed for steric reasons. The minor product was shown 
by elemental analysis and mass spectrometry to have the 
formula c ^ 14N2°2’ however ^  was no't possible to 
unambiguously deduce its structure from spectroscopic 
data alone. The structure of this minor product was 
elucidated by X-ray crystallographic techniques and 
shown to be the (Z) a -hydroxybenzy1idene derivative 
(188) (see X-ray Section Pg. 105)which was stabilised
?due to intramolecular hydrogen bonding between the sp 
nitrogen atom and the hydroxyl hydrogen atom.
(187) R = COPh
(188) R = H
r il T—
Rcr\ph
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The stabilising influence of the sp hybridised nitrogen 
atom of the quinazoline ring in (188) may lend support 
to the earlier hypothesis that compounds such as (177), 
(178) and (179) are similarly stabilised by hydrogen 
bonding.
2
Further evidence to substantiate this theory was
obtained following preparation of the 3-hydroxymethylene
derivative (106) which was obtained in 83% yield.
Spectroscopy confirmed the enol structure and it is
probably favoured due to the intramolecular hydrogen
2bonding between the sp nitrogen atom and the hydroxyl 
hydrogen atom. The 3-acetyl derivative (189) was 
carefully prepared by the treatment of the (E) enol 
acetate (182) with sodium methoxide. The crystalline 
material obtained analysed as a monoacetyl derivative. 
The infra-red spectrum of this compound contained an OH 
stretch and no band corresponding to a ketone C=0 was 
evident. The p.m.r. spectrum indicated that in solution 
both tautomeric forms (189a) and (189b) were present.
H
(189b)
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The proton on C-3 appeared as an exchangeable doublet of 
doublets integrating for approximately half a proton and 
there appears to be two methyl singlets at 8 2.43 and 
8 2.02 in a ratio of approximately 2:1. No signals 
appeared below 8 10 but the signal for the hydroxyl 
proton may be broad and hence not be easily observed. 
Therefore the probable structure of the 3-acetyl 
derivative in solid state is (189b). Both (189) and the 
hydroxymethylene compound (106) reacted as carbonyl 
compounds. The hydroxymethylene compound (106) 
underwent a Robinson type anellation with methyl vinyl 
ketone to yield the spiroenone (190) whilst (189) formed 
a phenylhydrazone (191).
Prolonged hydrolysis of the (E) enol acetate (182) or
its (Z) benzoate counterpart (187) yielded
deoxyvasicinone (1) in 85% and 67% yields respectively.
The reaction of (106) with excess sodium borohydride did 
not yield any 3-hydroxymethyl derivative (192). Instead 
the two compounds which were isolated from the reaction 
mixture were identified as the methyl compound (150) and
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the more polar component as the secondary amine (193) 
which is present as a mixture of diastereoisomers.
One possible mechanism to account for the formation of 
these compounds is shown in Scheme 38. The expected 
compound (192) is produced during the reaction but 
suffers dehydration to yield the 3-methylene derivative 
(194). Reduction of the C=N bond in (194) followed by 
tautomerism yields (150) which is further reduced to 
(193).
Scheme 38
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This mechanism is supported by the results of several 
experiments. Deoxyvasicinone (1) is known to undergo 
reduction at the C=N bond and when the reduction was 
undertaken by Zharakeev the reduced analogue (195) was 
isolated. The analogue of (1) 3-methyl-2,3-dihydro 
pyrro1o[2,1-b]quinazolin-9(1H)-one (1 50) was shown to be 
similarly reduced to (193).
Further supporting evidence was obtained by the result 
of an attempted direct hydroxymethylation of (1 ) with a 
large excess of formaldehyde and potassium hydroxide in 
ethanol. In addition to unreacted (1) a three component
mixture was obtained. The mixture crystallised to yield 
the diol (196) whilst chromatography of the residue gave 
(194) and (197). The mechanism is thought to proceed as 
shown in Scheme 39. Any (192) which is formed is 
immediately dehydrated to yield (194). Attack by 
hydroxide or ethoxide on (194) followed by reaction with 
formaldehyde leads to both (196) and (197).
(195)
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Scheme 39
99
Taylor has reported that the [1,2-a] analogue of (1) 
undergoes condensation with bis(dimethy1 ami no)methane to 
yield an exocyclic methylene derivative similar to 
(194). When a solution of (1) in acetic anhydride was 
treated with bis(dimethylamino)methane the expected 3- 
exomethylene derivative (194) was isolated as the major 
product by column chromatography. A second more polar 
product was recovered from the column and shown by 
microanalysis and spectroscopy to have the structure 
(198).
39
(198)
The formation of the 3-acetoxymethy1-2,3-dihydro-3- 
dimethyl ami nomethyl pyrrolo[2,1-b]quinazolin-9(1H)-one 
(198) can be rationalised on the basis of the reaction 
of the original exomethylene product (194) with an 
acetate anion followed by reaction with a further mole 
equivalent of amine. (Scheme 40).
The reaction of a number of active methylene compounds
with the Mannich reagent tris(dimethylamino)methane has
152been reported by Weingarten and Edelmann . The 
reaction of deoxyvasicinone (1 ) with this reagent 
yielded a complex mixture from which no new products 
could be isolated.
100
»Scheme 40
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The exomethylene compound (194) was shown to react 
extensively with the Diels-Alder reagent dimethyl 
acety1 enedicarboxyl ate but isolation of pure components 
from the complex reaction mixture did not prove 
possible.
Although the formation of acety 1 vasicinone (8 6 ) has been
3 31reported ’ the oxidation 
position to give the 3-oxo 
been achieved.
of deoxyvasicinone at the 3- 
derivative (199) has never
Unfortunately experiments conducted during this study 
which attempted to effect the isolation of such a 3-oxo 
derivative were unsuccessful. Thus treatment of (1) or 
its benzylidene derivative (160) with the oxidising 
mixture of sodium chromate/acetic anhydride/acetic acid 
yielded only unreacted starting material whereas the 
reaction of (1 ) with selenium dioxide resulted in 
extensive decomposition yielding a purple black mixture 
which could not be resolved.
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Taylor has reported that the [1,2-a] analogue of (1) 
undergoes condensation with amyl nitrite in the presence 
of sodium ethoxide to yield an oxime. It was hoped that 
the hydrolysis of such an oxime of (1 ) would result in 
the formation of the desired 3-oxoderivative (199).
When (1) was treated with amyl nitrite under basic 
conditions the oxime (200) was isolated in 71% yield.
It was not possible to record the p.m.r. spectrum of 
this compound because of its highly insoluble nature. 
This insolubility made the compound extremely 
difficult to hydrolyse. A reaction was induced when the 
oxime (2 0 0 ) was stirred for fourteen dayswith lead 
tetraacetate in glacial acetic acid, however the brown 
solid obtained from the reaction mixture decomposed 
prior to isolation of any pure component (t.l.c.).
31Onaka has shown that 3,3-dibromo-2,3-dihydropyrro1o 
[2,1-b]quinazoli n-9(1H)-one (84) and 3-bromo-2,3- 
dihydropyrrolo[2,1-b]quinazolin-9(1H)-one (85) may be 
obtained from the free radical initiated bromination of
(1) with N-bromosuccinimide. This reaction was repeated 
but the low yield of the dibromo product (84) obtained
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prevented it being used to prepare the 3-oxo derivative 
via a hydrolysis reaction. However, the monobromo 
derivative (85) was characterised following a 
nucleophilic displacement reaction with the anion of 
methyl thioglycolate. The product from this latter 
reaction, the 3-carbomethoxymethylthio-2,3- 
dihydropyrro1 o [ 2  , 1  -b]quinazolin-9(1 H)-one (2 0 1 ) was 
identified as a thio ester using i.r. and p.m.r. 
spectroscopy. The p.m.r. spectrum of (201) was unusual 
in that the methylene protons attached to the sulphur 
atom appeared as a doublet at 5 3.754. The coupling 
constant appears to be smaller than normal geminal 
coupling yet larger than might have been expected for 
long range coupling.
Other nucleophilic displacement reactions on either (85)
q i
or similar compounds have been reported by Onaka or 
Kbkbsi et al^^.
Deoxyvasicinone or its analogues have been treated with 
a number of other electrophilic reagents (ethyl 
bromopyruvate, ethyl oxalyl chloride, 
methanesulphonyl chloride, phenacyl bromide, phenyl 
isocyanate, p-toluenesulphony1 azide, ethoxycarbony1 
isothiocyanate) but to date no other products have been 
isolated (see Experimental).
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X-Ray Crystallography
X-rays have wavelengths comparable to the distances 
between atoms in a crystal. An X-ray beam is therefore 
diffracted by a crystal and it is possible to obtain a 
detailed picture of the contents of the crystal at the 
atomic level by analysing the diffraction pattern 
produced. Once this information is available and the 
positions of the individual atoms are known precisely, 
the interatomic distances, bond angles and other 
features of the molecular geometry can be calculated.
A crystal can be regarded as being built up by the 
continuing three dimensional translational repetition of 
a basic structural pattern. Each repeating unit cell 
may be represented by a point and the arrangement of 
these points reproduces the size, orientation and shape 
of the unit cell. The array formed is a lattice and the 
points are lattice points. A crystal lattice is a 
regular three dimensional arrangement of points such 
that the view in a given direction from each point in 
the lattice is identical with the view in the same 
direction from any other lattice point.
When an X-ray beam strikes a crystal the diffraction 
pattern obtained is of a crystal arranged on a lattice 
that is reciprocal to the real lattice. A picture of 
this reciprocal lattice may be obtained using a number
105
of techniques and the reciprocal lattice may then be 
used to work out the unit cell and eventually the 
crystal structure.
The reaction between deoxyvasicinone (1) with benzoic 
anhydride at 230° gave the expected enol benzoate (186) 
and a second compound of spectral mass 290.3288 which 
could not be identified confidently from the 
spectroscopic data. Three possibilities for the 
structure were proposed (188), (202) and (203) and the 
X-ray analysis conducted has shown the product to be (Z)
2,3-dihydro-3-hydroxyphenylmethylenepyrrolo[2,1-b] 
quinazolin-9(1 H)-one (188).
( 202 ) (203)
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The study was conducted using the following methods.
Small yellow prisms of (188) were obtained following
recrystallisation from dimethylformamide or ethanol.
Two crystals (0.3 x 0.4 x 0.3 mm), free from any obvious
defects and small enough to be bathed in the X-ray beam
were selected under a microscope and mounted with
shellac (which does not diffract X-rays) onto a glass
fibre attached to a goniometer head. Each, of the
crystals was in turn set optically on a two circle
goniometer to align a principle zone of faces with the
goniometer axis. Initial data was then collected on a
Weissenberg camera. Firstly a single oscillation
photograph was taken, the crystal to be examined was
mounted on the camera and the mounting shaft oscillated 
o
by ±10 while the X-ray beam (40kV, 20mA, Ni filtered 
CuKce radiation) was directed through a collimator onto 
the crystal.
A double oscillation photograph was then taken. This 
photograph has two images of the layers on the same film 
produced by the crystal rotating by 180° between 
exposures. As well as checking the crystal setting 
these oscillation techniques gave information about 
lattice type and the unit cell dimensions. When the 
crystal was perfectly aligned a Weissenberg photograph 
of the zero layer was taken and from this and the 
oscillation photographs the complete set of unit cell 
dimensions and symmetry information was obtained. The
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compound (188) was shown to crystallise in space group 
P 2 ^ /C, the unit cell is monoclinic with dimensions 
a = 113.0pm, b = 1167.2pm and c=964.7pm, /S =110.23°. The 
next step in the data collection, i.e. the measurement 
of the upper layers in the crystal involved the use of a 
stoe STADI 2 diffractometer to collect intensities 
i(hki) which were later processed to give a list of 
observed structure factor amplitudes f^^i)* The 
diffractometer is a quantum counting device which 
directly measures the number of photons from the 
diffracted X-ray beam. This diffractometer has two 
moving circles.
a) co- rotates the crystal shaft and is used to 
bring any chosen reflexion of an orientated 
crystal into the diffracting position.
b) 2 0 - moves the detector so that it rotates about
a vertical axis, i.e. in a horizontal plane, 
ensuring that the plane containing the incident 
and diffracted beam is always horizontal.
Intensities were collected over the range 0 < 2 0  < 55° 
for crystals mounted on the a(h= 0  to 2 ) and b(k= 0  to 8 ) 
axes. Theco-scan technique was employed and 2552 unique 
reflexions were measured.
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Direct methods of structure solution were then employed 
to solve the structure from the collected data. Two 
assumptions are made whenever direct methods are used ;
a) The electron density map can never be negative in 
the ce1 1 .
b) Atoms are atom shaped, i.e. electron density 
around an atomic centre is approximately 
spherically symmetrical.
Direct methods attempt to assign the phases of a limited 
number of the most intense reflexions by statistical 
relationships. A Fourier map (or E-map) is then 
calculated for these phased reflexions and is examined 
to see if the peaks correspond to a model which is 
recognisable as at least a part of the expected 
structure. If the peaks do correspond with the model 
they are called atoms and are then used to phase the 
whole data set.
1 54The routine Tang (on SHELX 76) using 1115 of the most 
intense of the original 2552 reflexions, was employed to 
produce the best E-map which revealed all the non H- 
atoms. Once the approximate positions of the non H- 
atoms were known refinement of the structure took place. 
The atomic parameters (co-ordinates of atoms in cell) 
which were obtained from the E-map were used to
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calculate structure factors (fc) for all the hk1 values. 
The data set and that of the observed structure factor
systematic variation in order to give the best possible 
agreement between the two data sets. Since this problem 
involved many parameters succesive refinement cycles 
were needed before the structure converged to the stage 
at which shifts in the atomic parameters from cycle to 
cycle were negligible with respect to experimental 
error. The co-ordinates were then refined using a 
least squares procedure with isotropic thermal parameters 
for each atom to give improved values of (fc). The least 
squares method of refinement works on the basis that the 
best values for the principles of a linear function are 
those which minimise the sums of the squares of 
differences between (fc) and (fo) values for all the 
observed hkl's, the process being repeated until a 
reasonable match of fc and fo is obtained. At this 
point R = 0.11 (R being a measure of how well the 
calculated model fits the observed data and it should be
0.1 for most structures). Once the match of (fc) and (fo) 
was obtained the atoms were made, anisotropic (i.e. 
instead of having a spherical model for the thermal 
vibration of each atom, the parameters are altered to 
produce an ellipsoidal distribution of electron density, 
which is more like the movement of a real atom). The 
structure was now complete except for the position of
amp 1 itudes were refined via a process of
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the hydrogen atoms. The H atoms were included as riding 
atoms at calculated positions with grouped isotropic 
temperature parameters except for the hydroxyl proton 
which is involved in hydrogen bonding. This atom was 
located on a difference Fourier map and refined with an 
isotropic temperature parameter. Further refinement of 
the structure by least squares gave a final R value of
0.0689 for 1115 observed reflexions although the 
hydroxyl proton did not refine completely satisfactorily 
giving a final temperature parameter of 0.16A° . The 
atomic co-ordinates are given in Table 1*(estimated 
standard deviations in parenthesis). Table 2*gives the 
bond lengths and angles within the compound whilst 
figures 7, 8  and 9 show the molecule from a number of 
angles. The X-ray analysis has proved the molecule to 
be the Z isomer of (188) stabilised by a hydrogen bond 
between 0(22) and N(4) (257.1(6)pm) as previously 
mentioned. The respective bond lengths were 0(22) -
H(221 ) 103.1 pm(10) and N(4)......H(221 ) 1 69.8( 10)pm . The
phenyl group C(23)....C(28) is close to coplanar with
the pyrroloquinazolinone fragment giving the maximum 
extended I~I - bonding. The torsion angle C(3)-C(21 )- 
C(23)-C(24) is 171.27(7)° and the angle between the 
normals to the mean planes of the two benzene rings is
o
7.55(8) . All calculations were performed on the Dundee
University DEC 10 computer using the SHELX 76^^, XANADU 
1 56and PLUTO program packages. A list of structure 
factors, anisotropic thermal parameters and H-atom co- 
(* See Appendix at end of Section).
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155
ordinates have been deposited in the British Library, 
Lending Division.
Screening Results
A number of the compounds prepared during the course of 
this study were screened for possible fungicidal, 
insecticidal and herbicidal activity. Generally the 
benzylidene derivatives (156), (157), (159), (160) and 
(161) were demonstrated to have little activity over the 
range of screening tests however (156) was reported to 
be slightly active as a fungicide. Slight fungicidal 
activity was also recorded for the methyl analogues of
(1) being (150) and (152) and the ester (154). No 
herbicidal, insecticidal or fungicidal activity was 
recorded for the other compounds (151), (167), (168), 
(174), (177), (179) and (182) tested. No data was 
available on the herbicidal activity of (154), (156), 
(177) and (182) or the fungicidal activity of (177) and 
(182). The above information is the result of a 
screening program performed by Shell Research Ltd. ,
Sitttingbourne, Kent, England. The action of the (E) 
enol acetate (182) and the ch1 oroethy1 idene derivative 
(177) as anti tumour agents was also investigated.
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However the observation that these compounds exhibited 
high toxicities at increased dosage meant that studies 
into their activity were terminated.
These data are the results of screening performed under 
the auspices of the Developmental Therapeutics Program, 
Division of Cancer Treatment, National Cancer Institute, 
Bethesda, Maryland.
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Table Fractional coordinates (x 104) and equivalent 
isotropic thermal parameters (8  ^ x 1 0 ^).
Ueq • U • • a*a*a. . a . .  j  i j  i  j  i  J
X y
c (1 ) 4700 (4) 5088
C(2 ) 5570 (4) 4911
c (3 ) 5001 (4) 3871
C (3 a) 3887 (4) 3493
C(4a) 2085 (4) 2414
C (5) 1285 (5) 1472
C (6 ) 206 (5) 1259
C (7) -82 (5) 2 0 0 1
C (8 ) 709 (5) 2916
C(8 a) 1810 (5) 3132
C(9) 2675 (5) 4078
C ( 21 ) 5360 (5) 3337
C (23) 6470 (5) 3610
C (24) 6743 (5) . • 2839
C (25) 7728 (6 ) 3063
C (26) 8482 (5) 4048
C (27) 8232 (5) 4817
C (28) 7238 (5) 4599
N(4) 3146 (3) 2617
N( 10) 3696 (4) 4196
0 ( 0 1  ) 2548 (3) 4748
0 (2 2 ) 4634 (3) 2457
Ueq or U
(4) 8188 (4) 53 d )
(4) 7437 (4) 49 d)
(3) 6593 (4) 38 d)
(3) 6797 (3) 36 d)
(4) 6557 (4) 41 d)
(4) 5983 (4) 50 (D
(5) 6256 (4) 6 0 (2 )
(5) 7095 (5) 60 (2 )
(5) 7668 (4) 55 (2 )
(4) 7420 (4) 43 (1 )
(4) 8063 (4) 48 (2 )
(4) 5709 (4) 39 (D
(4) 5375 (4) 43 (D
(5) 4559 (5) 64 (2 )
(6 ) 4160 (5) 77 (2 )
(6 ) 4580 (5) ’ 6 8 (2 )
(5) 5389 (5) 64 (2 )
(4) 5790 (4) 55 (2 )
(3) 6249 (3) 41 (D
(3) 7687 (3) 41 (D
(3) 8847 (3) 6 8 (1 )
(3) 5016 (3) 48 (1 )
Appendix I
Table 2. Interatomic: distances (8 ) and angles (°).
C(2)-C(1) 1.540(8) N(4)-C(3a)-C(3) 126.6(4)
N(1 0 )-C{1 ) 1.468(5) N(10)-C(3a)-C(3) 109.7(3)
C(3)-C(2) 1.511(6) N(10)-C(3a)-N(4) 123.7(5)
C(3a)-C(3) 1.424(7) C(8a)-C(4a)-C(5) 120.3(5)
C(21)-C(3) 1.368(7) N(4)-C(4a)-C(5) 118.3(4)
N(4)-C(3a) 1.300(5) N(4)-C(4a)-C(8a) 121.4(4)
N(10)-C(3a) 1.376(6) C(6)-C(5)-C(4a) 119.7(5)
C(5)-C(4a) 1.395(6) C(7)-C(6)-C(5) 119.8(5)
C(8a)-C(4a) 1.402(7) C(8)-C(7)-C(6) 120.5(6)
N(4)-C{4a) 1.385(7) C(8a)-C(8)-C(7) 120.5(5)
C(6 )-C(5) 1.383(9) C(8)-C(8a)-C(4a) 119.2(4)
e(7)-C(6) 1.403(8) C(9)-C(8a)-C(4a) 120.3(5)
C(8 )-C(7) 1.367(7) C(9)-C(8a)-C(8) 120.5(5)
C(8 a)-C(8 ) 1.392(8) N(10)-C(9)-C(8a) 113.2(4)
C(9)-C(8a) 1.456(6) 0(01)-C(9)-C(8a) 126.3(5)
N(10)-C(9) 1.375(8) 0(01)-C(9)-N(10) 120.5(4)
0(01)-C(9) 1.226(6) C(23)-C(21)-C(3) 127.9(4)
C(23)-C( 2 1 ) 1.469(8) 0(22)-C(21)-C(3) 119.2(5)
0 (2 2 )-C(2 1 ) 1.352(5) 0(22)-C(21)-C(23) 112.9(4)
C(24)-C(23} 1.393(8) C(24)-C(23)-C(21) 117.8(4)
C(28)-C(23) 1.382(7) C(28)-C(23)-C(21) 124.2(5)
C(25)-C(24) 1.372(10) C(28)-C(23)-C(24) 118.0(5)
C(26)-C(25) 1.370(8) C(25)-C(24)-C(23) 121.2(5)
C(27)-C(26) 1.374(9) C(26)-C(25)-C(24) 1 2 0 .1 (6 )
C(28)-C(27) 1.380(9) C(27)-C(26)-C(25) 119.6(6)
C{28)-C(27)-C(26) 120.6(5)
N( 10)-C(1)-C(2) 104.2(3) C(27)-C(28)-C(23) 120.5(5)
C(3)-C(2 )-C(1 ) 104.9(4) C(4a)-N(4)-C(3a) 117.6(4)
C(3a)-C(3)-C(2) 108.6(4) C(3a)-N(10)-C(1) 112.5(4)
C(2 1 )-C(3)-C{2 ) 130.8(5) C(9)-N(10)-C(1) 123.8(4)
C(21)-C(3)-C(3a) 120.6(4) C(9)-N(10)-C(3a) 123.7(4)
Appendix II
EXPERIMENTAL
Experimental \
Infra-red spectra were recorded for potassium bromide
discs and for films in sodium chloride plates using
Perkin-Elmer 197 and Pye Unicam SP3-200
spectrophotometers. Ultra violet spectra were measured
on a Perkin-Elmer 402 ultraviolet-visible
spectrophotometer. The proton magnetic resonance
spectra were recorded either neat or in the appropriate
solvent using tetramethy1 si1 ane as internal standard on
Jeol JMN PMX 60 si and Jeol FX90Q machines at 60 MHz and
1390 MHz respectively. C n.m.r. spectra were recorded 
on a Bruker WP80DS spectrometer and mass spectra with an 
AEI MS9 spectrometer at 70 eV. X-ray diffraction 
analysis was conducted using a Stoe STADI-2 
d i ffractometer.
The melting points are uncorrected and were determined 
on an Electrothermal melting point apparatus.
Hydrogenation over Raney Nickel was carried out by the 
Boots Co. Ltd.
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Chromatographica1 Techniques
A Perkin-Elmer 8310 gas chromatograph containing an 0V- 1 7 
column was utilised for gas chromatography. Absorption 
chromatography was carried out using silica gel (Merck, 
70-230 mesh). Separations using pressurised short path 
columns were achieved with Kieselgel 60H as absorbent. 
Thin layer chromatography was conducted exclusively on 
pre-coated aluminium backed plates (Merck D.C. Alufolein 
Kieselgel ^OF^ ,,^ ). The following systems were used as 
eluents in chromatography.
System 1 Ethylacetate Triethyl amine (9: D
System 2 Ether
System 3 Ether : Light Petroleum (1:1)
System 4 Ether : Light Petroleum (7:3)
System 5 Ether : Light Petroleum (2:3)
System 6 Ether : Light Petroleum (1:3)
System 7 Ethyl Acetate : Light Petroleum (1:4)
System 8 Ethyl Acetate : Light Petroleum (3:7)
System 9 Ethyl Acetate : Light Petro1eum (1 :1 )
System 1 0  - Ethyl Acetate : Light Petroleum (2 :1 )
System 1 1 - Ethyl Acetate : Light Petro1eum (7:3)
System 1 2  - Ethyl Acetate : Light Petro 1 eum (4:1)
System 13 - Ethyl Acetate : Light Petro1eum (9:1)
System 14 - Ethy 1 Acetate : Dichloromethane (3:1)
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System 15 Ether : Ethyl Acetate : Light 
Petroleum (2:2:6)
System 16 - Propan-1,-ol : Water (3:1)
System 17 - Ethanol : Chloroform (1:19)
System 18 - Ethanol : Chloroform (1:99)
Preparative layer chromatography was achieved on glass 
plates (20 x 20cm) coated with silica gel (Kieselgel 
60H), thickness 2mm or the equivalent precoated glass 
plates (Merck P.S.C. Kieselgel 6.0F2 5 4 ) -
Developing Reagents for Thin Layer Chromatography
The following detection methods were used:
(a) Ultraviolet irradiation of t.l.c. plates
impregnated with a fluorescent indicator was 
routinely employed.
(b) Iodine vapour was a general but indiscriminating 
reagent.
(c) Development using 0.5% aqueous potassium
permanganate solution with warming if necessary 
was used as a general method.
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(d) Development using 5% ethanolic solution of 
anisaldehyde with a trace of concentrated 
sulphuric acid and heating was often used.
This reagent was foilnd to be particularly useful 
since each reaction component developed at a 
different rate to afford a different colour.
Hence coincidental components, or components with 
similar Rf values could be readily distinguished.
Solvents
All solvents are reagent grade unless otherwise stated. 
Light petroleum refers to petroleum ether boiling range 
60 - 80°. Ether refers to diethyl ether.
Tetrahydrofuran and diethyl ether were dried by 
distillation from lithium aluminium hydride.
Diisopropylamine was dried over KOH pellets for 48 hours 
prior to use. When necessary chlorinated hydrocarbons 
were dried over calcium chloride prior to storage over 
molecular sieve. Aromatic solvents were dried over 
sodium wire or sodium/lead alloy prior to use.
Anhydrous magnesium sulphate was used as a standard 
drying agent for all organic solutions. Charcoal was 
employed routinely as the decolourising agent.
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Reagents
Bis(dimethylamino)methane was prepared using aqueous
solutions of dimethy1 amine and formaldehyde according to
1 57the method of Lindsay and Hauser
Benzoic anhydride was prepared from benzoic acid
and acetic anhydride using the procedure of Clarke and
n . 158Rahrs
Lithium diisopropylamide was prepared in situ using
a standard technique from n-buty1 1  ithiurn and
diisopropylamine as demonstrated by Jahngen, Phillips,
159Kobelski and Demko
Triethyloxonium tetraf1uoroborate was produced in situ
95according to the method of Meerwein from boron 
fluoride etherate, ether and epichlorohydrin.
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General Preparatory and I s o l a t o r y  Techniques
Procedure (a)
The mixture was heated at 80-90° for 4 hours and cooled to 
room temperature. After, cooling the contents of the 
flask were acidified (dilute hydrochloric acid) and 
extracted with ether. The ether layer was washed twice 
with water, then with approximately 50ml of 0.1% sodium 
bicarbonate, 2 0 ml of brine and finally again with water. 
After drying the ethereal solution was concentrated by 
distillation and the products obtained by distillation 
through a 30cm Vigreux column at reduced pressure.
Procedure (b)
An equivalent quantity of water was added portionwise to 
the flask throughout the reaction and after a further 30 
minutes the mixture was cooled and the colloidal iron 
removed by filtration through sand and cotton cloth. 
Concentration of the filtrates afforded a brown mass 
which was extracted with acetone and filtered. The 
solid was washed with acetone and the mother liquors and 
washings were combined. Concentration in vacuo of 
these combined extracts yielded a thick brown syrup 
which was distilled under reduced pressure to give the 
product.
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Procedure (c)
As much benzene as possible was decanted from the 
reaction mixture and the mixture was stirred with a 50% 
aqueous solution of potassium carbonate (4ml/g 
pyrro1idinone) for 30 min. This heterogeneous liquid 
was extracted with ether ( 2  x 1 0 0  ml) and the combined 
ethereal extracts dried over magnesium sulphate in a 
stoppered flask for 30 min. This dried solution was 
quickly filtered into a second flask and the ether 
removed by distillation through a 30cm Vigreux column.
The remaining benzene was removed by distillation under 
reduced pressure (water pump) and continued distillation 
yielded the required imidate.
Procedure (d)
The thick suspension which formed was quickly filtered 
and washed with dich 1 oromethane. The filtrate was 
separated and the organic phase dried over magnesium 
sulphate in a sealed flask. Rapid filtration followed 
by distillation through a 30cm Vigreux column removed 
the solvents. The concentrated solution was distilled 
under reduced pressure (water pump) to give the product.
Procedure (e)
The mixture was cooled, diluted with ice/water and made 
alkaline with concentrated ammonium hydroxide. The 
aqueous solution was extracted with chloroform (3 x
123
150 ml) and the combined extracts dried, decolourised 
and concentrated in vacuo to give the crude 
pyrro1 oquinazo1 one as a syrup.
Procedure (f)
The mixture was cooled and concentrated in vacuo. The 
concentrated reaction mixture was partitioned between 
dich1 oromethane (1 0 0 ml) and a saturated solution of 
sodium bicarbonate (10ml) followed by water (5ml). The 
organic phase was dried, decolourised and concentrated 
in vacuo to give the crude pyrroloquinazolone as an 
orange syrup.
Procedure (g)
The flask was cooled to 0° and treated with ether. 
Agitation induced crystallisation of the crude 
benzylidene which was recrystallised from ethanol.
Procedure (h)
The mixture was cooled and excess reagent destroyed with 
glacial acetic acid. Neutralisation was effected using 
a saturated solution of sodium bicarbonate. The mixture 
was concentrated in vacu'o and evaporated with methanol 
(3 x 20ml) to remove borate. The residue was 
partitioned between dich1oromethane (150ml) and water 
(5ml). The organic layer was dried and concentrated in 
vacuo.
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Procedure ( i )
A solution of (1)in dry tetrahydrofuran (10m1/g(1)) was
added dropwise over 30 min, to a solution of lithium
diisopropylamide prepared according to the method of 
1 59Jahngen et al from the addition of n-buty11ithium 
(2.7 1 of a 1.6M solution in hexane/mol. of (1)) to 
anhydrous diisopropy1 amine (408g/mol.(1)) in dry 
tetrahydrofuran (10ml/g diisopropylamine) at -20° in a 
dry nitrogen atmosphere. The mixture (a deep burgundy 
red) was stirred for 1 hour prior to the addition of 
electrophiles.
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2-(4-Chlorobutyryl)aminobenzamide (17)
Acetic acid (400 ml) followed by a saturated solution of 
sodium acetate ( 2 0 0  ml) was added to anthrani1 amide 
(54.4g). The mixture was stirred to give a golden 
yellow solution. 4-chlorobutyry1 chloride (84.4g, 1.5 
mol.equiv.) was added dropwise to the solution with 
constant stirring at room temperature. After 1 hour the 
solution was diluted to 1600 ml with water to produce a 
white slurry. Filtration, drying and subsequent 
recrystallisation from ethanol gave the white 
crystalline product (17)(59.7g, 62%) m.p. 114°
(reported m.p. 120° (Landii Vittory and Ga t t a ^ O) )  t.l.c. 
(system 2) Rf 0.425.
2,3-Dihydropyrrolo[2,1-b]quinazolin-9(IH)-one(deoxy- 
vasicinone) (1) and 2, 3-d.i hydropyrro lo[ 1,2-a]-quinazol in- 
5(1 H)-one (16)
The chloro compound (17)(59.7g) was added portionwise to 
a solution of sodium methoxide (prepared from sodium 
metal (6.07g, 0.26g/atom) in methanol (500 ml) and the 
mixture refluxed on a water bath for 4 hours. On cooling 
the methanolic solution was decanted into a large round 
bottomed flask. The residue in the reaction vessel was 
washed with methanol and dichloromethane and these 
washings were also added to the round bottomed flask.
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Concentration of the organic solution afforded a pink
solid, t.l.c. (system 1) R^ 0.03, 0.482. The solid was
extracted portionwise with hot ether (soxhlet).
t.l.c. (system 1) indicated Rf 0.482 in ethereal
solution, Rf 0.03 in the crystalline residue. The
crystalline residue was dried and gave white crystals of
(16)(9.82g, 21%), m.p. 222° (reported m.p. 222° Landii
40.Vittory and Gatta ).
The ethereal solution was cooled and the ether reduced 
in volume on the evaporator. The addition of light
petroleum promoted crystallisation of (1) (22.07g, 47%),
o o ,  om.p. 109 - 110 (reported m.p. 110, Landii Vittory and
40Gatta ), t.l.c. (system 1 ) Rf 0.482; Vmax(KBr):3050 - 
2875, 1675 (C=0), 1620 (C=N), 1460, 1380, 1030, 780, 
690cm"1; Xmax (CHC13 ): 245 (£ 7000), 267 (£ 3800), 304 
(£ 1750), 31 1nm (£ 1500); 5 (60MHz , CDC13) : 2.30 (2H, 
quintet, JAB7Hz, >N-CH2-CH 2-CH 2- ) » 3.20 (2H, t, J AB7Hz , 
>N-CH2 CH2 -CH2-) , 4.30 (2H , t, J Ag7Hz , >N-CH 2-CH 2~CH £- ) , 
7.40-8.05 (3H,m,3 aromatic protons), 8.43 (1H, d , J 8 Hz, 
C-8 -H).
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2,3-Dihydropyrrolo[2,1-b]quinazolin-9(1H)-one (1)
Phosphorous oxychloride (50ml) was added to a mixture 
of anthranilic acid (21g) and 2-pyrrolidinone (9) (19g,
1.5 mol.equiv.) and the mixture heated for 1 hour on a 
water bath. The product was isolated as in procedure
(e). The crude product was recrystallised from 
cyclohexane to give deoxyvasicinone as a white powder 
(14.96g, 52%) identical in all respects (m.p., m.m.p., 
t.l.c. and i.r.) to an authentic sample.
2,3-Dihydropyrrolo[2)1-b!lquinazolin-9(1H)-one (1)
Anthranilic acid (20g) and 1-aza-2-methoxycyc1opent-1- 
ene (34) (17.2g, 1.2 mol.equiv.) in toluene (300ml) were 
heated at reflux for 1.5 hours and the crude product 
isolated using procedure (f). The syrup crystallised 
from ether/light petroleum to give colourless prisms of
(1) (15.6g, 58%) identical in all respects (m.p., 
m.m.p., t.l.c., i.r.) to an authentic sample.
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Ni troesters
These were obtained using the method of Moffet which
5 3 ~ 61was a refinement on the techniques of many authors 
Methyl 4-methy1-4-nitropentanoate (48)
Methyl acrylate (8 6 g) was added over 15 minutes to a 
stirring solution of 2-nitropropane (89g, 1 mol. equiv.) 
dioxane (50ml) and Triton B (10ml) heated to 70°. A 
slight exotherm was recorded and isolation by procedure 
(a) gave (48)(155g, 89%) as a nearly colourless oil,
b.p. 68°/0.7mm Hg (reported bp 79°/1mm Hg, Moffet^);
GLC(155°, Gas Pressures N£ 601b/in^, a i r 20.51 b/i n^ V b^Slb/in^ 
R-f. = 3.88 minutes. Area (1 0 0 %); Vmax(NaCl, film): 3000 
- 2875, 1738 (C = 0), 1540(N02) , 1350(N02), 1200 (C-O)cm' 1 
; 5 (60MHz): 1.58{6H, s,>C(CH3 ) 2  ), 2.28(4H,s,-CH2 -CH2-), 
3.52(3H,s,-OCO-CH3).
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Methyl 2-Methy1-4-nitrobutanoate (50) and dimethyl 
2,6-dimethyl-4-nitropimelate (51).
Methyl methacrylate (100g) was added over 15 minutes to 
a stirring solution of nitromethane (91.5g, 1.5 mol. 
equiv.), dioxane (50ml) and Triton B (10ml) heated to 70 
A slight exotherm was recorded. Isolation using 
procedure (a) gave the monoester (50)(25.59g, 16%) as a 
faint yellow oil, b.p. 64°- 66°/0.8mm Hg (reported b.p.
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82°- 83°/3mm Hg, Leonard and Shoemaker , ^maxfNaCl, 
film): 2975, 2950, 1735(C = 0) , 1550(NO 2), 1380(NOg), 
1200(C-0)cm'1; 8 (60 MHz): 1.14(3H,d,JAB7Hz, >CH-CH3), 
1.80 - 2.70(3H,m,-CH2-CH<), 3.54(3H,s,-0C0-CH3) 4.28 
(2H,t,JAB7Hz,-CH2 -CH2 -N02).
Continued distillation gave the diester (51)(20.38g,
8 %) as a yellow oil, b.p. 117.5°- 119.5°/0.7mm Hg
o 59(reported 134-136 /3mm Hg, Leonard and Shoemaker );
'Vmax(NaCl,film): 2975, 2950, 1730(C=0), 1550(N02),
1380(N02 ), 1200(C-0)cm'1; 8 (60 MHz): 0.94
(6 H,dd,JAB7HzOAM1Hz,2 x >CH-CH3), 1.32 - 2.48(6H,m,2 x -
CH^-CH<), 3.20(6H,s,2x-0C0-CH3), 4.32(1H,quintet,J^g7Hz,
;b h^>c h -n°2).
Methyl 3-methy1-4-nitrobutanoate (52)
Methyl crotonate (100g) was added over 15 minutes to a 
stirring solution of nitromethane (91.5g, 1.5mol.equiv.) 
dioxane (50ml) and Triton B (10ml). A slight exotherm 
was recorded. Isolation using procedure (a) afforded 
the monoester (52)(80.37g, 50%) as a faint yellow oil, 
b.p. 84°/2mm Hg (reported b.p. 77 - 79°/1mm Hg, Kambe 
and Yasude^); l)max(NaCl ,f i lm): 3100, 2900, 1740 
(C = 0), 1555(N02), 1385(NO2), 1180(C-0)cm"1; 8 (60 MHz): 
1.03(3H,d,JAB7Hz, >CH-CH 3), 2.20-3.00 (3H ,m, _cH|>£i±-CH 2  
-C02 CH3), 3.56(3H,s ,-0C0-CH3), 4.00-4.64(2H,m,
chL
-CH2 > CH- ^ 2 -N0 2 >-
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Attempted Preparation of Methyl 3,3-dimethy1-4-
n itrobutanoate.
Several attempts were made to obtain the expected 
condensation product from methyl senecioate and 
nitromethane using similar reaction conditions to those 
shown previously. However, distillation of the liquid
obtained using procedure (a) realised only starting 
materials (i.r., p.m.r. analysis) and these 
condensations were terminated prior to obtaining the 
desired product (methyl 3,3-dimethy1-4-nitrobutanoate) 
(see discussion).
Preparation of Pyrro1 idinones
5,5-Dimethyl-2-pyrrolidinone (58)
Methyl 4-methyl-4-nitropentanoate (48)( 155g, 1.08 mol.) 
was added to a stirring solution of glacial acetic acid 
(1200ml) and water (300ml) at 90°. Reduced iron powder 
(500g, 8.95g/atom) was added portionwise over 2 hours. 
Procedure (b) was used to isolate 5,5-dimethy1-2- 
pyrrol i d i none (45g, 37%) as a clear oil which solidified 
on standing as colourless needles, b.p. 89°/0.4 mm Hg; 
m.p. 40°- 41° (reported b.p. 126.5 - 128.5°/12mm Hg; 
m.p. 42°- 43°, Moffet^. g.l.c. (120°, gas pressures N2
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2 2 2 - 601 b/in , air - 20.51b/in , H2-231b/in Rt = 2.52 min., (area
100%); "Vmax ( NaCl ,f i lm): 3700 - 3000 (N-H), 2970 - 2875,
1 6 90(C = 0), 1420, 1 385, 1365, 1240 , 1220cm“ 1 ; 5 (60MHz,
CDC1 3) : 1.26(6H,s,>C(CH3) 2), 1.68 - 2.60 (4H ,m ,-CH 2>CH 2
-), 7.81(1H,s,D20 exchangeable, >N-H).
3-Meth,yl-2-P,yrrolidinone(56)
Methyl -.2-methyl-4-n itrobutanoate (50) (34.42g , 0.21 mol) 
was added to a stirring solution of glacial acetic acid 
(250 ml) and water (60 ml) at 90°. Reduced iron powder 
(1 0 0 g, 1.79g/atom) was added portionwise over a 2 hour 
period. Isolation using procedure (b) afforded 3-methyl-
2-pyrrolidinone (9.72g, 47%) as a clear oil which 
solidified as colourless needles on standing, b.p.
76°/0.4mm Hg; m.p. 59-60° (reported b.p. 96-97/4mm Hg, 
Cologne and Pouchol^, m.p. 58-59.5°, Adams and Fles®®)
Vmax(NaC1,film): 3600-3000(N-H), 3000-2850, 1700 
(C=0), 1490, 1460, 1430, 1380, 1295, 1260cm ;5(60MHz,
CDC13 ): 1.18(3H,d,Jab7Hz , >CH-CH3), 1.24-3.96
(5H,m, >CH-CH2 -CH2-) , 7.78(1H,s,D20 exchangeable, >N-H).
4-Methy1-2-pyrrolidinone (54)
Methyl 3-methyl-4-nitrobutanoate (52)(107g, 0.66 mol) was 
added to a stirring solution of glacial acetic acid (750
1 3 2
ml) and water (180 ml) at 90°. Reduced iron powder 
(160g, 2.86g/atom) was added portionwise over 4 hours. 
Isolation using procedure (b) gave 4-methyl-2- 
pyrrolidinone (37g, 57%) as a clear oil which solidified 
as colourless needles on standing, b.p. 98°/1.5mm Hg; 
m.p. 42-45° (reported b.p. 89-92°/1mm Hg, m.p. 42.4°, 
Crook67; Vmax(NaCl.film) , 3600-3000(N-H) , 3000 - 
2850, 1695 (C=0), 1490, 1460, 1420, 1380, 1345, 1290, 
1270, 1060cm'1; S(60MHz, CDC1,): 1.18(3H,d,JAg7Hz, 
>CH-CH3, 1.64-3.80(5H,m, -CH2 -fH-CH2), 7.38(1H,s,
D^O exchangeable, >N-H).
5-Carbethoxy-2-pyrrolidinone (57)
Crystalline sodium bicarbonate (35g, 0.99 mol.equiv.) was 
added portionwise with stirring to a suspension of 
diethyl glutamate hydrochloride (1 0 Og) in water ( 1 0 0  
ml). After 30 minutes the suspension was concentrated 
in vacuo and the concentrated mass extracted with 
dicholoromethane (2 x 100 ml). The organic extracts 
were dried and concentrated in vacuo to yield an orange 
syrup (6 8 .8 g). This was heated under reflux with 
toluene (300 ml) for 2h. The solvents were removed in 
vacuo to produce a second syrup (57.8 g) which was 
distilled under reduced pressure to give the crude 
pyrrolidinone (48.72g, 74%). Recrystallisation afforded
133
pure (57)(42.15g, 64%) as colourless needles, m.p. 54 - 
55° ; 'Vmax(NaCl,film) : 3500-3100 (N-H), 3050-2950,
1745(C=0, ester), 1705(C = 0, ring) , 1470-1420, 1390, 
1200cm" 1 ; 8  (60MHz, CDC1J: 1 .27 (3H, t , J . „7Hz ,-OCO- 
CH -CH ), 1,88-2.48(4H,m,-CH2-CH -), 3.92-4.38(38, 
m,-CH„>CH-C0 -CH -CH ), 7.30(1H,D 0 exchangeable, >N-
^  C Cm O Cm
H); m/e 157 (2%), 84 [M-73 ]+ (100%). (Found: C,
53.0; H, 7.0; N, 8.9. C^H^NO^ requires C, 53.5; H, 7.0; 
N, 8.9%).
Diethyl 3-cyanog1utarate (60)
A solution of ethanolic sodium ethoxide (2 mol.equiv.) 
(prepared from sodium (23g) in ethanol (500 ml)) was 
added portionwise to a mixture of t-butyl cyanoacetate 
(70.5g) and ethyl ch1oroacetate (122.5g, 2 mol.equiv.) 
over a period of 5 hours so that the temperature 
remained below 40°. The mixture was heated at 35 - 40° 
for 2 hours and then cooled to room temperature. 
Concentrating the mixture in vacuo afforded a white 
slurry which was partitioned between water ( 1 0 0  ml) and 
ether (3 x 150 ml). The ethereal extracts were combined 
and washed with a 1% aqueous acetic acid solution (50 
ml) and then water (15 ml) prior to drying over 
magnesium sulphate. The dried organic extracts were 
concentrated in vacuo to give the crude red (diethyl 3- 
t-butoxycarbonyl-3-cyanoglutarate) (144)(149.73g). This
1 3 4
liquid was heated at 140°- 160° with PTSA (125 mg) for 
3 hours until elimination of carbon dioxide had ceased. 
Fractional distillation under reduced pressure yielded 
the pale yellow diethyl 3-cyanog1utarate (60)(79.69g, 
75%) b.p. 120°/0.5 mm Hg (reported b.p. 141-144°/2 mm Hg 
Henecka77) ; Vmax(NaCl,film): 3000-2890, 2250(C = N), 1730 
(C = 0); 1470, 1445, 1200cm" ; d (60MHz, CDC13)
1.26(6H,t,Jab7Hz , 2 x-0C0-CH2 -CH3 ), 2.54-3.64(5H,m,-CH2- 
_CH (CN )-CH2- ) , 4.14(4H,q,JAB7Hz, 2 x-0C0-CH2 -CH3).
4- Et hox.y carbonyl me thy 1-2 ‘-pyrrolidinone (59)
Diethyl 3-cyanog1utarate (60) was reductively cyclised 
with hydrogen over Raney Nickel to give the crude 
pyrrolidinone (59). A portion (20g) of the crude 
material was purified by distillation under reduced 
pressure to give the pure ester (59) ( 1 1.80g) , b.p. 165°- 
169°/2mm Hg (reported b.p. 180-185°/4mm Hg (Henecka^); 
>Jmax(NaCl,film): 3700-3050(N-H), 3000-2080, 1740(C=0, 
ester), 1700(C = 0, ring) 1460, 1390, 1 190(C-0)cm ' 1
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Preparation of Imidates
1 -Aza-2 -methoxycyc1 opent-1 -ene (34)
Dimethyl sulphate (92.60g, Imol.equiv.) in dry benzene 
( 1 0 0  ml) was added dropwise with stirring to a refluxing 
solution of 2-pyrrol idinone (9)(62-5g) in dry benzene (367 
ml) over 4 hours. The reaction mixture was left to cool 
and purified as shown in procedure (c) to give (34) as a
colourless oil (45.86g, 63%), b.p. 35°- 40°/30imn Hg
o 94(reported b.p. 118-120 , Peterson and Tietze );
»max(NaCI ,film): 2950, 2850, 1695(C=N), 1440, 1345,
1238, 1040cm.
1-Aza-2-methoxy-5-methylcvc1opent-1-ene (145)
Dimethyl sulphate (25.45g, Imol.equiv.) in dry benzene
(150 ml) was added dropwise with stirring to a refluxing
solution of 5 -methyl-2 -pyrrol idinone (.53) (20g ) in dry
benzene (100 ml) over 2.5 hours. The mixture was
stirred at reflux for 4 hours and allowed to cool.
Isolation using procedure (c) yielded (145) (13.31g,
o59%) as a clear colourless liquid, b.p. 55 /15mm Hg;
''Jmax( NaC 1,f i 1m): 2975, 2875, 1650(C = N) , 1462, 1460,
1445, 1440, 1298, 1258, 1208, 1020, 990, 950cm"1;5 
{60MHz): .1.21 (3H,d , 0AB 7Hz, >CH-CH3  ), 1.84-2.64(4H ,m ,-CH2  
-CH2-), 3.34(1H,q,JAB7Hz, >_CH-CH3  ) , 3 . 6 8  (3H , s ,-OCHg ).
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Dimethyl sulphate (22.30g, 1 mol.equiv.) in dry benzene 
(50 ml) was added dropwise with stirring to a refluxing 
solution of 5 ,5-dimethyl-2-pyrrolidinone(58)(2Og) in dry 
benzene (100 ml) over 2.5 hours. The mixture was 
stirred at reflux for 6.5 hours and allowed to cool. 
Isolation following procedure (c) gave (146) (13.84g, 
62%) as a clear colourless liquid, ^max(NaCl ,film) :
2950, 2875, 1640(C=N), 1440, 1345(gem methyl), 1238,
1205, 1015, 975cm"1; 8 (60MHz): 1.20(6H,s, >C(C.H3)2),
1.74(2H, t, Jab7Hz ,-CH2 -CH2-(0CH3)C = N-), 2.47(2H,t, JAB7Hz, 
-CH2 CH2 -(0CH3 )C=N-, 4.68(3H,s ,-0CH3).
1-Aza-2-methoxy-5 ,5-d imethy lcyc lopen t -1-ene (146)
1 -Aza-2 -ethoxy-4-methyl eye 1opent-1-ene(78)
70.11 g (1.3 mol.equiv.) of triethyloxonium
tetraf1 uoroborate were generated in situ from dry ether
(123 ml), boron fluoride etherate (69.86g) and
epichlorohydrin (34.44g) according to the method of
Q C
Meerwein . The white etherate was washed thrice with 
dry ether (50 ml) and dissolved in dry dichloromethane 
(50ml). To this solution was added dropwise with 
stirring the 4-methyl-2-pyrrolidinone (54)(28.90g) in dry 
dichloromethane (50 ml). The solution was stirred for 
16 hours under dry nitrogen then treated with a cold 50% 
aqueous solution of potassium carbonate (150 ml).
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Procedure (d) was employed to isolate the imidate (78) 
(30.07g, 81%) as a colourless oil, b.p. 80°- 82°/30mm Hg; 
Vmax(NaC1, f ilm): 3000-2850, 1645(C = N), 1370, 1335,
1 225, 1 030cm"1; <5(60MHz): 1 .12-1.72(6H #m,-O-CHg-CH ,>CH- 
CH ), 2.92-4.12(5H,m,-CH -(CH )CH-CH2-), 4.30(2H,q,JAB 
7Hz , -0-CH2 -CH3).
1-Aza-5-carbethoxy-2-ethoxycyclopent-1-ene (147)
Triethyloxonium tetraf1uoroborate (35.05g, 1.3 
mol.equiv.) were generated in situ from dry ether 
(61.5ml), boron fluoride etherate (34.93g) and 
epicholorohydrin (17.22g) according to the method of 
Meerwein^ . The white etherate was washed with dry 
ether (3 x 50 ml) and dissolved in dry dichloromethane 
(20 ml). To this solution was added dropwise with 
stirring 5-carbethoxy-2-pyrro1 idinone (57)(22.57g) in dry 
dichloromethane (50ml). -The solution was stirred for 
1 2  hours under dry nitrogen whereupon a cold solution of 
50% aqueous potassium carbonate (100 ml) was added. 
Isolation using procedure (d) yielded the imidate (147)
(17.15g, 65%) as a colourless liquid, b.p. 78°/0.5mm Hg; 
Vmax(NaCl,film): 3000-2890, 1740(C=0), 1635(C=N), 1480- 
1420, 1405, 1380, 1340, 1270, 1030cm‘1; 5 (60MHz):
1.24(3H,t,J ,b7Hz-CH2 -CH3), 1.28(3H,t,JAB7Hz-CH2-CH3), 
2.0-2.72(4H,m,-CH2-CH2-), 3.32-3.52(1 H,m,>CH.-C02 CH2 -CH3  
3.88-4.60(4H,m,-0-CH2-CH3,-0C0-CH2CH3).
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1 - Az a - 4 - c  a r b e t  h o x y  m e t h y l  - 2 - e t h o x y  c.ycl o p e n t - 1 - e n e  ( 1 4 8 )
Triethy1oxonium tetraf1uoroborate (16.18g, 1.3
mol.equiv.) were generated in situ from dry ether (29.5
ml), boron fluoride etherate (16.74g) and
epichlorohydrin (8.25g) according to the method of 
95Meerwein . The white etherate was purified by washing 
with dry ether (3 x 50 ml) and dissolved in dry 
dich 1 oromethane (10 ml). To this solution was added 
dropwise with stirring 4-carbethoxymethy1-2- 
pyrrol idinone (59) (11.80g) i n dry dichloromethane (25 ml). 
The solution was stirred for 12 hours under dry 
nitrogen. A cold solution of 50% aqueous potassium 
carbonate solution (75 ml) was added and isolation using 
procedure (d) afforded the pure imidate (148) (8.7g,
63%) as a colourless liquid, b.p. 140°- 142°/3.5mm Hg, 
Vmax(NaCl.film): 3000-2850, 1740(0=0), 1630(C=N), 1390, 
1340, 1270, 1180(C-0)cm'1.
1 3 9
Preparation of substituted 2,3-dihydropyrro1o[2,1-b]
quinazoli n-9(1H)-ones.
2,3-Dihydro-1-methylpyrrolo[2,1-b]quinazolin-9(1H)-one
(149)
P0 C1  ^ ( 2 0  ml) was added portionwise to a.mixture of 
anthranilic acid (8.4g) and 5-methy1-2-pyrrolidinone 
(53) (7.6g, 1.3 mol.equiv.) and the mixture heated on a 
steam bath for 1 hour. Procedure (e). A short path 
bulb to bulb distillation (Kugelrohr) at 150°/0.8 mm Hg 
of this orange syrup yielded the pure compound (149) as 
a clear syrup which crystallised from ether/light 
petroleum as colourless 'prisms (6 .6 g, 55%), (149), m.p. 
70°- 71°; t.l.c. (system 1), R^, 0.529; Vmax(KBr): 3075, 
2975-2800 , 1 670(C = 0) , 1610(C = N) , 1560 , 1465, 1440, 1423, 
1380, 1370, 1330, 1260, 1180, 1140, 1108, 1030, 870,
790, 702 cm"1; 5(60 MHz, CDC1,): 1.29(3H,d,0 7Hz , >CH-3 AB
CH-, 1.6-2.6(2H,m,-CH2 -CH2 -CH<), 2.72-3.32(2H,m,-CH2-CH2 
-CH<), 4.62(1H,m,-CH2-CH-CH3), 6.98-7.72(3H,m, aromatic 
protons), 8.00(1H,d,J 7Hz, C-8 -H); m/e 200 [M+ -]; (Found: 
C, 71.6; H, 6.1; N, 13.9. C 12H 12N2° requires C, 72.0; H, 
6.0; N, 14.0%).
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2,3-dihydro-1-methylpyrrolo[2,1-b]quinazolin-9(1H)-one 
( 149)
Anthranilic acid (6.58g) and 1-aza-2-methoxy-5- 
methylcyclopent-1-ene (145) (5.96g, 1.1 mol.equiv.) in 
toluene (150 ml) were heated at reflux with stirring for 
2 hours. The orange syrup obtained following isolation 
using procedure (f) was crystallised from ethyl 
acetate/1ight petroleum to give (149), as a colourless 
solid (7.04g), 73%). An analytical sample was obtained 
as colourless prisms following a short path bulb to bulb 
distillation (Kugelrohr) at 15cP/0.4mm Hg and was found 
to be identical to an authentic sample (m.p., m.m.p., 
i . r . ) .
2,3-Dihydro-1,1-dimethylpyrrolo[2,1-b]quinazolin-9(1H)- 
one (152)
Anthranilic acid (9.67g), 1-aza-2-methoxy-5,5- 
dimethyl eye 1 opent-1-ene (146) (10.76g, 1.2 mol.equiv.) 
in toluene ( 2 0 0  ml) were mixed and heated at reflux 
for 1 h.and the crude product isolated using procedure
(f). The syrup crystallised on agitation and 
recrystallisation from ether/light petroleum afforded 
colourless prisms of (152) (10.16g, 67%). An analytical 
sample was prepared via a short path bulb to bulb 
distillation (Kugelrohr) at. 150^0.8 mm Hg (152); m.p.
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105 - 106°; t.l.c. (system I) 0.665; Vmax(KBr): 3075, 
3010 - 2900, 1670(C=0), 1620(C=N), 1470, 1455 (doublet, 
gem methyls), 1350, 1330, 785, 705, 695cm 6  (60 MHz,
CDC13 ) : 1 . 6 8 ( 6 H , s , >C (CH3 ) 2 )-,. 2.02(2H , t , JAB7Hz ,-CH2 -CH2  
-C (CH3 ) 2-) , 3.00(2H,t,JAB7Hz, -CH2 -CH2 -C;(CH3)2-) , 7.00- 
7.64(3H,m,aromatic protons), 8.06(1H,d,J 7Hz, C-8 -H); 
m/e 214 [M+*] (58%) , 199 [M-15]+ (100%) ; (Found: C,
72.4; H, 6 .8 ; N, 12.7. ■C-|3 .H^N20 requires C, 72.8; H,
6 .6 ; N, 13.1%).
2,3-Dihydro-2-methylp,yrrolo[2,1-b]quinazolin-9(1H)-one
(151)
Anthranilic acid (5.48g) and 1-aza-2-ethoxy-4- 
methy1 eye 1opent-1-ene (78) (6 .3 0 g , 1.1 mol.equiv.) in 
toluene (150 ml) were heated at reflux with stirring for 
2 hours. Isolation of the crude product was achieved 
using procedure (f). The orange syrup (7.5g) was 
purified via a short path bulb to bulb distillation 
(Kugelrohr) at 130°/1 mm Hg to give (151) as a 
colourless solid (3.32g, 42%). An analytical sample was 
obtained as colourless needles after chromatography on 
silica gel (25g) using ethyl acetate as eluant. (151), 
m.p. 154.5-155.5°; t.l.c. (system 2) R f  0.26; Vmax(KBr): 
3100-3000, 3000-2875, 1670(C = 0) , 1625(C = N) , 1465,
1435, 1335, 790, 775, 700cm. 8 (60 MHz, CDC13):
1 .24 (3H, d , J 7Hz , >CH-CH3), 2.98-3.42 (3H ,m, CH 2 -CH.-CH 3),
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3.64(1H,dd,J12Hz, 0BD7Hz, -CON-CH-CH(CH, ) -) ,
4.28(1H,dd,0.12Hz, 0 7Hz, -CON-CH-CH(CHg)-), 7.05- 
7.78(3H,m ,aromatic protons), 8 .10(1H,m,C-8-H); m/e 200 
[M+3 (6 6 %), 185 [M-15]+(100%); (Found: C, 71.9; H, 6.0; 
N, 13.75. C H N 0 requires C, 72.0; H, 6.0; N,
1 2 i 2 2
14.0%).
2,3-Di hydro-3-methyl pyrrolo[2,1-b]quinazolin-9(1H)-one 
(150)
Phosphorous oxychloride (30 ml) was added portionwise to 
a mixture of anthranilic acid (12.Og) and 3-methyl-2- 
pyrrolidinone (56) (13g, 1.5 mol.equiv.) and the mixture 
heated on a water bath for 1 hour. The black syrup 
(15.2g) isolated using procedure (e) was chromatographed 
on silica gel (15Og) and elution with system 9 yielded a 
yellow syrup which crystallised from ether. 
Recrystallisation from ether gave colourless needles of 
(150) (4.50g, 26%). An analytical sample was prepared 
via a short path bulb to bulb distillation (Kugelrohr) 
at 155°/0.3 mm Hg (150), m.p. 135-135.5°; t.l.c. (system
1) Rf 0.627; Vmax(KBr): "3100-2850, 1665(C = 0), 1620(C = N), 
1470, 1385, 1345, 1335, 788, 740, 700cm"1; Xmax(CHCl,) 
246(£ 6000), 267(^  8000), 305(£ 4000), 317nm(£ 3600) ;§
(60MHz, CDC1 ): 1.24 (3H, d , J. „ 7Hz , >CH-CH, ), 1.58-4.24
3 A d __3
(5H,m,-CH^-CH^-CH<), 7.10-7.70(3H , m, aromatic protons),
8.08(1H , d , J 7Hz , C-8 -H); m/e 200 [M + -] (82.4%), 185 [M-
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1 5 ]+, (25.25%); (Found: C, 71.7; H, 6.0; N, 13.9. C 1 2 H-|2
N2 O requires C, 72.0; H, 6.0; N, 14.0%).
1-Carbethoxy-2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)- 
one (153) .
Anthranilic acid (2.74g) and 1-aza-5-carbethoxy-3- 
ethoxycyclopent-1-ene (147) (4.01g, 1.1 mol.equiv.) in 
dry toluene ( 1 0 0  ml) were heated at reflux for 2 hours. 
The syrup obtained using procedure (f) crystallised from 
ether/light petroleum as colourless needles of (153)
(2.25g, 44%), m.p. 1 18.5-1200 ; t.l.c. (system 2) Rf
0.269 ; Vmax(KBr): 3075, 3000-2890, 1740(C=0, ester), 
1690(0=0, ring), 1625(C=N), 1470, 1390, 1380, 1330,
1320, 1220(0-0), 1040, 770, 700cm ; 5 (60MHz, C D C13 ):
1.24(3H,t,OAB7Hzr OCO-CH2-CH3 ), 2.00-3.6 8 (4H,m,-CH2 -CH2- 
4.16(2H,q, JAb7Hz,-0C0-CH2 -CH3) , 4.98( 1H, dd , JAB 2.4Hz,
J/\b 6 .0Hz ), 7.00-7.80(3H,m,aromatic protons),
8.08(1H , d , J 7.0Hz, C-8 -H); (Found: C, 65.0; H, 5.4; N, 
10.65. C1 4  H1 4  N2 O3 requires C ,• 65.1; H, 5.4; N, 10.85%).
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2 - C a r b e th o x y m e th y l - 2 , 3 - d i h y d r o p y r r o l o [2 , 1 - b ]q u in a z o l i n -
9(1H)-one (154)
Anthranilic acid (4-35g) and 1-aza-4-carbethoxymethy1-2- 
ethoxycyclopent-1-ene ( 148)(7.30g, 1.1 mol.equiv.) were 
heated for 2.5 hours in toluene (200 ml). The syrup 
(7.59g) obtained using procedure (f) was chromatographed 
on silica gel (200g) and elution with system 7 yielded 
a second orange syrup (6.14g) which crystallised on 
cooling at 0°. Recrystallisation of the solid from 
ethyl acetate/1 ight petroleum afforded the product 
(5.20g, 58%) as colourless need 1es ,(154) m.p. 90-91°; 
t.l.c. (system 1) Rf 0.65; >)max(KBr): 3000-2900, 1730 
(C = 0, ester), 1680(C = 0, ring), 1620(C = N), 1480, 1430, 
1390, 1340, 1 180(C-0), 788, 705cm'1; 5(60MHz, CDC13 ):
1.26(3H,t, JAB7.0Hz,-OCO-CH2 -CH3), 2.24-4.64(9H,m,
-§h| >CH-CH2 -0C0-CH2 -CH3), 7.08-7.60(3H,m,aromatic 
protons), 8 .10(1H,m,C-8-H). (Found: C, 65.80; H, 5.80; 
N, 10.25. c 1 5 H-|5 n 2 ° 3  requires C, 6 6 .2 0 ; H, 5.90; N, 
10.30%).
2-Carboxymethyl-2,3-dihydropyrrolo[2,1-b]quinazolin- 
9(1H)-one (155)
The ester ( 154) (690 mg) was added to a previously 
prepared solution of sodium ethoxide (sodium 280 mg,
0.12g/atom) and ethanol (18 ml). The flask was sealed
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and stirred for 16 hours at room temperature and the 
colourless precipitate was removed by filtration. The 
precipitate (500 mg) was dissolved in water (20 ml) and 
the resulting solution made slightly acidic (pH 6 ) with 
dilute sulphuric acid. Cooling produced a crystalline 
deposit which was filtered from the flask. Drying gave 
(155)(380mg, 61%) as colourless needles, m.p. 247-249°; 
t.l.c. (system 9) R 0.55; 'Vmax(KBr): 3700-2200(H-bonded 
OH), 1 730(C = 0 , acid), 1680(C = 0, ring), 1630(C = N), 1480, 
1420, 1400, 1205(C-0), 780, 710cm"1; (Found: C, 63.6;
H, 5.0; N, 11.35. C,,H,,N,°, requires C, 63.9; H, 4.9;
N, 11.37%).
Preparation of Benzylidene Derivatives
2,3-Dihydro-3-phenylmethylenepyrrolo[2,1-b]quinazolin- 
9(1 H)-one (160)
The compound (1)(5.65g) and benzaldehyde (20 ml) were 
heated together at 150°- 160° for 1 hour. The product 
was isolated following procedure (g) as feathery yellow 
needles (7.00g, 85%), m.p. 136°- 138° (reported m.p. 137° 
- 139°, S h a k h i d o y a t o v .
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2 ,3 -D ih y d ro -1 -m e th y l - 3 -p h e n y lm e th y le n e p y r ro l o [2 ,1 -
b]quinazolin-9(1 H)-one (161)
The compound (149) (1.32 g) and benzaldehyde (5 ml) were 
heated at 150 - 160° for 1 hour. Isolation of the 
product using procedure (g) gave (161) (1.02g, 54%) as 
feathery white needles, m.p. 168.5 - 169.5°; t.l.c. 
(system 1) Rf 0.667; S)max(KBr): 3050, 2975-2925,
1 665(C = 0 , ring), 1590(C = N), 1558, 1460, 1445, 1435,
1382, 1370, 1330, 770, 760, 695, 685cm'1; S(90MHz,dg 
DMS0): 1.45(3H,d,0AB7Hz, >CH-CH3 , 2.88(1H,dt,JAB=JAX 
2.7Hz, JGEM 17.7Hz,CH3>CH-CH>C = C<fjh ), 3.53(1H,ddd,JAB 
8.7Hz, JAX,3.3Hz, JgEM17..7Hz, CH3>CH-6lH;>C = C<fjh)4.74- 
4.95(1H,m,>CH-CH3 ), 7.36-7.90(9H,m,>C = C<jjt , 3 aromatic 
protons), 8.15(1H,d,J 7Hz, C-8 -H); m/e 288 [M+‘] (40%), 
287 CM-1]+ (100%); (Found: C, 7.87; H, 5.5; N, 9.75. C1 9
H1 6 N20 requires C, 79.2; H, 5.6; N, 9.7%).
2,3-Dihydro-1,1 -d imethyl-3-phenylmethylenepyrrolo[2 ,1 - 
b]quinazo1in-9(1H)-one (157)
The compound (152), (1.70g) and benzaldehyde (5ml) were 
heated together at 150 - 180° for 1 hour. Isolation 
using procedure (g) gave the product (157) (1.62g, 6 6 %) 
as yellow prisms, m.p. 172.5-173°; t.l.c. (system 3) Rf
0.49; Vmax(KBr); 3075-2900, 1665(C = 0) , 1590(C = N), 1560, 
1470, 1378, 1355, 1330, 765, 698, 690cm"1 ; 5 (60MHz, CDC1,
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~CH2 Ph
1.78(6H,s,>C(CH3)2), 3.08(2H,d,JAX 2.4Hz, >C = C<H 
7.16-7.96(9H,m,>C = C<‘jJ"~ , 3 aromatic protons),
8.24(1H,d,J 7.0Hz, C-8 -H); m/e 302[M+] (58%), 301[M-1]+ 
(100%); (Found: C, 79.5; H, 5.96; N, 9.3. <20^8^°
requires C, 78.9; H, 6.25; N, 9.4%).
2,3-Pi hydro-2-methyl-3-phenylmethylenepyrrolo[2,1-b] 
quinazol in-9(1H)-one (156)
The compound (151), (800 mg) and benzaldehyde (5 ml) 
were heated together at 150°- 160° for 1 hour.
Procedure (g) realised the product (156) (580 mg, 50%) 
as colourless needles, m.p. 154.5-155.5°; t.l.c. (system 
4) Rf 0.445 ; Vinax (KBr): 3500-3000, 3000-2875, 1670(C = 0), 
1590(C=N), 1495, 1465, 1450, 1390, 1380, 770, 760, 690cm 
5( 90MHz, dKDMS0): 1.252(3H,d,J„„7Hz, >CH-CH,), 3.798-
b  ( A B  — 1  P h
4.360(3H,m,N-CH2-CH-CH3), 7.377-7.817(9H,m,>C = C<H , 3 
aromatic protons), 8.149(1H,d,J 7.0Hz, C-8 -H); m/e 288 
[M+'] (36%), 287 CM-1)+ (100%); (Found: C, 79.15; H, 
5.65; N, 9.60. C19^16N2^ recluires C, 79.2; H, 5.56; N,
9.72%).
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Treatment of 2,3-dihydro-3-methylpyrrolo[2 ,1 - 
b]quinazolin-9(1H)-one (150) with benza1dehyde.
The compound (150), (500 mg) was heated with benzaldehyde 
(5ml) at 150 - 180° for 3 hours. No reaction appeared 
to take place. Treatment of the cooled reaction mixture 
with ether afforded the crude starting material (430 mg) 
identical in all respects m.p., m.m.p. and i.r. to an 
authentic sample.
1-Carbethoxy-2,3-d i hydro-3-phen.y lmeth.y lenepyrrolo[2,1 -b] 
quinazolin-9(1H)-one(158)
The compound (153), (500 mg) and benzaldehyde (5 ml) were 
heated together at 150 - 160° for 1 hour. Isolation 
using procedure (g) furnished (158) (480 mg, 76%) as 
colourless needles, m.p. 204-205°; t.l.c. (system 4)
0.50; Vmax (KBr) 3100-2900, 1735(C = 0, ester), 1680(C = 0, 
ring), 1 590(C = N ) , 1465, 1450, 1400, 1380, 1330, 1215(C- 
0), 780, 700cm"1; <5(90 MHz , dgDMSO) : 1.206 (3H, 
t,JAB7Hz, -0C0-CH2 -CH3), 3.234(1H,dt,JAX= JAB>3.0Hz, JgEM 
18Hz , plT>C = Cl,c<rCH< 3.760( 1H,ddd, JAX3.06Hz, JAB9.4Hz, J
H GEM;>c=c<„ H18Hz , ), 4.184(2H,q,JAB7Hz,-0C0-CH2-CH3),fl
5.237( 1H,dd, JAB3.50Hz, JAB9.80Hz,-C]i^CHl< ^ 2
Et
Ph
), 7.416 -
7 . 9 3 9 (  9H,m,>C = C<-pp , 3 aromatic protons), 8 . 0 9 0 -  
8.197(1H,complex doublet,C-8-H); m/e 346 [M+‘] (25%),
345 [M-1]+ (15%), 273 [M-C02 C 2 H5]+ (100%); (Found: C, 72.7;
149
H, 5.3; N, 8.0. C2 1 H -j q N2 O3 requires C, 72.8; H, 5.2; N,
8 .1%).
2-Carbethoxymeth,y 1 -2,3-d i hydro- 3 -phenyl met hy lenepyrrol 0  
[2,1-b]quinazolin-9(1H)-one (159)
The compound (154), (1.57g) and benzaldehyde (10 ml) were 
heated at 150°- 180° for 1 hour. The isolation technique
(g) was used to obtain the product (159) (1.30g, 65%) as 
colourless needles, m.p. 156°; t.l.c. (system 1) 0.63;
Vmax(KBr): 3100-2800, 1730(0=0, ester), 1680(0=0, ring), 
1590, 1470, 1400, 1385, 1190(C-0), 1030, 780, 770,
700cm- 1 ; <5(90MHz, CDC 13 ) : 1.245(3H,t,J 7Hz, -CH :CH3), 
2.377-2.905(2H,m,-CH2-C02C2H5), 4.047-4.389(5H,m, >N-CH2- 
_CH-CH2 -C02 -CH2 -CH3) , 7.265-7.875 ( 9H ,m , >C = C«pp ,3 
aromatic protons), 8.305( 1H,d,J 7.87Hz,C-8-H); (Found :
C, 73.2; H, 5.7; N, 7.8. ^22^20^2^3 recluires 73.34;
H, 5.56; N, 7.78%).
3,3-Dideutero-2,3-d ihydropyrrol 0 [2,1-b]quinazolin-9(1H)- 
one (166)
Deoxyvasicinone (1) (200 mg) and deuterium oxide (D2 0) 
(5ml) were heated together in a sealed tube for 15 hours 
at 150°- 156°. The tube was cooled to room temperature 
and the solvents removed in vacuo. The residue was
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dissolved in dichloromethane and the resulting solution 
decolourised. The mixture was filtered and concentrated 
under reduced pressure. .Recrystallisation of the 
residue from ether yielded the white crystalline (166) 
(160mg, 79%), m.p. 109.5-110°; t.l.c (system 1) R^ 0.482; 
Vmax(KBr): 3050-2875, 1675(C=0). 1620(C=N), 1460, 1380, 
1330, 775, 700cm; S(60MHz, CDC13): 2.30(2H,t,JAB7Hz, 
>N-CH2 -CH2-), 4.30(2H,t,JAB7Hz, >N-CH2 -CH2-) , 7.04- 
8.05(3H,m,aromatic protons), 8.43(1H,d,J 8 Hz, C-8 -H); 
m/e 188 [M+-]; (Found : C, 69.7; H, 6.5; N, 14.75. C, 1 l-fc 
N20 requires C, 69.5; H, 6.4; N, 14.75%).
Reactions of (1) and its analogues.
Reaction of (1) with ethyl chloroformate
Method A
3-(Ethoxyethoxycarbonyloxymethylene )-2,3- 
dihydropyrrolo[2,1-b]quinazolin-9(1H)-one (167)
Ethyl chloroformate (25 ml) and (1) (21.5 g) were heated 
under reflux until a thick paste was produced (ca 1 
hour). Further quantitites of ethyl ch1oroformate (4 x 
10 ml) were added at 30 minute intervals and the paste 
heated at 110 - 120° for a further 5 hours. The mixture 
was diluted with ethyl acetate ( 1 0 0  ml) and filtered to
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remove the hydrochloride of (1)(14.1g). After 
decolonisation and concentration the syrupy residue was 
crystallised from ether to yield (167) (4.35 g). 
Recrystallisation from ethyl acetate/ether gave pure 
(167) (4.06 g, 11%), m.p. 100-101°; Vmax(KBr): 2990,
2940, 2800, 1750(0 = 0,ester), 1690(0 = 0 ,ring), 1625(C = N)cm" 1 
6(60 MHz ,CDC13), 1.20(6H,t,JAB7Hz, 2 x O-CH^CH,), 
2.83(2H,m,>N-CH2-CH2-), 4.10(6H,m, 2 x 0-CH2 -CH,,>N-CH2- 
C H 2-), 6 .95-8.20(4H ,m,aromatic protons); % ppm 
13.92(0-14), 14.41(0-17), 25.79(0-2), 43.34(0-1), 
60.03(0-13), 64.03(0-16), 98.81(0-3), 119.73(0-12), 
120.00(0-10), 125.09(0-6), 127.31(0-9), 133.70(0-8), 
138.74(0-7), 143.29(0-5), 152.07(0-4), 159.07(0-11), 
164.42(0-15); m/e 330 (23%) [M+‘] ( Found : C, 62.1; H, 5.5;
N, 8.3. c17H18N2°5 recIuires c> 61.8; H, 5.45; N, 8.5%).
Method B
Ethyl chloroformate (50 ml) and deoxyvasicinone (22.80 
g) were heated under reflux until a thick paste was 
formed. The paste was maintained at 100°- 120° for 1 
hour. Ethyl ch1oroformate (50 ml) was added to the 
paste and the mixture heated until the paste was again 
produced. The paste was again heated at 100°- 120°
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prior to cooling and dilution with ethyl acetate. The 
hydrochloride of (1 ) was removed by filtration and 
reconverted to (1 ) with dilute sodium hydroxide 
solution. The regenerated starting material was 
combined with the organic filtrates, the solution 
concentrated in vacuo and the above cycle repeated 
another 4 times. Finally the mixture was heated to 155° 
for 1 hour and cooled. Ethyl acetate (100 ml) aided the 
removal of the hydrochloride of (1) (5.29 g). The 
organic filtrates were washed with dilute sodium 
hydroxide solution and water prior to being dried and 
decolourised. On concentration a colourless syrup was 
obtained which rapidly crystallised from ether as 
colourless prisms of the diester, 3,3-dicarbethoxy-2,3- 
dihydropyrro1 o[2 ,1 -b]quinazo1 in-9(1 H)-one (168). (3.16g , 
10%). m.p. 119-120°; t.l.c (system 2)R^ 0.531;
Vmax(KBr): 2990, 2970, 2800, 1730(0=0, ester), 1680(0=0, 
ring), 1625, 1610(C=N), 1465, 1380, 1275(0-0, ester), 
780, 700cm'1; S(60MHz, CDC13): 1.38(6H,t ,JAB7Hz, 2x-0C0- 
CH2 -CH3), 3.00(2H,t,JAB7Hz, >N-CH2 -CH2-) , 4.1-4.5(6 H,m,
2 x 0C0-CH2 -CH3, >N-CH2 -CH2-), 7.40-8.05(3H,m, aromatic 
protons), 8.42(1H,d,J 8 Hz,C-8 -H); c ppm (Downfield 
from TMS): 14.0(0-14), 30.07(0-2), 43.87(0-1), 62.88(0- 
13), 64.95(0-3), 121.03(0-10), 126.09(0-8), 127.08(0-9), 
128.06(0-6), 134.10(0-7), 149.00(0-5), 153.73(0-4), 
160.53(0-11), 166.91(0-12); m/e 330 [M+‘] (19%); (Found: 
C, 61.7; H, 5.6; N, 8.4. C17^18^% requires C, 61.8;
H, 5.45; N, 8.5%).
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The mother liquors from the crystallisation were 
concentrated and chromatographed on silica gel. Elution 
with system 5 gave crude 2-ethoxy-(4H)-3,1-benzoxazin-4- 
one (169)(2.64g) as a pink solid. Recrystallisation from 
ether/light petroleum gave pure (169) as colourless 
leaflets (2.15 g, 12%) m.p. 92°, t.l.c. (system 9)
0.650; Vmax(KBr): 3050-2875, 1760(C=0), 1635, 1610 cm" 1 ;S 
(60MHz, CDCI3 ): 1.48(3H,.t,JAB7Hz,-0C0-CH2 -CH3 ),
4.59(2H,q, JAB 7Hz,-0C0-CH2 -CH3 ) , 7.20-8.00 (3H,m, 
aromatic protons), 8.25(1H,d,J 8 Hz, C-8 -H); m/e 191 [M+‘] 
(60%); (Found: C, 63.1; H, 4.6; N, 7.0. C1 0 Hg N03  
requires C, 62.8; H, 4.7; N, 7.3). Further elution with 
system 10 afforded the 3-carbethoxy-2,3-dihydro-3- 
hydroxypyrrolo[2,1-b]quinazolin-9(1H)-one (172)(1.8g ,
7%) as colourless needles, m.p. 126.5-127.5°; t.l.c. 
(system 1) Rf 0.608; Vmax(KBr): 3240(0-H), 2970, 2900,
1750(C = 0, ester), 1690(C = 0, ring) 1625 (C = N), 1480,
1405, 1280, 1200 (C - 0), 780-700cm"1; 6  (60MHz, CDCK):
1.23(3H,t,JAB7Hz, -0C0-CH2 -CH3), 2.72(2H,t,JAB7Hz, >N- 
CH2 -CH2-), 4.00-4.50(4H ,m, >N-CH2 -CH2 ,-OCO-CH2 -CH3),
5.63(1H,s,D2 O exchangeable, -0-H), 7.10-7.8 6 (3H,m, 
aromatic protons), 8.21(1H,d,J 8 Hz, C-8 -H),^C ppm (off 
resonance, downfield from TMS): 13.9821 (q , C-14),
32.781 1 (t, C-2) , 43.6501 (t, C-1 ), 63.291 1 (t, C-13),
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80.4259(s , C-3) , 121.1709(s, C- 10) , 126.4661 (d , C-6 ),
1 27.1 035(d , C-9), 127.7524(d, C-8 ) , 134.2798(d , C-7 ) ,
1 49.0217(s, C-5) , 1 57. 2661 (s, C-4) , 160.7184(s , C-11),
171.1521 (s , C-12); m/e 274 [M+-]; (Found: C, 61.2; H,
5.15; N, 10.1. C H N 0 requires C, 61.3; H, 5.10; N,
14 14 2 4
1 0 .2 %).
(172) 
Method C
Ethyl ch1oroformate (50 ml) and (1) (10.71g) were heated 
as shown in Method B omitting heating to 155°. The 
hydrochloride of (1 ) was removed as previously shown and 
concentration of the filtration residues gave a 
colourless syrup which rapidly crystallised in ether. 
Recrystallisation of the product from ether/ 
dich1 oromethane gave colourless prisms of (168) (6.18g, 
33%) identical in all respects to an authentic sample.
The mother liquors from the crysta11isat ion were 
concentrated and purified by p.l.c. Desorption with hot 
ethyl acetate yielded (169) (0.55g, 5%) identical in all 
respects to an authentic sample.
155
Conversion of  (167) i n to  (168)
Ethyl ch 1 oroformate (10 ml), the hydrochloride of (1) 
(0.25g) and (167) (0.67g) were heated under reflux until 
a thick paste was produced. The paste was maintained at 
1 2 0  for 8  hours, cooled and ethyl acetate ( 2 0  ml) added. 
The mixture was filtered and the filtrate concentrated 
to yield a solid. Recrystallisation from ether/ 
dich1oromethane gave (168) (0.45 g), m.p. 118-119°, 
identical in all respects to an authentic sample.
3-Ethoxycarbonyl-2,3-di hydropyrro1o[2,1-b]quinazolin-9- 
(1H)-one (170)
A solution of (168) (0.47g) in ethanol (25 ml) 
presaturated with dry ammonia gas was allowed to stand 
overnight. The solvents were removed in vacuo and the 
residue crystallised from ether. Recrystallisation from 
ether gave the pure monoester (170) (0.21g, 62%), m.p. 
91-92°; Vmax(KBr): 2975, 2900, 1735 (C=0, ester), 1685 
(C = 0, ring), 1620 cm"1, 8 (60MHz, CDC13) 1.29(3H,t ,JAB 
7Hz,-OCO-CH2 -CH3) , 2.60(2H,t, Jab7Hz ,-0C0-CH2 -CH3) ,
4.23(5H,m,>N-CH2 -CH2 “CH-), 7.30-7.90(3H ,m , aromatic 
protons), 8.30(1H,d,J 8 Hz,C-8 -H); m/e 258 [M ] (23%). 
(Found.: C, 64.8; H, 5.4; N, 10.6%. C ^ 4 H -j 4 N 2 O 3 requires 
C, 65.1; H, 5.4; N, 10.85%).
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React ion Between (168) and Sodium Borohydr ide
The diester (168) (500 mg) and sodium borohydride (60 
mg, 1 mol.equiv.) in ethanol (20 ml) were stirred at 
room temperature for 48 hours. The original pink 
solution became vibrant yellow and analysis by t.l.c. 
(system 1) showed one polar spot (Rf 0.177). The yellow 
syrup (430 mg) obtained using procedure (h) was purified 
via p.l.c. (2 plates) using system 1 as eluant.
Desorption with ethyl acetate and concentration in vacuo 
afforded a colourless syrup which crystallised as prisms 
(120 mg) the identity of which has not been ascertained, 
m.p. 134-136°(dec ), t.1.c.(system 1) R^0.177. *9max(KBr): 
3600-3000, 3000-2900, 1660, 1618, 1560, 1468, 1388,
1338, 1300, 1275, 1050, 780, 700cm"1; 6 (60 MHz, CDCl,):
2.22(2H,t,J 7Hz ), 3.26-3.58( 1H , t ,J 7Hz), 3.60-4.40(4H,m) , 
7.0-7.64(3H,m) , 7.96(1H,d,J 7Hz).
3,3-Dicarbethoxy-2,3-dihydro-1-methylpyrrolo[2,1- 
b]quinazolin-9(1H)-one (173)
The compound (149) (1.5g) and ethyl chloroformate (7ml) 
were heated at reflux for 2 hours. A further 30 ml of 
ethyl ch1oroformate were added portionwise to this 
refluxing mass over the period of 45 hours. Cooling and 
treatment with ethyl acetate (25 ml) afforded the pink 
hydrochloride of (173). This was removed by filtration
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and reconverted to starting material (0.72g) with dilute 
sodium hydroxide. The organic filtrates were 
concentrated in vacuo to realise an orange syrup 
(0.80g). Purification by chromatography on silica gel 
(20g) gave the white crystalline solid (173)(510 mg, 
38%), m.p. 90.5-91°, t.l.c. (system 1) Rf 0.78; 
Vmax(KBr): 3000-2860, 1740, 1730(C=0, ester), 1680(0=0, 
ring), 1625, 1610(C=N), 1470, 1450, 1390, 1380, 1335, 
1285, 1260, 1220, 1 185, 1 120, 1035, 1025, 785, 720cnr1 ;S 
(60MHz, CDCI3 ): 1.30(6H,t,JAB7Hz, 2 x -0C0-CH2 -CH3 ) ,
1 ,52(3H,d,0AB6Hz, >CH-CH3 ), 2.56(1H,dd,JgEM 13.2Hz,0AB 
2.4Hz ,>CH-pH — _H), 3.16( 1H, dd , JGEM 13.2Hz , JAg 8 .4Hz ,>CH-CH- 
H), 4.06-4.58(4H,q, Ja b7Hz , 2 x -0C0-CH2 -CH3 ) , 4.60- 
4.92(1H,m,CH3-CH-CH2 ), 7.16-7.82(3H,m, aromatic 
protons), 8.18(1H,d,J 7Hz, C-8 -H).
3-Carbethoxymethyl-2,3-dihydropyrrolo[2,1-b]quinazolin- 
9(1 H) -one (176)
Method 1
Ethyl ch1oroacetate (10 ml) and (1) (1g) were heated 
under reflux for 7 hours, cooled and excess ethyl 
chloroacetate removed in vacuo. The residue was 
chromatographed on silica gel (30 g). Elution with
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ether gave an orange syrup which rapidly crystallised. 
Decolourisation and recrystallisation gave the pure ester 
(176) (170 mg, 11%), m.p. 92°; t.l.c. (system 1) Rf 0.75; 
Vmax(KBr): 3050, 2975-2900, 1730(0=0, ester), 1670(0=0, 
ring), 1620, 1610(C=N), 1470, 1450, 1390, 1378, 1285, 
1275, 1180(0-0), 770, 695cm"1; 5(60 MHz, CDC13):
0.98(3H, t ,0 7Hz, -0C0-CH2 -CH3), 1.26-4.16(9H,m, >N-CH2- 
CHo-CH-CHo-COpCHoCHg), 6 .8-7.4(3H,m, aromatic protons)
7.82(1H,d , J 7Hz, C-8 -H); m/e 272 [M + *]; (Found: C,
66.2; H, 5.8; N, 10.3. C15H16N2°3 reQuires C, 66.2; H,
5.9; H, 10.3%).
Method 2
(1 ) ( 1  g) and ethyl bromoacetatewere heated under reflux 
for 1.5 hours. Isolation using the method shown above 
gave the mono ester ( 176) (300 mg, 2 0 %) identical in all 
respects to an authentic sample.
Preparation of (E) and (Z) 3-acetoxyethy1idene-2,3- 
dihydropyrrolo[2,1-b]quinazolin-9(1H)-ones (182) and 
(183)
Method 1 - Condensation with acetic anhydride
A mixture of (1) (2g) and acetic anhydride (5ml) was 
heated under reflux for 12 hours. The mixture was cooled,
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solvents removed in vacuo and the residue
chromatographed on silica gel (70 g). Elution with
system 4 gave the E-enol acetate (182) which was
recrystallised from ether/ethyl acetate to yield pure
o
(182) as colourless needles (550 mg, 19%), m.p. 177 ; 
t.l.c. (system 1 ) Rf 0.84; Vmax(KBr): 2900, 1750(0=0, 
acetate), 1670(C = 0 , ring), 1600(C = N) 1470, 1380, 1 180, 
780, 700cnf1; 6  (60MHz, CDC13): 2.18(3H,s, -02 C-CH3), 
2.60(3H,d,JAX, 1.60Hz, >N-CH2 -CH2 -C=C<QAp ), 2.76(dt,J.B 
7Hz, Ja x 1.60Hz , >N-CH2 -CH2-C = C < ^ 3  ), 4.02 ( 2H, t, JAB7.2Hz, 
>N-CH2 *-CH2 " ) , 7.10-7.80(3H,m,aromatic protons),
8.16(1H,d,J 8 Hz,C-8 -H); m/e 270 [M+]; (Found: C, 6 6 .8 ; H,
5.3; N, 10.3. C15H14N2°3 recluires c> 66.7; H, 5.2; N, 
10.4%). Further elution gave the isomer (183) as a 
syrup which rapidly crystallised. Recrystallisation 
gave pure (183) as fine colourless needles (100 mg, 4%), 
m.p. 184.5-185.5°; t.l.c. (system 1) R^  0.74; Dmax(KBr): 
2900 , 1 760(C = 0, acetate), 1680(C = 0, ring), 1600(C = N), 
1470, 1380, 1330, 1 190, 775, 700cm"1; 6(60 MHz, CDCI3 ) :
2.06(3H,d,JAX1.60Hz, CH2>C = C^£Hl ), 2.38(3H,s , -0,C-CH,)
0AC  ^ __—
2.90(2H,dt,JftB7Hz,JAX 2.4Hz, -CH2 -CH2^  CH3  )
4.11 (2H,t,JAB7Hz, >N-CH2 -CH2 ~), 7.08-7.76(3H,m, aromatic
protons), 8.16(1H,d,J 8 Hz, C-8 -H); m/e 270 [M+3; (Found:
C, 66.4; H, 5.3; N, 10.3. gH^NgO^requires C, 66.7;
H, 5.2; N, 10.4%).
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Method 2 - Condensation between deoxyvasicinone
hydrochloride and acetic anhydride.
A mixture of the hydrochloride of (1) (6 .1g) and acetic 
anhydride (15ml) was heated under reflux for 72 hours. 
The solvents were removed in vacuo and the residue 
extracted with ethyl acetate. The concentrated extracts 
were purified by preparative t.l.c. ( 1 2  plates) using 
system 1 as eluant and gave the pure(E)enol acetate 
(182) (1.21g, 17%) and the pure(Z)enol acetate (183)
(550 mg, 8 %). Both products were identical in all 
respects to the compounds described above.
Method 3 - Condensation of deoxyvasicinone (1) with 
acetyl chloride.
A mixture of (1) (5g) and acetyl chloride (30 ml) was 
heated at reflux for 89 hours. The reaction mixture was 
cooled, diluted with ethyl acetate and the hydrochloride 
of (1) (5.21g) was filtered from the mixture. The mother 
liquors were concentrated in vacuo then partitioned 
between ethyl acetate ( 1 0 0  ml) and a saturated solution 
of sodium bicarbonate (5 ml). The organic phase was 
separated, dried and reduced in volume on the 
evaporator. Addition of ether promoted crystallisation 
of the(E)enol acetate (182) (110 mg, 4%). The 
crystallisation residues were concentrated in vacuo and
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chromatographed on silica gel (20g). Elution with
system 4 gave the(Z)enol acetate ( 183) (50 mg, 2%) and
finally a third unidentified component (40 mg), m.p. 141-
143°; t.l.c. (system 1) Rf 0.698; Vmax(KBr): 3070, 3000
-2925, 1730, 1690, 1665, 1600, 1463, 1380, 1370, 1263,
-1
1190, 1180, 1080, 1060, 1020, 890, 780, 705, 700cm .
(Yields are based on 3g of (1) being isolated from its 
hydrochloride).
Methods 1 and 3 were repeated using pyridine as a 
solvent, t.l.c. analysis of these reaction mixtures 
showed the component ratios to be similar to those shown 
above.
Treatment of (182) with sodium methoxide (Method A)
2 ,3-Dihydro-3-(2 -hydroxyethylidene)pyrrolo[2 ,1 - 
blquinazolin-9(1H)-one (189).
The enol acetate (182) (660mg) in methanol (100 ml) was 
added to a solution of methanolic sodium methoxide 
(prepared from sodium (5mg) in methanol (10 ml)). O.n 
gentle warming the reaction darkened through yellow to 
brown/black. The reaction was quenched with acetic acid 
(2 drops) and the solvent removed in vacuo. The residue
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was partitioned between dichloromethane ( 1 0 0  ml) and 
water (5 ml). The organic phase was dried, decolourised 
and concentrated in vacuo to give a yellow syrup. 
Crystallisation from ether afforded the product (189) as 
lustrous yellow needles (320mg, 64%), m.p. 221 - 223°; 
t.l.c. (system 1) R^O.58; ^)max(KBr): 3325 (0-H, enol), 
3080-2890, 1670(C = 0, ring), 1640(C = NJ, 1545 , 1495, 1494, 
1360, 755, 710cm" 1;S(90MHz, CDC13): 2.02(<v1H,s), 2.27- 
2.48( 3H,m,+$), 2.85(1H,t), 4.05(2H,t), 4.39(ft^ H,dd, 
exchangeable), 7.29-8.16(4H,m,aromatic protons), m/e 228 
[M+•]; (Found: C, 68.1; H, 5.25; N, 12.1. C 1 3 H 1 2 N20
requires C, 68.4; H, 5.3; N, 12.3%).
Proof of structure (189)
A solution of (189) (1OOmg), pheny1hydrazine (40mg, 1 
mol.equiv.) and glacial acetic acid (3 drops) in ethanol 
(15ml) was heated carefully on a water bath for 20 
minutes. The mixture was allowed to cool at 0° and the 
white crystalline deposit (1 1 Omg) which formed was 
removed by filtration. The solid was dissolved in hot 
ethanol and the solution decolourised and reduced in 
volume on the evaporator. A crystalline solid was 
filtered off from the cooled ethanolic solution and 
after drying was identified as (191) (80mg, 57%), m.p. 
185°- 186°; t.l.c. (system 11) 0.69; 'tfmaxfKBr): 3340
(N-H), 3100-2900, 1 670(C = 0), 1620(C = N), 1610(C = N) , 1470,
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1380, 1345, 1320, 1 155, 775, 695cm-1; m/e 318 [M+‘] 
(56%); (Found: C, 71,9; H, 5.70; N, 17.7. CigH1 8 N40 
requires C, 71.8; H, 5.67; N, 17.6%).
Treatment of (182) with sodium methoxide (Method B)
Sodium methoxide generated from sodium metal (60mg) and 
methanol (10ml) was added to (182) (326mg). The mixture 
was refluxed for 40 minutes. The mixture was cooled, 
neutralised (dilute acetic acid) and concentrated in 
vacuo. Column chromatography of the residue on silica 
gel (1 0 g) using ether as eluant gave deoxyvasicinone (1 ) 
(190 mg, 85%) identical in all respects (m.p., t.l.c.,
i.r.) to an authentic sample.
Reduction of (182) with NaBH^ »
To a stirring solution of the enol acetate (182) (500mg) 
in ethanol (100 ml) was added sodium borohydride (140mg, 
2 mol.equiv.). After heating at reflux for 1 hour, 
t.l.c. (system 1 ) of the reaction mixture indicated no 
starting material and a major spot at 0.80. The 
brown syrup obtained using procedure (h) was 
chromatographed on 4 plates using system 1 as eluant. 
Desorption,filtration and subsequent concentration of 
the band gave colourless needles of the (Z) ethylidene 
derivative ( 186) (240mg‘, 61%) identical in all respects
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to  an a u th e n t ic  sample. (See page 187).
Reduction of (183) with NaBH 
----------------------- ---- *
To a stirring solution of the (Z) enol acetate (103) 
(410mg) in ethanol was added sodium borohydride (90mg,
1.5 mol.equiv.). The mixture was heated at reflux for 2 
hours t.l.c. (system 1) showed one major spot R 0.70.
An orange syrup was obtained following isolation using 
procedure (h). The syrup was purified following 
chromatography on a short column (silica gel 2 0 g). 
Elution with system 9 afforded the pure (E) ethylidene 
derivative (98) (110mg, 34%) as colourless needles 
identical to an authentic sample (m.p., i.r., t.l.c.).
(See page 186).
Attempted react ion of (182) with benzy l amine.
The enol acetate (182) (100mg) and benzylamine (41mg, 1 
mol.equiv.) in dry THF (5ml) were heated at reflux for 
8  hours, t.l.c. (system 1 ) indicated no reaction had 
taken place and the reacion was abandoned.
Attempted acylation of (1)
Benzoyl peroxide (5mg) was added to a stirring solution 
of (1 ) ( 1 0 0  mg) in dry carbon tetrachloride ( 1 0  ml).
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After 10 minutes acetyl chloride (84 mg, 1.95 
mol.equiv.) was added and the mixture refluxed for 1 0  
hours. On cooling, the mixture was dissolved in CCI4  
and washed with water (2 x 5ml). The organic phase was 
dried. Filtration followed by concentration under 
reduced pressure gave (1) (50mg) identical in all 
respects to an authentic sample.
Attempted acylation of (1)
Deoxyvasicinone (1) (667mg) was added to a solution of 
sodium amide (140mg, 1 mol.equiv.) in dry xylene (50 ml) 
to give a ye 11ow/orange solution. Acetyl chloride 
(280mg, 1 mol.equiv.) was added and the mixture stirred 
at room temperature for 1 hour, t.l.c. (system 1 ) showed 
one component R^. 0.482. Heating the reaction for 4
hours and reanalysis by t.l.c. showed the reaction to be 
similar to that between (1 ) and acetyl chloride in 
pyridine. No isolation of this reaction was attempted.
Reaction of (1) with benzoic anhydride
Liquified benzoic anhydride'(13ml) and (1) (5g) were 
heated at 230° for 2 hours. The cooled mixture was diluted 
with ethanol to yield a brown solid. The crude solid 
was dissolved in warm chloroform, decolourised and 
concentrated in vacuo to yield colourless needles of 
pure 3-(benzoyloxyphenyl methylene)-2,3-dihydropyrrolo
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[2 ,1 -b ] q u inazolin-9(1H)-one (187) ( 1.39g, 13%), m.p. 186- 
187°; t.l.c. (system 18) Rf 0.323; Vmax(KBr): 3050,
1738(C = 0, benzoate), 1680(C=0, ring), 1595(C = N), 1558, 
1495, 1470, 1385, .1250(0-0), 1 190, 1 180, 1025, 780, 710, 
700cm"1; 5(60MHz, CDClj): 3.22(2H,t,JAB7Hz, >N-CH2 -CH2-), 
4.12(2H,t,Jab7Hz , >N-CH2 -CH2-), 6.58(1H,dd,0 7Hz,J 1Hz, 
C-5-H), 7.04-7.96( 10H,m, 2 x Ph), 8.08(3H,m, aromatic 
protons); m/e 394 [M+] (23%). (Found: C, 75.8; H, 4.6;
N, 7.1. c 18H 14N2°2 recJuires C» 74.15; H, 4.8; N,
9.7%). Concentration of the mother liquors from the 
crystallisation gave a solid which was repeatedly 
recrystallised from dimethylformamide to yield (188)
(400 mg, 4%) as pale yellow prisms, m.p. 164-165°; t.l.c. 
(system 18) Rf 0.242; Vmax(KBr): 3600-3000(0H-H bonded), 
3100-2800, 1675(C = 0), 1630, 1580(C = N), 1475, 1390, 1330, 
1290, 1275, 765, 760, 690, 680;RM.R(due to the 
insolubility of this material a satisfactory spectrum 
was not obtained; m/e 290 [M+] (14%); (Found: C, 74.1;
H, 4.8; N, 9.9. C18H14N2°2 recluires c> 74.15; H, 4.8;
N, 9.7%).
Hydrolysis of (187) with sodium methoxide
The enol benzoate (187) (500 mg) was added to a previously 
prepared solution of methanolic sodium methoxide 
(prepared from Na (10mg) in methanol (100 ml)). The 
mixture was stirred for 48 hours at room temperature
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decolourised and concentrated in vacuo. Ether induced 
crystallisation of the salt of (1 ) and the crude free 
base was obtained following acidification with dilute 
acetic acid. The crude mixture was partitioned between 
chloroform ( 1 0 0  ml) and a saturated solution of sodium 
bicarbonate (5 ml). The organic phase was dried, 
concentrated and the solid obtained recrystallised from 
ether/light petroleum as colourless needles of (1 ) (160 
mg, 67%) identical to an authentic sample (m.p., m.m.p., 
t.l.c., i.r.).
3-(Chlorophenylmethylene)-2,3-dihydropyrrolo[2,1- 
b ] q u inazo1in-9(- 1H)-one (185)
Method 1). Benzoyl chloride (12 ml) and (1) (1 -4g) were 
heated under reflux for'1.5 hours. The mixture was 
cooled, flooded with light petroleum and the insoluble 
material crystallised from ether to yield a cream solid 
(1.12g). Recrystallisation from ethyl acetate gave the 
pure a -ch1orobenzy1idene derivative (185) (1.01g , 43%), 
m.p. 1 62- 1 63 °; 'tfmax(KBr) 3050-2875, 1675(0 = 0) .
1610(C = N), 1590, 1470, 1380, 780, 700cm" 1; S (60MHz , CDCl,)
: 3.10 (2H,t,JAB7Hz, >N-CH 2-CH 2-), 4.17 (2H, t , J Ag7Hz ,
>N-CH2 “CH 2-), 7.07-7.90(8H,m,3 aromatic protons,Ph),
8.19 (1H, dd , J 2Hz , J 8 Hz,C-8 -H); m/e 310 [M+‘J (25%) 308 [M + ‘] 
(75%); (Found: C, 70.00; H, 4.0; Cl, 11.3; N, 9.0. C 1 8
H1 3 C1N20 requires C, 70.00; H, 4.2; Cl, 11.5; N, 9.1%).
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Method 2). Benzoyl chloride (5ml) and the hydrochloride 
of (1) (510mg) were heated under reflux for 5 hours. The 
mixture was treated as above to yield pure (185) (210 mg, 
29%). m.p. 162-163°.
3-(2>2,2-Trichloro-1-hydroxyethy1)-2,3-dihydropyrrolo 
[2,1-blquinazolin-9(1H)-one (175)
Chloral hydrate (5.34g ) and (1) (5g) were intimately 
mixed and heated gently until the resulting clear 
homogeneous solution darkened. The mixture was cooled 
and the thick red paste treated with chloroform/ether to 
yield a white crystalline solid. Recrystallisation from 
ether gave white needles of the chloral derivative (175) 
(3.7g, 41%), m.p. >300° (dec); t.l.c. (system 1) 0.70;
Vmax(KBr): 3700-3100(0H, broad), 3050, 3000-2900, 
1660(0=0), 1620(C=N), 1465, 1390, 1340, 1278, 805, 780, 
700cm'1; 5 (60MHz,dgDMSO); 2.10-2.90(2H,m, >N-CH„-CH2-),
3.60-4.40(3H,m,CH2-£H-CH(0H)CCl,), 4.90(1H,d,0 7Hz, >CH- 
^H(0H)CC13 ), 7.14(1H,d,J 7Hz , D20 exchangeable, O-H), 
7.30-7.80(3H,m, aromatic protons), 8.06(1H,d,J 7Hz, C-8 -
H); m/e 334, 332 both [M+ 3; (Found: C, 46.5; H, 3.4;
Cl, 31.9; N, 8.1. 1 C13N2°2 recJuires c> 46.8; H,
3.3; Cl, 31.9; N, 8.1%).
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Reaction between (175) and a solution of ethanolic KOH.
A solution of ethanolic KOH (prepared from KOH (3.2g) in 
ethanol ( 1 0  ml) was delivered portionwise to a solution 
of the chloral derivative (175) (1.7g) in ethanol (20ml). 
The mixture was heated for 3 hours and stirred at room 
temperature for 48 hrs. to give a purple/black solution.
The solution was cooled, neutralised (glacial acetic 
acid) and then concentrated in vacuo. The black solid 
was partially dissolved in chloroform and the insoluble 
material filtered off to give 2 2 0  mg of starting 
material (175). The mother liquors and washings from 
filtration were combined, washed (H^O, 2 x 5ml) and 
dried. Deco 1 ourisation of this organic solution was 
unsuccessful and isolation of the desired acid was not 
achieved.
Condensation of (1) with chlorinated acid chlorides.
a) Chloroacetyl chloride. Preparation of 3-(1,2- 
dichloroethylidene)-2,3-dihydropyrrolo[2,1-b]quinazolin- 
9(1 H)-one (177)
A mixture of (1) (1 g) and chloroacetyl chloride (10ml) was 
heated under reflux for 3.5 hours. The mixture darkened 
considerably during the reaction and on cooling the 
excess chloroacetyl chloride was removed in vacuo. The
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residue crystallised from ethyl acetate and the crude 
product was decolourised and recrystallised from ethyl 
acetate to yield pure (177) (820 mg, 57%), m.p. 211.5- 
212.5°; t.l.c. (system 1) Rf 0.88; ^max(KBr): 3025,
2975, 1 670(C = 0) , 1590(C = N), 1485, 1465, 1430, 1380,
1330, 1290, 1270, 780, 700cm-1; <$ (90MHz,dgDMSO): 3.05
(2H,quintet, Ja x1Hz ,Jab7Hz , >N-CH2 -CH2-C = C<bJ| ) , 4.08(2H,
t.J 7Hz , >N-CH2 -CH2-), 5.49(2H,t,Ja x1Hz , >N-CH2 -CH2-C = C < ^ 2C1)
7.4-7.9(3H,m, aromatic protons), 8.14(1H,m,C-8-H);
m/e 284, 282, 280 all [M+]; (Found: C, 55.7; H, 3.5; N,
9.95. c 13h 16C12N2° reQuires C, 55.5; H, 3.6; N,
10.00%).
Attempted reaction of (177) with benzylamine/ >.
Benzylamine (20 mg, 1 mol. equiv.) and the 
chloroethy1idene compound (177) (50 mg) in dry THF (5 
ml) were heated together for 63 hours, t.l.c. (system 1) 
indicated no reaction had taken place and the reaction 
was abandoned.
Reduction of (177) with sodium borohvdride.
/
The chloroethylidene (177) (800 mg) was dispersed in 
ethanol ( 1 0 0  ml) and to this stirring solution was added 
sodium borohydride (200 mg, 1.8 mol.equiv.). After
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heating at reflux for 1 hour, t.l.c. (system 1 ) of the 
translucent green mixture showed no starting material.
The brown syrup which was obtained following isolation 
using procedure (h) was chromatographed on 4 plates 
using system 5 as eluant. Desorption, filtration and 
subsequent concentration of the least polar band gave 
colourless needles of (180) or (181) (220 mg, 31%) from 
ether, m.p. 79-80°. t.l.c. (system 1) 0.79;
Vmax(KBr): 3080, 3020-2950; 1680(C = 0), 1630(C = N), 1470, 
1400, 1340, 1320, 795, 710cm'1; S(60MHz, CDCI3 ): 1.40- 
2.90(4H,m), 3.04-4.60(5H,m), 7.00-7.80(3H,m , aromatic 
protons), 8.06(1H,d,J 7Hz, C-8 -H). m/e 248 [M+]. (Found: C, 
62.4; H, 5.1; Cl, 14.4; N, 11.1. C-jgH-jgCl^O requires 
C, 62.8; H, 5.25; Cl, 14.3; N, 11.25%).
The polar band was treated similarly and afforded the 
(E)3-ethy1idene derivative of ( 1 ),. (98) (250 mg, 41%) as 
colourless prisms from ether. Identical in all respects 
(m.p., m.m.p., t.l.c., i.r., p.m.r.) to an authentic 
sample.
b) Dichloroacetyl chloride. 3- ( 1  ,2 ,2 - 
trichloroethylidene)-2,3-dihydropyrrolo[2,1-b] 
quinazol in-9(1 H)-one (178)
A mixture of (1) (1g) and dichloroacetyl chloride (10 ml) 
was heated gently under reflux for 1.5 hours, the mixture
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was cooled, excess acid chloride removed in vacuo and
the residue chromatographed on silica gel (24g).
Elution with system 3 gave an orange oil which
crystallised from ether. Recrystallisation and
deco 1 ourisation gave ( 178) (200 mg, 12%), m.p. 189-190.5°;
t.l.c. (system 1) 0.88; ^)max(KBr): 2990, 1685(C=0),
1600(C=N), 1485, 1465, 1430, 1390, 1340, 780, 700cm_1;S
(90MHz,dgDMSO): 3.09(2H,t,J 8 Hz, >N-CH.-CH - ),
4.10(2H,t,J 8 Hz, >N-CH -CH -), 7.40-8.00(3H,m,aromatic 
AB _ 2  2 C1
protons), 8.20(1H,dd,J 1Hz,8 Hz,0-8-H), 9.27(1H,s,>C=C<CHC12 )
m/e 318, 316, 314, all [M+-] ; (Found: C, 49.4; H, 2.8;
N, 9.0. C.,H.C1,N 0 requires C, 49.4; H, 2.8; N, 8.9%).T o y  i d
c) Tricholoroacetyl chloride.
3-(Hydroxytrichloromethylmethylene)-2,3-di hydro 
pyrrolo[2,1-b]quinazolin-9(1H)-one (179).
A mixture of (1) (2.02g) and tricholoroacetyl chloride 
(10ml) was heated under*reflux for 1.5 hours. The 
mixture was cooled, excess tricholoroacetyl chloride 
removed in vacuo and the residue chromatographed on 
silica gel (60g). Elution with system 14 gave a 
brown semi-solid mass. Decolourisation and 
recrystallisation gave pale yellow needles of (179) (310 
mg, 9%), m.p. > 235°(dec); t.l.c. (system 18) R^  0.55; 
>)max(KBr): 3600-3100 (OH, broad), 3100-2850, 1690 (C = 0),
1640(C=N), 1542, 1480, 1420, 1340, 1320, 1300, 1280,
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1202, 770, 700cm”1 ; 6 (90MHz,dgDMSO), 3.19(2H,t,0AB8Hz , 
>N-CH2 -CH2-) , 4.16(2H,ts0AB8Hz, >N-CH2 -CH2-), 7.20- 
8.10(4H,m, aromatic protons), 11.84(1H,s, D£ 0 
exchangeable, 0-H);m/e 334, 332, 330 all [Nit]; (Found:
c,  47.1; H, 2.4; Cl, 32.5;; n , 8.5. C ^ 3HgCl3N20
requi res C , 47.1; H, 2.7; Cl, 32.1 ; N, 8.5%).
d) 3-Ch1oropropiony1 Chloride
A homogeneous solution of deoxyvasicinone (1) (2g) and 3- 
chloropropionyl chloride ( 1 0  ml) was heated at reflux 
for 5 hours, t.l.c. (system 1) indicated no starting 
material and the excess 3-chloropropiony1 chloride was 
removed under reduced pressure after cooling. Flooding 
the flask with ether promoted precipitation of a powdery 
brown solid. This was recrystallised from ether/ethano1 
as golden flakes ( 1 2 0  mg) the identity of which is 
unknown, m.p. 130° (dec); Mmax(KBr): 3700-3200, 2950, 
1720, 1650, 1580-1540, 1400, 1380, 1290, 1190, 1020,
760, 680cm~S (Found: C, 57.1; H, 5.4; Cl, 8.5; N,
5.2%).
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Reaction between (1) and tris(dimethylamino)methane
To an ice cold suspension of deoxyvasicinone (1) (1g) and 
tris(dimethylamino)methane (1 . 6  ml, 1 mol.equiv.) under 
dry nitrogen was injected acetic anhydride (10 ml). An 
immediate red hue was observed in the original 
colourless solution, til.c. (system 1 ) indicated a 
complex mixture of products were present and the 
experiment was abandoned.
2,3-Dihydro-3-methylenepyrrolo[2,1-b]quinazolin-9(1H)- 
one (194) and 3-Acetoxymethy1-2,3-dihydro-3-dimethy1 
aminomethylpyrrolo[2,1-b]quinazolin-9(1H)one (198)
Acetic anhydride (60 ml) was added slowly to an ice cold 
suspension of (1) (3.3g) in freshly distilled 
bis(dimethy1 ami no)methane (60 ml). The mixture was 
stirred at room temperature for 1 hour and the excess 
reagents removed in vacuo. The residue was treated with 
ice/water, neutralised with solid sodium bicarbonate and 
then extracted with dich1oromethane. The dried, 
concentrated organic extracts were chromatographed on a 
column of silica gel (10 0 g). Elution with system 9 gave 
crude (194) as a syrup. Preparative t.l.c. (5 plates) 
using system 6 as eluant was employed to further purify 
this syrup. Pure (194) was thus obtained as a colourless 
crystalline solid (660mg, 19%). m.p. 140-144°, t.l.c.
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(system 6 ) Rf 0.66; ^max(KBr): 3100, 2900 , 1670(C = 0),
1 598(C = N) , 1435, 1410, 1395, 1385, 1340, 1310, 800, 800, 
700cm"1 , \max(CHCl3  ), 249(f 18000), 308nm(.f . 1 05000 ) , 6  
(60MHz, CDC13), 3.24(2H,m, >N-CH2 -CH2-), 4.14(2H,t, 
Jab7.2Hz , >N-CH2 -CH2-) , 5.48 (1 H , t, J 2.4Hz , :CH2>C = C<j{) , 
6.36(1H,t,J 2,4Hz , >C = C<|]) , 7.26-7.80(3H, m , aromatic 
protons), 8.18(1H,d,J 7Hz, C-8 -H); m/e 198 [M+*] (89%);
197 [M-1]+ (100%) (Found: C, 73.2; H, 5.5; N, 13.9.
C 1 2 H10N2° rec1uires c» 72.8; H, 5.8; N, 14.1%).
Further elution of the column with system 12 gave pure 
(198) as a syrup which crystallised rapidly from toluene as 
colourless prisms (840 mg, 17%), m.p. 110.5-111°; t.l.c. 
(system 1) 0.67; Vmax(KBr): 2940, 2770, 1740(C=0,
acetate), 1675(C=0, ring), 1470, 1340, 1240(C-0, 
acetate), 785, 700cm'1; 5(60MHz, CDC13 ): 1.96(3H,s, 
-CH2 -0C0-CH3) , 2.20-2.80( 10H,m,>N-CH2 -CH2 -C-CH2 -N(CH3) 2)
4.14(2H,t, Ja^Hz , >N-CH2 -CH2-) , 4.30(2H,s, -CH2 -0 C0 - 
CH3), 7.20-7.70(3H,m, aromatic protons), 8.20(1H,d,J 
7Hz, C-8 -H) ; m/e 314 [M-1]+ (3%); (Found; C, 64.8; H,
6.7; N, 13.3. c -j 7 H2 1 N 3 O 3 requires C, 64.8; H, 6.7;
N, 13.3%).
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Reaction of (194) with dimethyl acetylenedicarboxy1 ate
(194) (140 mg) and DMAD (100mg, 1 mol. equiv.) were 
carefully heated on a steam bath for 3 hours, t.l.c. 
(system 1 ) indicated no reaction and a mantle was used 
to heat the mass for 1 hour. The dark brown mass 
produced was cooled, dissolved in ethyl acetate, 
decolourised and concentrated in vacuo to give a thick 
syrup. Analysis by t.l.c. (system 1) of the syrup 
showed a complex mixture of products. No attempt was 
made to isolate the numerous components from the syrup.
2,3-Dihydropyrrolo[2,1-b]quinazolin-3,9(1H)-dione-3- 
oxime (2 0 0 )
A solution of (1) (4.23 g) in ethanolic sodium ethoxide 
(prepared from sodium (2.3g) and absolute ethanol (150 
ml)) was stirred at room temperature and amyl nitrite 
(5.6g) added. The mixture was warmed to 60° and stirred 
at this temperature for 40 minutes. The resulting 
orange solution was stirred at room temperature 
overnight and the solvent removed in vacuo. A pale 
green solid which became pink on addition of aqueous 
acetic acid was obtained. The mixture was treated with 
saturated sodium bicarbonate solution until neutral and 
the mixture extracted with chloroform (2 x 150 ml).
1 7 7
From the dried chloroform extracts unreacted (1) (2.5g) 
was recovered whilst filtration of the aqueous phase 
gave a pink solid. Recrystallisation of the solid from 
a large volume of ethanol gave the pure oxime (2 0 0 ) as 
lustrous needles (1.50g, 71%, based on recovered 
starting material), m.p. >300° (dec); 'l)max(KBr),
3160(=N-0H , oxime), 3050, 2850, 1680(C = 0) , 1600(C = N) , 
1480, 1460, 1400, 1320, 1300, 780, 690cm'1; m/e 215 [M+ *] 
(100%); (Found: C, 61.7; H, 4.2; N, 19.4. C11H9N302
requires C, 61.4; H, 4.2; N, 19.5%).
Due to the insolubility of this compound p.m.r. and Rf 
measurements were impossible.
Attempted hydrolysis of (200)
A suspension of the oxime (200) (1g) in a (1:1) solution 
of acetone/HCl (200 ml) was stirred for 48 hours room 
temperature. The solid was filtered from the mixture 
and the filtrate neutralised with a solution of 
saturated sodium bicarbonate and extracted with 
chloroform (3 x 150 ml)*, t.l.c. (system 1) of the 
extracts and the original solid indicated no new 
products and the reaction was discontinued.
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Reaction between (200) and lead tetraacetate.
The oxime (200) (2g) was added to a stirring mixture of 
lead tetraacetate (4.25g, 1.03 mol.equiv.) in glacial 
acetic acid (100 ml). The suspension was stirred at 
room temperature in a sealed flask and after 95 hours a 
dark brown mixture was apparent. After 336 hours the 
brown precipitate of lead salts was removed by 
filtration. Neutralisation of the filtrates with 
aqueous concentrated ammonia solution followed by 
further filtration afforded a second brown liquid. This 
liquid was extracted with ethyl acetate ( 6  x 1 0 0  ml), 
dried and concentrated in vacuo to give a brown solid 
(t.l.c. (system 1 ), 0.42) which rapidly decomposed on
standing, t.l.c. (system 1) R 0.42, 0.62, 0.82).
Reaction between (1) and selenium dioxide
Selenium dioxide (3g, 1 mol.equiv.) was added to a 
solution of deoxyvasicinone (1) (5g) in dioxan (100 ml) 
and allowed to stir at room temperature for 16 hours, t.l.c. 
(system 1) indicated no reaction had taken place. After 
a further 48 hours t.l.c. evidence showed no reaction 
and the mixture was carefully heated to reflux. Heating 
promoted a rapid darkening of the mixture through purple 
to black. After 30 minutes the mixture was cooled to 
room temperature, t.l.c. (system 1 ) evidence exposed 
extensive decomposition and the reaction was abandoned.
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Attempted oxidation of (1) with sodium chromate in acetic 
acid/anhydride.
Sodium chromate (210 mg, 0.4 mol.equiv.) was added 
portionwise to a stirring solution of deoxyvasicinone (1 ) 
(615mg) in 12.5 ml of a 3:2 mixture of acetic acid/ 
acetic anhydride at 0°. The mixture was allowed to rise 
to room temperature and after 72 hours a bright green 
colour was visible in the flask, t.l.c. (system 1 )
0.50. The reaction mixture was slowly added with 
stirring to a saturated solution of sodium bicarbonate. 
After 3 hoursthe aqueous solution was extracted with 
chloroform (2 x 150 ml). The organic extracts were 
combined, dried, decolourised and concentrated in vacuo 
to afford a yellow syrup (700 mg) which crystallised 
from ether/light petroleum. Subsequent 
recrystallisation from the same solvent system gave (1 ) 
(500 mg) identical in all aspects (m.p., m.m.p. , t.l.c. 
and i.r.) to an authentic sample.
Attempted oxidation of (160) with sodium chromate in acetic 
acid/anhydr ide .
To an ice cold stirring solution of the benzylidene 
derivative (160) (1g) in 50 ml of a 1:1 mixture of 
acetic acid/acetic anhydride was added portionwise
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chromium VI oxide (380 m.g, 1.05 mol.equiv.). The orange 
brown mixture was allowed to rise to room temperature 
and stirred for 18 hours. The now dark green solution 
was partitioned between water (30 ml) and 
dich1oromethane (2 x 150 ml). Analysis of the organic 
extracts (t.l.c. (system 3)) R^major 0.195, 0.00, R f  
minor 0.707, 0.780. The combined organic extracts were 
washed with a saturated solution of sodium bicarbonate 
(40 ml) and then with water (40 ml). Drying, 
decolourisat ion and concentration in vacuo of the 
extracts gave a white solid (780 mg) shown to be 
identical in all respects (m.p., m.m.p. , t.l.c., i.r., 
p.m.r.) to a sample of (160).
Reaction of (1) with ethyl bromopyruvate
Deoxyvasicinone (1) (500 mg) and ethyl bromopyruvate 
(520 mg, 1 mol.equiv.) were heated gently together for 5 
min. The black mass was cooled and t.l.c. (system 1) 
showed extensive decomposition had occured. No attempt 
was made to isolate compounds from the mass.
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Reaction of (1) with ethyl oxalyl chloride
Deoxyvasicinone (1)(1g) and ethyl chloroglyoxalate (5 ml) 
were heated together under reflux for 1 hour, t.l.c. 
(system 1) indicated one major component R^O.89 and that 
no deoxyvasicinone remained. The now black tar was 
cooled and excess reagent removed on the rotary 
evaporator. The concentrated tar was dissolved in 
toluene yet despite repeated chromatography followed by 
decolourisation the expected product could not be 
isolated due to its rapid decomposition (t.l.c. 
evidence).
Attempted condensation of (1) with methanesu1 phony 1 
chloride).
Deoxyvasicinone (1) (1g) and methanesu1 phony 1 chloride 
(680 mg, 1 mol.equiv.) were gently heated on a mantle 
at 100° for 1 hour. The cooled black solid obtained was 
treated with water (1 ml) and allowed to stand for 2 hours. 
The mixture was extracted with chloroform (100 ml) and 
the organic extract separated, washed with a saturated 
solution of sodium bicarbonate (2 ml) and finally dried. 
Concentration in vacuo of this dried solution gave 
deoxyvasicinone (1 ) as a yellow powder with identical 
physical properties (m.p., i.r., t.l.c.) to those 
described previously.
182
Reaction between (1) and phenacyl bromide.
Deoxyvasicinone (1) (2.15g) and 2-bromoacetophenone 
(2.3g, 1 mol.equiv.) were heated for 1 hour at 1 2 0 °. 
t.l.c. (system 1) R^major 0.73, 0.69, 0.58, 0.48 (on 
prolonged heating extensive decomposition ensued). 
Separation of the individual components from the 
reaction via column chromatography proved to be 
impossible.
Reaction between (1) and phenacyl bromide in pyridine
Deoxyvasicinone (1) (1g), phenacyl bromide (1.06g , 1 
mol.equiv.) and pyridine (15 ml) were heated gently 
under reflux for 20 minutes. A colourless solid 
precipitated from the refluxing solution. Ethyl acetate 
( 2 0  ml) was added to the cooled solution and the solid 
collected by filtration. The solid (800 mg) m.p. 275- 
277° gave a positive sodium fusion test for bromine and 
is thought to be an addition product formed between 
pyridine and phenacyl bromide.
183
Reaction between (1) and phenyl isocyanate
Deoxyvasicinone (1) (290 mg) and phenyl isocyanate (1ml) 
were heated gently under reflux for 30 minutes. The red 
brown liquid was analysed by t.l.c. (system 1). This 
showed extensive decomposition had occurred during the 
reaction. No attempt was made to resolve the mixture.
Reaction between (152) and phenyl isocyanate.
The compound (152) (1.0g) and phenyl isocyanate (620 mg,
1.05 mol.equiv.) were heated gently together under dry 
nitrogen for 24 hours. On cooling toluene was added to the 
flask and a crystalline deposit filtered off at the 
pump. The crude solid was washed with ether and dried 
to give N, N-diphenylurea m.p. 239-241° (reported m.p. 238- 
239°, Dictionary of Organic Compounds^0, t.l.c. (system
1) Rf 0.83, Vmax(KBr): 3030, 1645(C=0), 1595, 1550,
1 495, 1 455, 755, 700. <5 ( 60MHz , C D C13 / d 6 DMS0) : 6 . 8  - 
7.6(10H,m, 2 x Ph), 8.12(2H,s, 2 x N-H) t.l.c. analysis 
of the filtrates indicated (152) and diphenyl urea.
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Reaction between (1) and para-to1uenesu1 phony 1 azide and 
p i peri dine.
Deoxyvasicinone (1) (186mg) and para-toluene 
sulphonyl azide (196mg, 1 mol.equiv.) and piperidine 
(85mg, 1 mol.equiv.) were stirred at room temperature 
for 8 hours and heated at reflux for 6 8  hours. Analysis 
of the brown/black mixture by t.l.c. (system 1 ) showed 
the major component of the mixture to be starting 
material R^, 0.48; three minor components were also seen 
Rf 0.50, 0.66, 0.84 but no attempt was made to isolate 
the minor quantities of these products from the reaction 
mixture.
Attempted condensation of (1) with ethoxycarbony1 
i soth iocyanate.
Deoxyvasicinone (1) (186 mg) and ethoxycarbony 1 
isothiocyanate (130 mg,*1 mol.equiv.) were heated 
together under reflux in dry toluene (5ml) for 80 hours, 
t.l.c. (system 1 ) indicated no reaction and (1 ) (105mg) 
was extracted from the mixture.
1 8 5
(E)3-ethylidene-2,3 ,-dihydropyrrolo[2,1-blquinazolin- 
9(1H)-one (98) and (Z)3-ethy1idene-2,3-dihydropyrro1o[2,1 - 
blquinazolin-9(1H)-one (186).
A mixture of (1) (5g), triethylamine (0.5ml) and vinyl 
acetate (12ml) was heated at 150° for 18 hours in a 
sealed tube during which time the mixture darkened 
considerably. The cooled tube was opened, volatiles 
removed in vacuo and the residue chromatographed on 
silica gel (150g). Elution with system 9 gave (98) as a 
white solid. Recrystallisation from ethyl acetate/1ight 
petroleum gave pure (98) as fine white needles (350mg, 
6 %), m.p. 148-150° (dec); t.l.c. (system 1) Rf 0.80;
Vmax (KBr): 3050, 2960, 1675(C=0), 1600(C=N), 1470,
1390, 1380, 780, 700, 670cm ; Xmax (CHClg): 250 (£
27000), 307nm( £ 13000); 5(60 MHz, CDC 13): 2.38(3H,dt,J^H 
7.2Hz, Jflx2Hz,-CH2 >C=<^H^), 2.8 6 (2H,m,>N-CH2 -CH2 >C=<”n ), 
4.05(2H,t, Jab7.2Hz , >N-CH2 -CH2-) , 6 .10(1H,m;CH2>C = C<jJH ), 
7.10-7.70(3H,m, aromatic protons), 8.08(1H , d,J 7.2Hz, 
C-8 -H) , double irradiation at56.10 causes the signal at5 
2.38 to reduce to a triplet and the signal at 52.86 to 
simplify; m/e 212 [M+‘]; (Found; C, 73.3; H, 5.65; N,
13.0. C ^ H 1 2 N2 ° requires C, 73.6; H, 5.7; N, 13.2%).
Further elution with the same solvent gave (186) as fine 
needles. Recrystallisation from ethyl acetate/1ight 
petroleum gave pure (186) (570 mg, 10%), m.p. 169-170°; 
t.l.c. (system 1) Rf 0.75; 'Omax(KBr): 3050, 2900, 1665
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(C = 0), 1600(C = N) , 1470, 1390, 1340, 785, 700, 690cm"1;
Amax (CHC1 3), 246(^16000), 307nm(£12000), 6(60MHz, CDC1,) 
1.80(3H,dt,JAM7.2Hz, JA)(2Hz, "CH2>C=C<^H3 ),
2.70(2H, m, >N-CHq-CH2 >C = C < F j H 3  ) ,
4.04(2H,t,0AB7.2Hz, >N-CH 2-CH z ~ ), 6.50-7.10 (1H ,m ,-CH2>C = C<jjH3 ) , 
7.10-7.80(3H,m , aromatic protons), 8.10(1H,d,J 7.2Hz, C- 
8 -H), double irradiation of the signal at 61.80 causes 
the signal at 62.70 to simplify and the signal at 66.50 
- 7.10 to collapse to a singlet with a slight shoulder 
at 66.82; m/e 212[M+ *]; (Found: C, 73.6; H, 5.7; N,
13.2. C 1 3 H 1 2 N 0 requires C, 73.6; H, 5.7; N, 13.2%).
Attempted condensation of (1) with acrylonitrile.
Deoxyvasicinone (1) (5g) and acrylonitrile (5 ml) were 
heated at 150° - 156° for 18 hours in a sealed tube. 
Treatment of the contents of the cooled tube with 
acetone, followed by filtration gave a crystalline 
polymeric substance derived from acrylonitrile 
(spectroscopic evidence), ^ max(KBr): 2250(C=N)cm"^ ^  
(60MHz, CDClg): large unresolved peaks at 61.40-3.20.
The filtrate and washings were combined and on 
concentration afforded crude deoxyvasicinone (4.8g) 
identical in all respects (m.p., m.m.p., i.r.) to an 
authentic sample.
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3-Bromo-2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one
(85) and 3,3-dibromo-2,3-dihydropyrro1o[2,1-b] 
quinazo1in-9(1H)-one (84).
Deoxyvasicinone (1)(4.1g> and N-bromosuccinimide (3.92g, 1 
mol.equiv.) in carbon tetrachloride (25ml) were heated 
at reflux for 41 hours. The mixture was cooled and 
concentrated in vacuo to give a dark brown mass which 
was chromatographed on silica gel (100g). Elution with 
(system 6 ) gave the dibromo derivative (84) as colourless 
prisms (310mg, 4%). m.p. 189° (dec), (reported m.p., 189 
191°, Oripov^’^  t.l.c. (system 1) 0.84; ))max(KBr):
3100-2900, 1685(C=0), 1625(C=N), 1470, 1380, 1335, 1325, 
1280, 780, 700cm"1;5 (60MHz, CDC13 ): 3.26 (2H,t, J«B 6 Hz, 
>N-CH2 -CH2-) , 4.17(2H,t, JAB6 Hz, >N-CH2-CHp - ) , 7.14- 
7.94(3H,m, aromatic protons), 8.20(1H,d,J 7Hz, C-8 -H); 
m/e 185 (56%), 184 (100%), 183 (32%), all CM-160]+*
(Found: C, 38.85; H, 2.2; N, 8.0. ciiH8Br2N2° requires 
C, 38.4; H, 2.3; N, 8.1%).
Further elution using system 9 gave the monobromo 
derivative (85) (2.09g, 39%) also as colourless prisms m. 
146°- 147°; (reported m.p. 144°- 146°, Oripov^’^  t.l.c. 
(system 1 ) Rf 0.70; Slmax (KBr) : 3050-2900, 1685(C = 0 ),
1625, 1610(0=0, doublet), 1470, 1390, 1330, 1290, 1280, 
750, 740, 695, 690cm"1; 8 (60MHz, CDC1-): 2.24-3.00 
(2H,m, >N-CH2 -CH2 -CHBr-), 3.84-4.44(2H,m, >N-CH2 -CH„- ,
CHBr- ) , 5.18( 1H,dd , JAB 2Hz, JAB 5Hz ,N-CH2 -CH2 -CHBr), 7.16-
7.84(3H,m, aromatic protons), 8.14(1H,d,J 8 Hz, C-8 -H); 
m/e 185 (100%)[M-80]+*; (Found: C, 50.5; H, 3.4; N,
10.4. C-j1 HgBrN20 requires C, 49.8; H, 3.4; N, 10.6%).
3-Carbomethox.y methy 1th io- 2,3-dihydro pyrrolo[2t1- 
b]quinazolin-9(1H)-one (201).
The bromo compound (85) (300 mg) was added to a previously 
prepared solution of the methyl thiogylcolate anion 
(prepared in situ from tnethanolic sodium methoxide (Na 
(50mg) in methanol (20 ml)) and methyl thioglyco.l.ate 
(20 ml). A slight exotherm was recorded and the mixture 
was stirred at ambient temperature for 48 hours. The mixture 
was concentrated in vacuo and flooded with 
dich 1 oromethane. The precipitated sodium bromide was 
removed by filtration and concentration of the organic 
filtrates under reduced pressure afforded a yellow 
syrup. The syrup crystallised from ethyl acelate/1 ight 
petroleum to give colourless prisms of the thio ester, 
3-carbomethoxymethy1thio-2,3-dihydropyrrolo[2,1- 
b]quinazolin-9(1H)-one (85) (190mg, 58%), m.p. 92-93°; 
t.l.c. (system 1) Rf 0.84; Vmax(KBr): 2990-2900, 1745 
(C=0, ester), 1665(C=0, ring), 1625(C=N), 1470, 1380,
1330, 1320, 1 120(C-0, ester), 775, 695cm"1; 8 (90MHz , dg 
DMS0): 1.987-2.260( 1H,m, >N-C1£C<[j-CH-S-), 2.485 ( 1H,m, 
>N-CH2-C<-p}-CH-S-), 3.564(3H,S,-0C0-CH3), 3.754(2H,d,J 
7.9Hz, >CH-S-CH2-C02CH3), 4.081(2H,m,>N-CH2-CH2-) ,
4.530( 1 H,dd,J 7.5Hz,J 4.5Hz,-CH2 -CH-S-CH2-), 7.446- . 
7.870(3H,m, aromatic protons), 8.085-8.188(1H,m, C-8 -H); 
(Found: C, 57.9; H, 4.8 ; N, 9.8; S, 11.1. C 1 4 H 1 4 N 2 03S 
requires C, 57.9; H, 4.8; N, 9.65; S, 11.0%).
3-Hydroxymethylene-2,3-dihydropyrrolo[2,1-b]quinazolin- 
9 ( 1  H)-one (106).
POC13 (13.6g, 2.2 mol.equiv.) was added with vigorous 
stirring and cooling to ice cold DMF (6.96g, 2.4 mol. 
equiv.). A further 10ml of DMF was added prior to the 
portionwise delivery of (1) (7.44g) to the flask. The 
reaction mixture was stirred for 1 2  hours, heated for 2  
hours on a water bath and allowed to cool. The mixture 
was diluted with ice/water and neutralised with a 
saturated solution of sodium acetate. The cream 
precipitate was removed by filtration and redissolved in 
dich1oromethane. Deco 1 ourisation and concentration in 
vacuo gave the crude a-hydroxyformy1 idene compound (106) 
(7.1g, 83%). An analytical sample was isolated as 
yellow needles following chromatography on silica gel. 
The crude product was used in all subsequent reactions 
without further purification. (106) m.p. 200 - 203° 
(reported m.p. 205 - 206°, Shakh idoyatov t.l.c.
(system 1) Rf 0.55; 'Vmax (KBr): 3700-3200(OH, broad), 
3100-3050, 3000-2800, 1650(C=0), 1585(C=N), 1485, 1440, 
1390, 1380, 1300, 770, 700cm"1.
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Reduction of  (106) wi th sodium borohydr ide.
The hydroxyformy1idene derivative (106) (1.5g) in ethanol 
(150 ml) was heated for 48 hours in the presence of NaBH^ 
(3.25g). The syrup (1.2g) obtained following isolation 
using procedure (h) was analysed by t.l.c. (system 1 ) 
and showed 2 components R^ 0.63, 0.54. The syrup was 
purified by preparative thin layer chromatography (4 
plates) eluant system 17. Desorption of the least polar 
band using ethyl acetate afforded (150) (400 mg, 28%), 
identical in all respects (m.p., m.m.p., t.l.c., i.r., 
p.m.r.) to an authentic sample.
The polar band was desorbed in a similar fashion to 
yield (193) as a mixture of diastereoisomers (250 
mg, 18%) as lustrous silver flakes, m.p. 181°- 186°; 
t.l.c. (system 1) Rf 0.54 (fluorescent); ^max(KBr):
3260(N-H), 3020, 3000-2870, 1630(C = 0) , 1480, 1450,
1435, 1305, 790, 695, 650cm"1; 8 (90MHz,d,DMS0) :
1.02(1H,0ab7Hz , >CH-CH3), 1.147(2H,d,J 6 Hz,>CH-CH,),
1 .30-2.56( 3H,m,-CH2 >CJH-CH3) , 3.408-3.574 ( 2H ,m, ^ -CHp-CH^-) 
4.462(fH,d,J 7.4Hz, >N-CH-CH(CH3 ),(Trans)), 4.980(*H, 
d,J 4.8Hz, >N-CH-CH(CH3 ),(Cis)), 6.698-6.816(4H,m,C-5- 
H,C-6-H,C-7-H,N-H), 7.599(1H,m,C-8 -H). m/e 202 [M+‘]
(76%); (Found: C, 71.3; H, 7.1; N, 13.6. C 1 2 H 1 4 N20
requires C, 71.3; H, 6.95; N, 13.85%.)
191
Reduction of  (150) wi th sodium borohydr ide.
(150) (820 mg) in ethanol (100 ml) was heated at reflux 
with NaBH^ (500 mg, 3.2 mol.equiv.) for 8  hours t.l.c. 
(system 1) indicated a fluorescent component Rf 0.54. A 
white solid (780 mg) was obtained using procedure (h).
This was purified by preparative t.l.c. (3 plates) 
eluant system 17. Desorption with ethyl acetate of this 
fluorescent band gave silver needles of (193) (110 mg, 13%) 
which had identical R^  and i.r. characteristics to an 
authentic samp 1 e.
Reaction of (1) with potassium hydroxide and 
formaldehyde.
Potassium hydroxide (33 g, 27 mol.equiv.) and 
paraformaldehyde (78g, t13 mol.equiv.) were added 
portionwise over 8  hours to a solution of (1 ) (4g) in 
ethanol (180 ml). On cooling the suspension was 
neutralised with sodium bicarbonate and the ethanol 
removed on the rotary evaporator. The aqueous 
suspension was extracted with dich1oromethane (3 x 150 
ml), and the organic extracts dried. Concentration of 
these extracts under reduced pressure yielded an ochre 
syrup (4.5g). The original aqueous suspension was 
reduced in volume and extracted with dich1 oromethane ( 2  
x 100 ml). Drying and concentration of these extracts
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yielded a colourless crystalline material (700 mg) which 
was recrystallised from ethanol to give colourless 
needles of the diol, 2 ,3-dihydro-3,3-dihyroxymethy1 
pyrro1o[2,1-b]quinazo1in-9(1H)-one (196) (500 mg, 11%) 
m.p. 207.5-209° (dec), t.l.c. (system 1) 0.17;
^max(KBr): 3700-3200(OH, peaks at 3470 and 3290),
1670(C=0), 1620(C=N), 1470, 1395, 1345, 1040, 780, 700cm'1 
; Xmax(CHCl3): 245(£ 8500), 270(S 6200), 304(£ 3600),
316 nm(£ 3100); 5 (90MHz.dgDMSO): 2.319(2H,t ,JAB7.4Hz,>N- 
CH2 -CH2-), 3.624(2H, d, J 5.5Hz, -CH2 0H, 3.683(2H,d,J 
5.5Hz ,-CH2 0H), 3.993(2H,t,JAB7.7Hz, >N-CH2 -CH2-),
4.946(2H , t, J 5.5Hz, D2 O exchangeable, 2 x OH),, 7.426- 
7.9(3H,m, aromatic portons), 8.134(1H,m,C-8-H). On 
deuteration the hydroxyl protons signal 54.946 
disappeared as expected and the signals at 53.624 and5 
3.683 were simplified to 2 singlets; m/e 246 [M+*] (19%); 
(Found: C, 63.1; H, 5.8; N, 11.2. C13 H1 4 N2°3 re0uires 
C, 63.4; H, 5.7; N, 11.4%).
The ochre syrup was chromatographed on silica gel (100g) 
and elution with system 11 gave (1) (400 mg) identical 
in all respects to an authentic sample (m.p., m.m.p.,
i.r.). The earlier fractions from the column were 
combined and concentrated in vacuo. The colourless 
syrup (1 .8 g) was separated into its pure components via 
preparative t.l.c. ( 6  plates) using system 15 as eluant. 
Desorption of the least polar band with ethyl acetate
193
gave on concentration 2,3-dihydro-3-methylenepyrrolo 
[2,1-b]quinazo1in-9(1H)-one ( 194) (670 mg, 17%) as 
colourless needles identical in all respects (i.r., R^ , 
p.m.r.) to an authentic sample but with a sharper m.p.
1 4 4  _ 145°. Similar treatment of the second band gave a 
thick orange syrup (800 mg) which crystallised from 
ether as colourless needles of 3-ethoxymethyl-2,3- 
dihydro-3-hydroxymethylpyrrolo[2,1-b]quinazolin-9(1H)- 
one (197) (700 mg, 13%), m.p. 82-84°; t.l.c. (system 11)
Rf 0.57; Vmax (KBr); 3580, 3510(OH, doublet), 3000 - 
2850, 1675(C = 0) , 1615(C = N), 1560, 1470, 1390, 1380,
1 1 0 0 (C-0 ), 1060(C-0), 770, 695cm' ; Xmax(CHCl3): 245(£
6400), 270(£ 6200), 304{£ 3300), 311nm(£ 2900); §(60MHz, 
dgDMSO); 1.06(3H,t,JAB7Hz, -0-CH2 -CH3), 2.38(2H,t,J 
7.2Hz,>N-CH2 -CH2-), 3.10-5.80(9H,m, >N-CH2 -CH2 -C<§jl2;;^CH2_CH3), 
7 .10-7.70(3H,m, aromatic protons), 8.10(1H,d, J 
7.2Hz, C-8 -H) ; m/e 274 [M+‘] (8 %), 199 ( 100%); (Found:
C, 63.3; H, 6.7; N, 9.8. c 15H18N2°3 squires C,
63.6; H, 6.36; N, 9.9%).
2,3-Dihydropyrrolo[2,1-b]quinazolin-9(1H)-one-3-spiro- —  - -
1 -cyclohex-2 -en-4 -one (190).
The 3-hydroxymethylene compound (106) (1g), triethyl amine 
(0.5 ml) and methyl vinyl ketone (500mg, 1.5 mol.equiv.) 
were heated on a steam bath for 18 hours. The thick black 
syrup produced was chromatographed on silica gel (2 0 g)
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using system 13 as eluant. The crude pink orange syrup
(600 mg) thus obtained was further purified by
separation on 3 preparative t.l.c. plates. Desorption
with ethyl acetate and concentration under reduced
pressure produced an orange syrup which crystallised
from ethyl acetate/cyc1 ohexane as colourless prisms of
(190) (350 mg, 28%). m.p. 169°- 170° t.l.c. (system 1) Rf
0.73. ^max(KBr): 3150-2850, 1680, 1690, 1685, 1670
(multiple bands 2 x C=0), 1620, 1615, 1610(multiple
bands C=C and C=N), 1470, 1390, 1340, 1320, 1285, 790,
-1. ....... J .C705cm'1; 6  ( 90MHz , dgDMSO): 2.158-2.709 (6 H ,m ^ N-CH2 -C1^><^7^> 
3.925-4.311(2H,m, >N-CH2 -CH2-), 6.057(1H,d,J 10.07Hz
N = 0
H' ), 7.062( 1H,d,J 10.06Hz,
I> = 0
HH , --- ---------------- ^
7.41 6-7.909 (3H,m, aromatic protons), 8 .1 10-8.320( 1H,m,
C-8 -H) ; (Found: C, 70.9; H, 5.4; N, 10.0. C16H14N2°2
0.25 H20 requires C, 70.98; H, 5.4; N, 10.35%).
Organometa11ic Reactions of Deoxyvasicinone Analogues.
3,3-Dicarbethoxy-2,3-dihydropyrrolo[2,1-b] quinazolin- 
9(1 H)-one (168).
A solution of (1) (930mg) in dry tetrahydrofuran 
(20 ml) was added dropwise over 30 minutes to a solution 
of lithium diiosopropylamide (prepared by the addition 
of n-buty11ithium solution (6.75 ml, 1.6 mol. in hexane) 
to anhydrous diiosopropylamine (1 .0 2 g) in dry
= 0 ),
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tetrahydrofuran (10 ml) at -20°. Ethyl ch1oroformate 
(4.4g, 8  mol.equiv.) in dry tetrahydrofuran (10ml) was 
added slowly. The burgundy colour was rapidly 
discharged and the mixture became pale yellow and 
finally bottle green. The mixture was stirred at room 
temperature for 1 hour, solvents removed in vacuo and 
the residue partitioned between water ( 1 0 0  ml) and 
dichloromethane (3 x 100ml). The combined, dried 
organic extracts were concentrated in vacuo to yield a 
colourless syrup (168). The syrup was chromatographed 
on silica gel (20g). Elution with system 7 gave (168) 
as colourless plates, (460 mg, 28%), identical in all 
respects (m.p., m.m.p., i.r.) to an authentic sample.
3,3-Dicarbethoxy-2,3-dihydrO“1,1-dimethylpyrrolo[2,1 - 
b]quinazo1in-9(1H )-one (174).
( 152) (4.28g) was metallated according to procedure (i) 
(replacing (1) for (152)). Ethyl ch1oroformate (8 .6 8 g, 4 
mol.equiv.) in dry tetrahydrofuran ( 2 0  ml) was slowly 
added to the red solution. The mixture was stirred at 
room temperature for 1.5 hours, water (5ml) was added 
and after 1 hour the yellow solution was concentrated in 
vacuo to afford an orange syrup, t.l.c. analysis (system
2) indicated 2 major componenets, Rf 0.65, 0.72. The 
syrup was chromatographed on silica gel (1 2 0 g) and 
elution with system 6 gave an orange syrup which was
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crystallised using ether/light petroleum.
Recrystallisation of this solid using the same solvents 
afforded (174) as colourless prisms (3.00g, 58%), m.p.
91°, t.l.c. (system 2) 0.72; ^)max(KBr): 3080-2950;
1755, 1730, 1720(C=0, ester, multiple bands),
1 680(C = 0, ring), 1620, 16 10(C = N) , 1470, 1390, 1 370, 1355, 
1330, 1305, 1290, 1280, 1260, 1240(C-0, ester, multiple 
bands), 1020, 780, 700cm'1; 5 (60MHz, CDC13): 1.30(6H,t,JftB 
7Hz, 2 x -0C0-CH2 -CH3), 1.72(6H,s, >C(CH3)2), 
2.80(2H,s,>N-C(CH3)2-CH2-C<), 4.30(4H,q,JAB7Hz, 2 x - 
OCO-Ch^-CHg), 7.07-7.78(3H,m aromatic protons),
8.13(1H,d , J 7.2Hz, C-8 -H); m/e 358 [M+’l (51*); (Found:
C, 63.7; H, 6.2; N, 7.7. ^19^22N2^5 recluires C, 63.7;
H, 6.1; N, 7.8%).
Further elution with ethanol gave unreacted starting 
material (152) (1.21g), identical in all respects (m.p., 
m.m.p., i.r.) to an authentic sample. The yield of (174) is 
based on the recovery of this starting material.
Reaction of lithiated (1) with ethylbromopyruvate.
A solution of lithiated (1) was prepared from (1)
(1.8 6 g) using method (i). To the cold stirring solution 
was slowly added ethyl bromopyruvate (2.92g, 1.5 
mol.equiv.) in dry tetrahydrofuran (20 ml). After 1 
hour the solution was allowed to rise to room
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temperature, t.l.c. (system 1 ) of the resulting brown 
solution indicated extensive decomposition had taken 
place in the mixture and the experiment was abandoned.
Reaction of lithiated (1) with acetyl chloride.
A solution of lithiated (1) was prepared from (1)
(1.8 6 g) using method (i). Acetyl chloride (2g, 2.5 
mol.equiv.) in dry tetrahydrofuran (1 0 ml) was added 
dropwise to the cold stirring solution. The resultant 
orange solution was allowed to stir at room temperature 
for 1 hour t.l.c. (system 1 ) indicated a complex 
mixture the individual components of which could not be 
i so 1 ated.
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